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Modeling sepsis using neural nets and biomarkers of organ
dysfunction in patients, with links to animal models
J Schentag
1*, D Parish
2, S Opal
3
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2CPL Associates LLC, Buffalo, NY, USA;
3Brown University, Providence, RI, USA
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Background: Most clinical trials of sepsis treatment modalities fail at their
primary objective of establishing superiority over placebo when added to
background standard of care. While there is no definitive explanation for
the high failure rate, it might be stated that our attempts to insert a new
therapeutic agent into standard of care encounters severe problems with
definition of exactly what stage is ongoing, and what are the criteria for
progression or resolution from that time point onwards. Clearly there is
need for a means of defining steps in the septic process that would apply
to individuals, and to better define the course of sepsis in each patient
after they are enrolled in a trial.
Methods: For core model development, 30 septic patients were studied
for time-related progression in relation to biomarkers, employing a Load
Model in a neural net algorithm in MatLab. Causative bacterial infections
were linked to primary infection sites. In order to minimize over-
parameterization, the model was allowed to estimate outputs using the
best three input parameters. Bacterial load was tracked from origin using
clinical and microbiologic data to provide an estimate at the start of
sepsis. The bacterial load as well as clinical and laboratory parameters
were model inputs with the output parameter being organ failures and/
or mortality.
Results: At onset of sepsis, human bacterial load estimates ranged from
between 10
8 and 10
11 CFU, which is consistent with inocula in animal
models of sepsis. Sepsis proceeds to organ failures and mortality in a
series of steps that are initially linked to bacterial load and inflammatory
response, followed by coagulopathy, ischemia, oxygen deprivation in
organs and tissues, and culminating in organ failures. The later stages of
sepsis are all driven by metabolic parameters, and there seems to be
little benefit to blocking inflammation at later stages. Substrate and
oxygen deficiencies must be addressed first.
Conclusion: Neural net progression models based on biomarkers and
physiological markers are able to describe the evolution of sepsis to
septic shock, organ failures, and provide some evidence that mortality
may be a consequence of the stages of sepsis. Overall, these models
appear useful to the task of sorting out organ failure endpoints and
mechanisms in individual patients with sepsis progression across sepsis to
septic shock.
P2
Extracellular matrix turnover, angiogenesis and endothelial function
in acute lung injury: relationship to pulmonary dysfunction and
outcome
S Sayed
*, N Idriss, H Sayyed
Faculty of Medicine, Assuit University, Assuit, Egypt
E-mail: 1@bmc.com
Critical Care 2012, 16(Suppl 3):P2
Background: Acute lung injury (ALI) is a syndrome with a diagnostic
criteria based on hypoxemia and a classical radiological appearance, with
acute respiratory distress syndrome at the severe end of the disease. Facts
recommended the occurrence of rupture of the basement membranes and
interstitial matrix remodeling during ALI. Matrix metalloproteinases (MMPs)
participate in tissue remodeling related with pathological conditions such
as ALI. We hypothesized the interrelationships between extracellular matrix
(ECM) turnover as MMP-9 and indicator of angiogenesis such as
angiopoietin-2 (Ang-2) as well as plasma von Willebrand factor (vWF) and
their correlation with arterial partial pressure of oxygen (PaO2), oxygen
saturation (SaO2) and mortality in ALI/ARDS.
Methods: Eighty-eight mechanically ventilated patients (68 male, mean
(SD) age 61 (10) years) were compared with 40 healthy controls (36 male,
mean (SD) age 57 (10)). All biomarkers were measured by ELISA.
Oxygenation, body temperature, leucocytes, and platelet counts were
noted.
Results: Plasma levels of all biomarkers were significantly different
among ALI/ARDS subjects (P < 0.001) and they inversely related to PaO2
and SaO2 and positively related to mortality. Plasma levels of MMP-9
were negatively correlated with PaO2 and SaO2%i nA L I / A R D Sp a t i e n t s
(r =- 0 . 7 5 ,P < 0.0001 and r = -0.81, P < 0.0001) respectively. Plasma level
of Ang-2 was negatively correlated with PaO2 and SaO2%i nA L I / A R D S
patients (r = -0.68, P <0 . 0 0 0 1a n dr = -0.63, P < 0.0001) respectively.
Plasma levels of vWF were negatively correlated with PaO2 and SaO2%i n
ALI/ARDS patients (r = -0.76, P < 0.0001 and r = -0.69, P < 0.001)
respectively. Elevated plasma levels of all indices were interrelated at the
first day of admission.
Conclusion: The observed diversity in plasma levels of MMP-9, Ang-2 and
vWF in ALI/ARDS patients (Table 1) revealed the activity and severity of the
disease, shedding more light on the pathogenesis and/or presentation of
ARDS.
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Thalidomide modulates macrophage-mediated inflammatory innate
immune response during Klebsiella pneumoniae B5055 infection in
BALB/c mice
V Kumar
*, S Chhibber
Panjab University, Chandigarh, India
Critical Care 2012, 16(Suppl 3):P3
Background: Lung innate immune response plays an important role in the
clearance of pathogens (that is, bacteria, virus or fungi) from lungs.
However, profound activation of innate immune cells (alveolar
macrophages or neutrophils) can lead to development of acute lung
inflammation or injury observed during pneumonia, acute respiratory
distress syndrome (ARDS), or sepsis by producing various proinflammatory
cytokines (that is, IL-1a,T N F a) and molecules (that is, hydrogen peroxide
(H2O2)). Thalidomide is a drug, which has its own place in the history of
medicine and has been used in various types of cancers and other chronic
inflammatory disorders (erythema nodosum leprosum) but its mode of
action as an immunomodulatory drug in acute infections (that is,
pneumonia and sepsis) is not clear. Thus, the present study was designed
to investigate its effect on pulmonary innate immune response during
acute lung infection in BALB/c mice.
Methods: Animals were divided into four groups (n = 20 for each group).
Acute lung inflammation was induced by intranasal instillation of Klebsiella
pneumoniae B5055 into mice without any anesthesia and treated with
thalidomide (30 mg/kg/day/p.o.) or normal saline orally using a treatment
schedule shown to modulate proinflammatory innate immune response.
Various proinflammatory (IL-1a, TNFa) as well as anti-inflammatory (that is,
IL-10) cytokines were estimated by ELISA. Pulmonary macrophage-
mediated phagocytosis and bactericidal assays were performed. Alveolar
macrophages were evaluated in terms of macrophage spreading ability
assay. H2O2 production by macrophages was assessed according to the
method based on the process of horseradish peroxidase-dependent
oxidation of phenol red assay. Neutrophil infiltration to the lungs was
determined by histopathological analysis.
Results: Thalidomide treatment modulated proinflammatory function of
alveolar macrophages by significantly decreasing their phagocytic potential
in terms of phagocytic uptake and intracellular killing, spreading and H2O2
release. Besides that, thalidomide treatment also significantly decreased
neutrophil infiltration into the lung alveoli. Remarkably, the levels of
proinflammatory cytokines (IL-1a and TNFa) were found to be decreased
significantly in the thalidomide-treated group but the levels of IL-10 were
found to be significantly elevated.
Conclusion: Thalidomide proved a promising immunomodulatory agent
with a potential to modulate aggravated innate immune response observed
during acute lung inflammation associated with pneumonia or sepsis
caused by Gram-negative bacterial infection.
P4
Immunoglobulin therapy of abdominal sepsis in
emergency surgery
O Butyrsky
*, V Starosek
Crimean Medical University, Simferopol, Ukraine
Critical Care 2012, 16(Suppl 3):P4
Background: The literature data demonstrate that the initial stage of
abdominal sepsis (AS) is characterized with typical immune shifts as white
blood cell (WBC) activation, decrease of T-lymphocyte and B-lymphocyte
function followed by dysimmunoglobulinemia. As AS progresses immunity
deficiency acquires severe combined character. Impact of immunity
deficiency on a course is not described.
Methods: We investigated 33 patients (male:female = 25:8) with
abdominal sepsis (total peritonitis following appendicitis, perforated
duodenal ulcer, pancreonecrosis). Anti-endotoxin (AE) antibodies (anti-
LPS-IgA, anti-LPS-IgM, anti-LPS-IgG) were determined by original
modification of hard-phase immunoenzyme analysis. Escherichia coli K30
LPS was used as antigen for AE antibody detection. All data were
compared with healthy donors (99 patients). As a method of immunity
correction we selected Sandoglobulin (Novartis, Switzerland), introduced
as 3 ml once intravenously.
Results: According to results of immunity parameter investigation on the
day of admission we shared all patients into two groups: with high initial
immunity (n = 6, no evidence from normal parameters) and low initial
immunity (n = 27, evident decrease of AE immunity parameters). All patients
needed comprehensive medication support. The patients with high
immunity did not need any immunotherapy. But the patients with low initial
immunity required immune therapy to avoid severe course of peritonitis and
unfavorable outcomes. Single introduction of Sandoglobulin on the fifth day
after surgery was accompanied with increase of immunity indices (Table 1).
Simultaneously with an increase of anti-LPS-immunoglobulin titer one
noticed sharp positive clinical changes (improvement of patients’ self-feeling,
body temperature decrease, decrease/normalization of WBC number,
neutrophil shift). We have the following data about routine laboratory
parameters in abdominal sepsis patients with Sandoglobulin introduction:
WBC, ×10
9/ l ,1 6 . 5±0 . 9b e f o r ei n t r o d u c i n ga n d9 . 8±1 . 2i n2d a y sa f t e r
introducing; stab neutrophils, %, 18.3 ± 1.6 and 10.8 ± 1.4 appropriately;
juvenile neutrophils, %, 4.1 ± 0.8 and 0.3 ± 0.1 appropriately (all changes
are evidently proved, P < 0.001). Successful surgical treatment and
immunotherapy of abdominal sepsis are accompanied by activation of AE
immunity, all-class anti-LPS-immunoglobulin concentration growth that
blocks mechanisms of further inflammation progress and result in rapid
patients’ recovery.
Conclusion: Peritonitis patients with initial low immunity need passive
nonspecific immunotherapy that stimulates organism protective functions
and promotes rapid recovery.
Table 1(abstract P2) Plasma levels of all biomarkers in cohort study on admission (first day of admission)
Mean (SD) Healthy controls (n = 40) ALI/ARDS patients (n = 88) P value
MMP-9 (ng/ml)
a90.23 (17.94) 582.00 (87.36) < 0.001
Ang-2 (ng/ml)
a12.48 (3.26) 297.30 (52.51) < 0.001
vWF (U/ml)
a124.50 (38.69) 367.40 (64.39) < 0.001
Data presented as mean (SD). MMP-9, matrix metalloproteinase-9; Ang-2, angiopiotein-2; vWF, von Willebrand factor. P value by Mann-Witney test. ALI/ARDS
patients were significantly different compared with healthy controls.
aP < 0.001.
Table 1(abstract P4) Dynamics of AE antibodies in abdominal sepsis patients with Sandoglobulin introduction
Patients with low immunity level (n = 27)
Before introduction (optic units) 2 days after introduction (optic units)
Anti-LPS-IgA 0.154 ± 0.015 0.342 ± 0.02*
Anti-LPS-IgM 0.213 ± 0.01 0.284 ± 0.02*
Anti-LPS-IgG 0.083 ± 0.007 0.186 ± 0.04*
*P < 0.001.
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Procalcitonin level as a marker of severe sepsis and septic shock
patients who required polymyxin-B immobilized fiber with
direct hemoperfusion
T Ikeda
*, K Ikeda, S Suda
Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
Critical Care 2012, 16(Suppl 3):P5
Background: When septic patients progress to endotoxin shock, the
mortality rate becomes high and is within 30 to 80% in those with
multiple organ failure.
Methods: We evaluated the levels of procalcitonin (PCT) and markers of
sepsis (IL-6, IL-8, IL-1ra and PAI-1) in 159 patients who had severe sepsis
and septic shock. Before starting the polymyxin-B immobilized fiber with
direct hemoperfusion (PMX-DHP) treatment, patients were divided into
three groups according to their PCT levels (L group: 0.5 < PCT ≦ 2.0 ng/ml,
M group: 2.0 < PCT ≦ 10.0 g/ml, H group: PCT > 10.0 ng/ml).
Results: Sixty-two percent of the patients showed high PCT levels
(>10.0 ng/ml). The APACHE II score and Sequential Organ Failure
Assessment score tended to be high in the H group, but there was
no significant difference among the groups. The survival rate declined with
high PCT levels. The levels of inflammatory (IL-6 and IL-8) and anti-
inflammatory (IL-1ra) cytokines tended to be high in the H group, but
there was no statistically significant difference among the groups. On
the other hand, the PAI-1 level was significantly increased in the H group
(498 ± 499 ng/ml) compared with the L group (157 ± 103 ng/ml) and
M group (311 ± 319 ng/ml).
Conclusion: Sixty-two per cent of patients who required PMX-DHP
treatment had high PCT levels. PCT might be a mediator of sepsis and
sepsis markers. PCT can potentially affect sepsis-related markers.
P6
Diagnostic accuracy of procalcitonin in proven and clinically suspected
systemic infection
S Das
*, D Anand, S Ray, S Bhargava, A Manocha, M Kankra, LM Srivastava
Sir Ganga Ram Hospital, New Delhi, India
Critical Care 2012, 16(Suppl 3):P6
Background: Sepsis is a common cause of morbidity and mortality in
critically ill patients. Microbiological culture is the gold standard for
diagnosis of sepsis but unfortunately culture results are positive in only
30 to 50% patients. Sepsis is also difficult to distinguish from systemic
inflammatory response syndrome (SIRS) because of similar clinical
presentations. Procalcitonin (PCT) and IL-6 are known biochemical
markers for diagnosis and prognosis of sepsis. The aim of this study was
to evaluate the diagnostic role of PCT and IL-6 in differentiating sepsis
(both culture positive and culture negative) from SIRS.
Methods: The study comprised three patient groups, age >18 years:
group 1 (n = 41), proven infection; group 2 (n = 29), clinically suspected
infection but negative culture; group 3 (n = 29), patients with SIRS. Blood
was collected at the time of admission for microbiological culture and
estimation of PCT (TRACE, Kryptor) and IL-6 (CLIA, Access).
Results: The median PCT level was significantly higher (P < 0.001) in both
groups 1 and 2 as compared with group 3, whereas the median IL-6 level
was significantly high (P < 0.001) only in group 1 as compared with
group 3. Receiver operating characteristic (ROC) curve analysis between
groups 1 and 3 for prediction of systemic infection demonstrates that
both PCT and IL-6 have a significant area under the curve (AUC) of 0.923
(P < 0.001) and 0.824 (P < 0.001) respectively. The best cutoff point of
PCT was at 1.48 ng/ml with 85% sensitivity, 83% specificity, 88% positive
predictive value (PPV) and 80% negative predictive value (NPV). However,
the best cutoff point for IL-6 was very high at 219 pg/ml, with 78%
sensitivity, 76% specificity, 82% PPV and 71% NPV. Similarly, ROC curve
analysis between groups 2 and 3 demonstrates that PCT has a significant
AUC of 0.848 (P = 0.001), whereas the AUC of IL-6 is 0.555, which is not
significant (P = 0.47). The best cutoff point for PCT was at 1.45 ng/ml
with 83% sensitivity, 79% specificity, 80% PPV and 82% NPV, whereas the
best cutoff point of IL-6 was 98.25 pg/ml, with only 59% sensitivity, 55%
specificity, 57% PPV and 57% NPV.
Conclusion: In differentiating SIRS from sepsis, IL-6 does not have a
diagnostic role in culture negative sepsis patients, whereas PCT showed a
better accuracy in differentiating SIRS from both proven and suspected
sepsis. Hence, inclusion of PCT in the initial diagnostic strategy may aid in
early and appropriate therapeutic intervention in culture-negative sepsis
patients.
P7
Evaluation of a soluble CD14 subtype in patients with surgical sepsis
Y Fukui
Kochi Health Sciences Center, Kochi, Japan
Critical Care 2012, 16(Suppl 3):P7
Background: Surgical sepsis remains a cause of poor outcome. In order to
treat surgical sepsis appropriately, it is important to reach diagnosis of
sepsis early during the course and start antibiotic treatment. The gold
standard of sepsis diagnosis is blood culture but there are issues with its
sensitivity along with contamination. Soluble CD14 subtype (sCD14st) is an
N-terminal fragment of CD14, and signal messenger of lipopolysaccharide
(LPS). sCD14st is reported to increase in sepsis patients. In this study, we
evaluated the specificity, clinical effectiveness of soluble sCD14st in
patients with surgical sepsis.
Methods: The study population was 18 operated patients in Kochi Health
Sciences Center between April 2010 and March 2011. We investigated
sCD14st using the compact automated enzyme immunoanalyzer PATHFAST
(Mitsubishi Chemical Medience Co., Japan) and other biomarkers
(procalcitonin (PCT), CRP, IL-6) at surgery (day 0) followed by 1, 3, 5, 7 days.
APACHE II and Sequential Organ Failure Assessment (SOFA) were used to
assess the sepsis severity. Sepsis was diagnosed according to the American
College of Chest Physicians/Society of Critical Care Medicine (ACCP/SCCM)
criteria.
Results: There were nine patients with acute abdomen, esophageal cancer
in five patients, cerebral bleeding in two patients, and a patient with
Fournier’s gangrene and trauma, respectively. The area under the curves
(AUC) of receiver operating characteristic (ROC) curve analysis for septic
infection were 0.92 for sCD14st, 0.82 for PCT, 074 for IL-6, and 0.82 for CRP.
Two esophageal cancer patients who indicated over 800pg/ml in sCD14st
had complicated nosocomial pneumonia. sCD14st also positively correlated
with SOFA sore (r = 0.41) and APACHE II score (r = 0.28).
Conclusion: sCD14st was a useful biomarker for the diagnosis of surgical
sepsis and reflected clinical severity after operation.
P8
Advance directives and end-of-life decision-making in the ICU:
results from an observational study
CS Hartog
1,2*, I Peschel
1, D Schwarzkopf
2, B Kabisch
1, A Günther
1, R Pfeifer
1,
H Skupin
1,2, K Reinhart
1,2, N Riedemann
1
1University Hospital Jena, Friedrich-Schiller University, Jena, Germany;
2Center for Sepsis Control and Care, Integrated Research and Treatment
Center, University Hospital Jena, Jena, Germany
Critical Care 2012, 16(Suppl 3):P8
Background: Advance directives (AD) are intended to ensure patient
autonomy in the event of loss of decision-making capacity. According to
German law, ADs are now legally binding. It is unclear whether they are
helpful in the ICU [1]. The aim of this study is to compare ICU treatment
with patients’ written wishes.
Methods: The setting was surgical, neurological and cardiological ICUs of
one German university hospital with a total of 72 beds. All patients with AD
who died on the ICU between December 2010 and December 2011 were
included. ADs were collected from patients’ files, and their exact
specifications, wishes and preferences were extracted and tabulated. Patient
demographics and medical treatment was extracted from an Electronic
Patient Data Management System. The time period was 48 hours preceding
death. AD were defined as applicable if they described the potentially
applicable clinical situation as ‘final stage of a fatal disease’ or ‘inevitable
immediate dying process’. In contrast, AD were defined as not applicable if
they described other situations, including ‘mental deterioration’, ‘breakdown
of vital organs’ or ‘(in)direct brain damage’.
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Page 3 of 58Results: Sixty-four ICU patients were included. AD were written a median
109 weeks (IQR 26.95, 261.11 weeks) before the ICU stay. Forty-four AD
were applicable according to the definition. Of 44 patients with applicable
ADs, 50% were surgical patients, 41% patients had severe sepsis. Within
48 hours prior to death, 27% received a DNR/I (do-not-resuscitate/intubate)
order or DND (do-not-dialyze) order. Eighteen per cent received a decision
to withhold, 43% a decision to withdraw therapy. Twenty-two patients
(50%) refused intensive care, 98% (43/44) specifically refused life-sustaining
measures and, in addition, many specifically named measures to be
avoided. Patients who refused life-sustaining measures received the
following treatments: within 48 hours prior to death, 12% received CPR
and 23% underwent surgery. Within 24 hours, 77% were mechanically
ventilated and on vasopressors. At the time of death, 72% were intubated,
74% with FiO2 >21%, 30% on vasopressors. Of these 43 patients, 21 were
surgical and 22 nonsurgical patients. Fourteen out of 43 applicable AD
were pre-printed forms, 29 were written individually. No trend was
noticeable regarding compliance with single patients’ wishes in these
subgroups.
Conclusion: AD do not seem to direct end-of-life care in the ICU. Our
findings strengthen concerns that AD in their current form may not be
suitable for this patient population. Moreover, inability to comply with
patients’ wishes may add to the emotional burden of ICU staff.
Reference
1. Tillyard AR: Ethics review: ‘Living wills’ and intensive care - an overview
of the American experience. Crit Care 2007, 11:219-224.
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Background: Streptococcus pneumoniae is a major cause of pneumonia and
meningitis. Several genetic polymorphisms have been described to explain
differences in susceptibility and severity of encapsulated pathogen-related
diseases. Among them, a functional FCGR2A polymorphism leading to amino
acid change of histidine (H) to arginine (R) at position 131 appears to be a
major candidate in adult invasive pneumococcal diseases (IPD). However,
previous reports needed confirmation in a large well-defined population.
Methods: A prospective genetic association study in a 24-bed medical ICU
of a tertiary teaching hospital over 7 years. Patients were retrospectively
selected from two prospective cohorts generated between January 2001 and
December 2008. All Caucasian subjects with proven IPD and hospitalized in
the ICU were included. Cases of IPD were defined by the isolation of
S. pneumoniae from a normally sterile site (blood, bronchoalveolar lavage,
quantitative tracheal aspiration, cerebrospinal fluid (CSF)). DNA from all
Caucasian patients with IPD (pneumonia and/or meningitis) was genotyped
for the FcgRIIa-R/H131polymorphism.
Results: Two hundred and forty-three patients with proven IPD were
enrolled, 202 (82%) with pneumonia and 55 (22%) with meningitis. Mean age
was 61 years, mean SAPS2 was 50.4, one-half of the patients had bacteremia,
84% of the cohort was mechanically ventilated and the hospital mortality
rate was 31%. In the IPD group, distribution of the FcgRIIa-R/H131 genotypes
(H/H: 25%; H/R: 53%; RR: 22%) was comparable with the distribution in the
Caucasian control group. Comparison of the FcgRIIa-R/R131 and the (FcgRIIa-
R/H131 + FcgRIIa-H/H131) groups did not demonstrate any difference for age,
SAPS2, origin of sepsis and other co-morbid conditions. However, the variant
FcgRIIa-R/R131 genotype was independently associated with decreased
hospital mortality (OR = 0.251, CI 0.098 to 0.645; P = 0.004). See Figure 1.
Conclusion: In a well-defined population of IPD patients, the frequency
of the variant FcgRIIa-R131 does not differ from other critically ill patients.
However, the FcgRIIa-R/R131 genotype was independently associated with
increased survival regardless of the site of infection.
P10
Examination of blood filtration membrane removal ability of HMGB1
H Imahase
*, Y Sakamoto, M Kusunose, H Koami, Y Nishimura, A Goto,
T Yamashita, A Nakashima, T Iwamura, N Kutsukata
Saga University, Saga City, Japan
Critical Care 2012, 16(Suppl 3):P10
Background: When the invasion of sepsis or trauma is applied to the
organism, systemic inflammation occurs. In the cascade from invasion to
inflammation, as one of the chemical mediators of systemic inflammation,
the relationship of HMGB1 to the onset of AKI and ARDS has been
pointed out. In this study we investigated the ability to remove HMGB1
by the hemofiltration membrane in vitro.
Methods: We dissolved HMGB1 in bovine serum, using a blood filtration
membrane filter made of two types of membrane: heparin graft AN69ST
(oXiris) and a membrane filter made of polyarylether sulfone (HF set).
Filtration experiments were performed in vitro. The HMGB1 concentrations
of the serum of inlet and outlet of the filter and of the filtrate were
measured over time up to 120 minutes. Using an electron microscope,
HMGB1 adsorption on the membrane was taken.
Results: The HMGB1 concentration (ng/ml) immediately after and
15 minutes after the start was oXiris: 15.4 ± 1.9 and 8.6 ± 1.2, HF set:
16.0 ± 0.8 and 16.5 ± 1.1 (mean ± SD). The concentration was significantly
decreased in 15 minutes immediately after the start of the oXiris set.
The blood clearance (ml/minute) immediately after the start was oXiris:
44.6 ± 2.51, HF set: 7.77 ± 2.35. The filtrate clearance was oXiris: 0.13 ± 0.23,
HF set: 0.43 ± 0.21. In the electron microscope, HMGB1 was adsorbed on the
membrane.
Conclusion: oXiris removed HMGB1 in a short time; its mechanism has
been shown to be adsorption. HMGB1 can be removed from the blood,
and there is a possibility to control the excessive inflammatory response
during severe invasion to an organism in vivo.
P11
Decreased expression of HLA-DR antigen-associated invariant chain
mRNA predicts mortality after septic shock
M-A Cazalis
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1,3,
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Critical Care 2012, 16(Suppl 3):P11
Background: Septic syndromes remain the leading cause of mortality in
ICUs. Patients rapidly develop immune dysfunctions of which intensity and
duration have been linked with increased risk of secondary ICU-acquired
infections and death. A decreased expression on circulating monocytes of
human leukocyte-antigen DR (mHLA-DR) measured by flow cytometry has
been shown to be a good marker of sepsis-induced immune dysfunctions
[1] and to correlate with increased risk of death and ICU-acquired
Figure 1(abstract P9) Kaplan-Meier anlaysis of the probability of
survival according to FcgRIIa polymorphism.
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Page 4 of 58infections [2,3]. However, pre-analytical and analytical issues inherent to
mHLA-DR measurement by flow cytometry limit the use of this marker in
large multicentric clinical studies and on a routine basis. We investigated
whether the whole blood mRNA expression of genes related to major
histocompatibility class II (MHC class II) antigens could correlate with
mHLA-DR protein expression measured by flow cytometry and predict
mortality in septic shock patients.
Methods: Ninety-three septic shock patients were included. PAXgene®
tubes were collected at days 3 to 4 after the onset of shock. The mRNA
expression of five MHC class II-related genes (that is, CD74, HLA-DRA,
HLA-DMB, HLA-DMA and CIITA) was measured by qRT-PCR. In parallel,
ethylene diamine tetraacetic acid-anticoagulated blood samples were
collected to measure mHLA-DR expression by flow cytometry.
Results: A significant correlation (r > 0.8) was found between the mRNA
expression of MHC class II related genes. As observed for mHLA-DR, the
mRNA levels were significantly decreased in nonsurvivors as compared
with survivors. The best predictive value was obtained for the invariant
chain (CD74) mRNA level (P = 0.003). This was confirmed by the receiver
operating characteristic curve analysis (AUC = 0.7, 95% CI = 0.574 to
0.822; P = 0.003). Importantly, this remained significant after multivariate
analysis including usual confounders (severity scores) and mHLA-DR
values (P = 0.016). Survival curves showed that the decreased CD74
mRNA level was associated with increased mortality after septic shock
(Figure 1).
Conclusion: Decreased invariant chain mRNA expression significantly
predicts 28-day mortality in septic shock patients. After validation in a
larger multicentric study, this biomarker could become a robust predictor
of mortality in septic patients. This is all the more because the availability
in routine laboratories of molecular biology platforms will enable
standardized and routine use of such biomarkers.
References
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Background: In 2008, Kaiser Permanente Northern California (KPNC),
which provides care to 3.3 million members in 21 hospitals, implemented
an initiative to improve sepsis care, a critical step to reduce hospital
mortality. The goals of the program were threefold: improve identification
of sepsis patients, appropriately stratify risk, and reliably provide treatment,
focusing on spread and sustainability across all medical centers.
Methods: In spring 2008, all hospitals reviewed the last 50 deaths and
sepsis was identified as a significant improvement opportunity. In May
2008, two hospitals began rapid cycle pilot testing, resulting in the
development of a playbook containing treatment algorithms, standardized
order sets and flow charts, and chart abstraction tools. These tools, along
with expectations for implementation, were shared with leaders and
champions from all 21 hospitals at the November 2008 Sepsis Summit. The
summit closed with a young mother sharing the story of how her life was
saved as a result of the work at the pilot hospital. Subsequently, all hospitals
convened multidisciplinary sepsis teams and began training and tool
adoption, focusing immediately on improving sepsis identification. Regional
mentors and medical center improvement advisors supported team-building
and rapid implementation; timely and actionable data allowed ongoing
identification of improvement opportunities. Identification and performance
monitoring were supported by the development of a web-based tool that
pulled information directly from the electronic medical record.
Results: The number of sepsis diagnoses per 1,000 admissions increased
from a baseline of 35.7 (March 2008) to 98.3 (December 2010). For septic
shock patients, bundle performance increased from 7.3% (Q3 2009) to
55.1% (December 2010), and EGDT population mortality decreased from
29.7% (July to August 2009) to 20.2% (Q4 2010). Overall sepsis mortality
decreased from a baseline of 24.6% (March 2008) to 11.5% (December
2010); mortality rates continued to drop to below 9% in May 2012. This was
associated with a 14% overall drop in raw hospital mortality. Subsequent
performance improvement programs encompass care of the intermediate
lactate population, pediatric patients and surgical patients. See Figure 1 and
Table 1.
Conclusion: The KPNC program is unique in its rapid rate of impro-
vement in sepsis measures, adoption of a single standard of care across
an entire 21-hospital system, sustainability well beyond the rapid
adoption period, and the quantification of mortality risk beyond the
shock population to the intermediate sepsis population. These results
demonstrate that a strong performance improvement engine can drive
large-scale, sustained improvements in care within a short duration.
P13
Dynamics of lymphocyte subpopulations during Legionnaires’ disease
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Background: Absolute lymphocytopenia (lymphocyte count <1.0 × 10
9/l)
is recognized as an important hallmark of the immune response to
severe infection and observed in patients with Legionnaires’ disease (LD).
Furthermore, LD is characterized by accumulation of activated T cells in
the lungs. To explore the immune response in patients with LD, we
studied the dynamics of peripheral blood lymphocyte subpopulations in
the acute and subacute phase of the disease.
Methods: EDTA-anticoagulated blood was obtained from eight LD patients
on the day the diagnosis was made (acute phase) through detection of
Legionella pneumophila serogroup 1 antigen in urine. A second blood
Figure 1(abstract P11) Kaplan-Meier analysis of septic shock
patients’ 28-day survival after stratification on CD74 mRNA
expression. The threshold was chosen based on the Youden index
calculated on the receiver operating characteristic curve. There is a
significant difference between the two curves (log-rank test, P < 0.001;
hazard ratio = 7.065, 95% CI = 2.56 to 19.48).
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Page 5 of 58Figure 1(abstract P12) Sepsis EGDT mortality rate compared with overall bundle compliance. Kaiser Permanente Northern California Hospitals.
As bundle performance passed 30%, a sharp decline in mortality was observed for septic shock patients who qualify for EGDT.
Table 1(abstract P12) Key results of the KPNC sepsis mortality reduction initiative (aggregate data for all 21 hospitals)
Measure Baseline Rapid adoption
(December 2010)
a
Sustainability
(May 2012)
a
Sepsis diagnoses per 1,000 admits 35.7 (2006 to early 2008) 98.3 137.9
Admitted patients with blood cultures in ED
have lactate test in ED
27% (early 2008) 96.5% 95.6%
ABX w/in 60 minutes of dx of shock 69.5% (Q3 2009) 90.4% 91.8%
CL w/in 2 hours of dx (first CVP of ScvO2 in
2 hours)
41.5% (Q3 2009) 78.6% 89.6%
Mean BP (MAP) at target 52% (Q3 2009) 90.4% 93.8%
CVP at target 41.5% (Q3 2009) 83.8% 92.8%
ScvO2 at target 30.8% (Q3 2009) 74.3% 81.4%
Lactate lower within 6 hours for EGDT 52% (Q3 2009) 91.2% 95.9%
EGDT bundle 7.3% (Q3 2009) 55.1% 70.1%
Sepsis raw mortality 24.6% (2006 to early 2008) 11.5% 8.7%
Sepsis observed/expected (O/E) mortality 1.07 (rolling year ending Q1 2008) 0.82 0.56
Sepsis O/E LOS 1.07 (rolling year ending Q1 2008) 0.89 0.75
EGDT population mortality (only patients
with refractory shock or lactate ≥4)
29.7% (239 cases, July to
August 2009)
20.2% (391 cases, Q4
2010)
18.6% (323 cases, March-May
2012)
Raw all cause adult non-OB KPNC hospital
mortality
3.63% (2006 to 2007) 3.11% (2010) 3.07% (year ending Q2 2012)
HSMR-Medicate only 0.92 (rolling year ending Q2 2008) 0.60 (YE 2010) 0.52 (YE 2011)
Balancing measures: EGDT associated harm July to December 2009 July to December 2010 December 2011 to May 2012
BSI 0 0 0
Retained guidewires 3 0 0
Pneumothorax 1 2 4
aRapid adoption and sustainability data reflect December 2010 and May 2012, respectively, unless otherwise noted.
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Page 6 of 58sample was obtained in the subacute phase. Multiparametric flow cytometry
was used to calculate absolute lymphocyte counts and B-cell, T-cell, NK-cell,
CD4
+ and CD8
+ T-cell counts. Expression of activation markers was analyzed
on CD4
+ and CD8
+ T cells. C-reactive protein (CRP) levels were used to
monitor treatment response.
Results: The absolute lymphocyte count (×10
9/l, mean ± SD) significantly
increased from 0.8 ± 0.4 to 1.7 ± 0.9 in the subacute phase. B-cell counts
showed no significant change, while the T-cell count (×10
6/l) significantly
increased in the subacute phase (481 ± 283 vs. 1,290 ± 738) as a result of
significant increases in both CD4
+ and CD8
+ T-cell counts (345 ± 168 vs.
898 ± 390 and 124 ± 104 vs. 333 ± 265). In the CD4
+ and CD8
+ T-cell
populations, significant increases were observed in the subacute phase in
absolute counts of activated CD38
+ HLA-DRA
+ cells (11 ± 7 vs. 81 ± 60 and
14 ± 13 vs. 68 ± 51) and CD45RA
- m e m o r yc e l l s( 1 4 1±6 8v s .4 7 8±1 8 5
and 28 ± 21 vs. 111 ± 44). Figure 1 shows the relative expansion (relative
decrease/increase of a lymphocyte subset related to the relative increase
of the absolute lymphocyte count) of the different lymphocyte subsets.
The CRP level (mg/l) decreased from 359 ± 72 to 33 ± 17 in the subacute
phase.
Conclusion: T h ea c u t ep h a s eo fL Di sc h a r a c t e r i z e db ya b s o l u t e
lymphocytopenia which recovers in the subacute phase with an increase
in absolute T-cell count and emergence of activated and memory-type
CD4
+ and CD8
+ T cells. This confirms a role for T-cell activation in the
immune response to LD.
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Background: The receptor for advanced glycation endproducts (RAGE/
AGER) plays a key role in infections by sustaining tissue-damaging
inflammation. This multiligand/multisignal pattern recognition receptor,
overexpressed in lung and on innate immune cells, was shown to
contribute to the pathogenesis of pneumococcal pneumonia and thus
may be an attractive therapeutic target to treat severe pneumonia, one
of the most common causes of death in western countries. Here, we
characterized a new anti-human RAGE antibody (SAR) and its in vivo
effect in a model of severe Gram-negative bacterial pneumonia in
immunosuppressed mice.
Methods: The SAR antibody was previously selected for binding affinity
for the human sRAGE (Biacore) and for RAGE ligand binding inhibition
(S100B, HMGB1, S100A6) by ELISA. A similar IC50 was found for SAR and
anti-RAGE XT-M4 antibody (Pfizer/Wyeth) with HMGB1. Since SAR did not
cross-react with mouse RAGE, transgenic C57Bl6 mice expressing human
RAGE were engineered for in vivo testing. Mice, receiving at day 4 and day 1
cyclophosphamide for immunosuppression, were challenged with intranasal
10
7 or 10
8 colony forming units (CFU) Pseudomonas aeruginosa (PA01 strain)
and treated 4 hours after with ciprofloxacin alone or in the presence of the
selected RAGE antibody: survival, CFU and bronchoalveolar lavage (BAL)
cytokines were measured. The anti-RAGE XT-M4 antibody was used as a
reference.
Results: In human RAGE KO/KI humanized mice, hRAGE expression was
validated at the mRNA (RT PCR) and protein (IHC) levels. In the pneumonia
model, higher loads of P. aeruginosa was used in transgenic versus wild-type
mice to achieve more than 80% of mortality 24 hours after infection
(10
8 CFU). XT-M4 antibody was injected at 15 mg/kg intravenously 4 hours
after infection (alone or with ciprofloxacin, 0.1 and 0.3 mg/kg, intra-
peritoneal given 4 hours and 24 hours after infection). The association of XT-
M4 and ciprofloxacin significantly inc r e a s e ds u r v i v a lc o m p a r e dw i t ht h e
antibiotic alone (ciprofloxacin 0.1/XT-M4 +54%, P < 0.066, ciprofloxacin
0.3/XT-M4 +78%, P < 0.01). The SAR antibody (7.5 and 15 mg/kg) also
induced significant improvement in delaying mortality in transgenic mice
w h e ng i v e ni nc o m b i n a t i o nw i t hc i p r o f l o x a c i nv e r s u sa n t i b i o t i ca l o n e .
Moreover, 30 mg/kg SAR with ciprofloxacin (10 mg/kg) reduced (but not
significantly) BAL cytokine release (TNFa, KC, IL-12) 18 hours after infection.
Conclusion: A survival benefit and partial control of inflammation was
observed with anti-RAGE antibodies in combination with antimicrobial
agent in a model of Gram-negative (P. aeruginosa)p n e u m o n i ai n
immunosuppressed mice. Thus, together with existing literature reports,
these data are in favor of the contribution of RAGE to the pathogenesis
of severe bacterial pneumonia.
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Background: In a surgical ICU, low-tidal volume ventilation was compared
with conventional tidal volume ventilation. Low-tidal volume ventilation is
preferentially used to provide mechanical ventilation in support of patients
with acute lung injury, acute respiratory distress syndrome, and inhalation
injury. However, few prospective studies have compared low-tidal volume
Figure 1(abstract P13) Relative expansion (mean values) of lymphocyte subsets compared with the absolute lymphocyte count in the
subacute phase compared with the acute phase of Legionnaires’ disease.
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Page 7 of 58ventilation with normal tidal volume ventilation in sepsis. The purpose of
this study was to prospectively compare the two ventilator modalities in
an ICU setting in patients of sepsis.
Methods: A single-center, prospective, randomized controlled trial,
comparing conventional tidal volume (12 ml/kg) ventilation with low-tidal
volume ventilation (6 ml/kg) in patients with sepsis. In an ICU at a tertiary
care teaching hospital, adult patients ≥18 years of age with documented
sepsis requiring prolonged (>24 hours) mechanical ventilation were
admitted to the ICU. Subjects were randomly assigned to receive
mechanical ventilation either by conventional tidal volume ventilation (n =
40) or a low-tidal volume ventilation-based strategy (n = 40). The first
primary outcome was death before a patient was shifted out of the ICU or
breathing without assistance. The second primary outcome was the number
of days without ventilator use from day 1 to day 28.
Results: At baseline, both the traditional ventilation group and the low-tidal
volume ventilation group had similar demographics to include median age
(interquartile range) (35 years (18 to 65) vs. 33 years (18 to 65), P =n o n
significant), weight (64 (50 to 82) versus 62 (53 to 70)). The primary outcome
was ventilator-free days in the first 28 days after randomization. Our study
revealed no significant difference between the low-tidal volume ventilation
and the traditional strategy ventilation groups in mean (± SD) ventilator-free
days (12 ± 9 vs. 11 ± 8, P = non significant) respectively), although the
number of days without ventilator use during the first 28 days after
randomization was greater in the low-tidal volume group. Mortality was
lower in the group treated with lower tidal volumes than in the group
treated with traditional tidal volumes (27.0% vs. 30.8%, P = non significant);
again the difference was not statistically significant.
Conclusion: Our study revealed that in patients with sepsis, mechanical
ventilation with a lower tidal volume may be beneficial in decreasing
mortality and increasing the number of ventilator-free days although the
difference was found to be statistically insignificant.
P16
Impact of daily auditing and weekly feedback on process of care and
patient outcome in resuscitation of severe sepsis and septic shock
B Afessa
*, CB Bowron, RD Danielson, K Ramar
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Background: Rivers’ randomized clinical trial showed that early goal-
directed therapy improves patient outcome in severe sepsis and septic
shock [1]. The findings were confirmed by multicenter international
prospective observational studies [2,3]. In our institution, we implemented a
Quality Improvement Project based on daily auditing of patients admitted to
a medical intensive care unit (MICU) for severe sepsis/septic shock followed
by weekly feedback on compliance of the Institute for Healthcare
Improvement (IHI) resuscitation bundle, and Sepsis Response Team (SRT)
activation [4]. Once the Quality Improvement Project was completed, the
daily audit and weekly feedback were stopped. This study aims to assess the
impact of this change on the process of care and hospital mortality.
Methods: The study was conducted in a 24-bed adult MICU of an
academic medical center. Only the first admission of each patient was
included. Patients who did not authorize their medical records to be
reviewed for research were excluded. During the first period of the study,
2009, daily auditing, weekly feedback to healthcare providers and SRT
were implemented. During the second study period, 2010, the daily
auditing and weekly feedback were stopped and the SRT activation was
continued. Baseline data collected during the two periods of the study
included gender, age, and resuscitation preference in case of cardiac
arrest. Process of care was measured using the seven elements of the IHI
resuscitation bundle. Patient outcome was measured by hospital mortality.
Statistical comparisons between the two groups were made using
Student’s t and chi-square tests. Two-tailed P < 0.05 was considered
statistically significant.
Results: A total of 777 patients were included in the study: 378 had
auditing and feedback and 399 did not. The mean (SD) age of the feedback
group was 65.4 (16.77) years compared with 66.3 (16.67) years for the
nonfeedback group (P = 0.459). Female gender accounted for 147 (38.9%) of
the feedback group compared with 206 (51.6%) of the nonfeedback group
(P < 0.001). At MICU admission 315 (83.3%) of patients in the feedback
group preferred full resuscitation in case of cardiac arrest compared with
317 (79.4%) in the nonfeedback group (P = 0.165). Compliance with all
elements of the bundle declined from 50.8% during feedback to 29.8%
during nonfeedback (Table 1). However, the hospital mortality rate did not
increase.
Conclusion: Continuous auditing and feedback to healthcare providers is
an important component of a Quality Improvement Project to maintain
compliance with the severe sepsis resuscitation bundle. However, it is not
associated with hospital mortality.
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Background: Candidemia is becoming increasingly widespread, especially
i nt h eI C Us e t u p .T h eC a n d i d as c o r eh a sb e e nd e v e l o p e da n du s e df o r
identifying patients at risk for developing candida infections. However, its
usefulness in predicting outcome of patients with candidemia has not
been evaluated. We aimed to determine the risk factors for mortality in
patients with candidemia admitted to an Indian medical ICU.
Table 1(abstract P16) Process of care and patient outcome differences between the two groups
Variable Feedback (n = 378) No feedback (n = 399) P value
Lactate measured 369 (97.6%) 376 (94.2%) 0.018
Blood culture 364 (96.3%) 370 (92.7%) 0.030
Antibiotic 344 (91.0%) 342 (85.7%) 0.022
Fluid achieved CVP 281 (74.3%) 238 (59.6%) < 0.001
Vasopressor 331 (87.6%) 330 (82.7%) 0.057
RBC transfusion 331 (87.6%) 336 (84.2%) 0.180
Inotrope 220 (58.2%) 146 (36.6%) < 0.001
Compliance with all 192 (50.8%) 119 (29.8%) < 0.001
Hospital death 92 (24.3%) 73 (18.3%) 0.040
Critical Care 2012, Volume 16 Suppl 3
http://ccforum.com/supplements/16/S3
Page 8 of 58Methods: An 18-month retrospective cohort analysis including 56
patients with candidemia was conducted. Baseline patient characteristics,
I C Uc o u r s ea n do u t c o m ew e r en o t e di nap r e d e s i g n e dpro forma.T h e
Candida score was calculated as previously described [1]. The primary
outcome measure was ICU mortality.
Results: Out of 3,142 ICU admissions, the incidence of candidemia was
17.8/1,000 admissions. Fifteen patients had co-existing candiduria with the
same species. The mean interval between ICU admission and candidemia
was 12.9 ± 14.4 days. Candida albicans was isolated in only 21.4% of blood
Candida-positive cultures. Among the nonalbicans species C. tropicalis was
the commonest species isolated from 28.6% isolates, followed by
C. glabrata that was isolated from seven (12.5%) patients. In 8.9% of
candidemia patients, the only measure taken was removal of the
indwelling catheter, but the rest of the patients required antifungal drugs.
Among the patients with candidemia, 53.6% required vasopressor support,
41.1% required renal replacement therapy and 64.3% required mechanical
ventilation during their ICU stay. The mean length of ICU stay was 22.9 ±
28 days and the mean hospital stay was 30.1 ± 30.2 days. Crude ICU
mortality was 33.93%. There was no statistically significant difference
between mortality rates of patients with C. albicans and nonalbicans
candidemia (P = 0.732). Patient parameters such as age, admission
APACHE II score, candida score, previous antifungals and underlying co-
morbidities, which were statistically significant in differentiating survivors
and nonsurvivors in the univariate analysis (Table 1), were included in the
multivariate analysis. Only two factors, previous antifungals (P =0 . 0 0 4 ,
OR = 101.4, 95% CI = 4.52 to 227.7) and Candida score >3 (P = 0.028, OR =
13.2, 95% CI = 1.3 to 125) were found to be independently predicting
mortality.
Conclusion: Candida infection is generally late-onset in ICU patients and
is associated with a prolonged ICU and hospital stay, and a high
mortality. Candida nonalbicans infection was much more common in our
cohort of ICU patients but there was no difference in mortality among
patients with C. albicans and nonalbicans infection. Patients who develop
candidemia, despite being on antifungals, were at a higher risk of dying
and a simple bedside candida score may be useful in predicting mortality
of ICU patients with candidemia.
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Background: Acute kidney injury (AKI) is an important predictor of
outcome in patients admitted to ICUs. The Acute Dialysis Quality Initiative
(ADQI) Group has defined and stratified AKI according to the Risk, Injury,
Failure, Loss and End-stage renal disease (RIFLE) criteria [1]. We aimed to
assess the ability of the RIFLE criteria to predict mortality in critically ill
patients admitted to a medical ICU.
Methods: A retrospective cohort study in an eight-bed medical ICU of a
tertiary care hospital over a period of 16 months. Data regarding patient
demographics and ICU course including need for organ support and
length of stay were recorded. We classified each patient according to their
RIFLE class using admission creatinine values (no AKI: <1.5 × baseline, Risk:
≥1.5 × baseline, Injury: ≥2 × baseline or Failure: ≥3×b a s e l i n e ) ,a s
previously described [1]. Qualitatived a t aw e r ea n a l y z e du s i n gt h ec h i -
squared or Fisher exact test as appropriate and quantitative data were
analyzed using Student’s t test. Inter-group and intra-group comparison for
quantitative data was done by one-way ANOVA. The primary outcome
measure was the ICU mortality, which was compared in five groups of
patients: no AKI, risk (R), injury (I), failure (F), and loss or end-stage (L/E).
Results: Data from 722 patients were included, no AKI: 362 (50.1%), risk:
168 (22.9%), injury: 71 (9.8%), failure: 80 (11.1%) and loss or end-stage: 44
(6.1%). Patients were evenly matched with regards to age and sex. The
ICU mortality was: no AKI (7.5%), risk (15.8%), injury (25.4%), failure
(38.8%) and L/E (20.5%). The need for renal support also varied according
to RIFLE criteria: no AKI (1.1%), risk (4.2%), injury (26.8%), failure (72.5%)
and L/E (77.3%) (Table 1).
Conclusion: The RIFLE classification is a simple tool, which can be used
to assess and classify AKI on admission to ICU. Moreover, it can reliably
be used to predict and prognosticate outcome and need for renal
support in ICU patients.
Table 1(abstract P17) Comparison patient parameters among survivors and nonsurvivors
Parameter of interest Overall (n = 56) Survivors (n = 37) Nonsurvivors (n = 19) P value
Age, mean 63.07 ± 20.7 59.11 ± 21.9 70.79 ± 16.1 0.045*
Sex, males (%) 41 (73.2%) 27 (73%) 14 (73.7%) 0.955
APACHE II score 19.38 ± 7.7 17.32 ± 7.6 23.37 ± 6.2 0.004*
Predicted death rate (%) 36.87 ± 22.6 31.05 ± 21.7 48.19 ± 20.2 0.006*
Nonalbicans infection 44 (78.6%) 31 (83.8%) 13 (68.4%) 0.302
Co-existing candiduria 15 (26.8%) 10 (27%) 5 (26.3%) 0.955
Underlying co-morbidities 41 (73.2%) 24 (64.9%) 18 (94.7%) 0.021*
Previous antimicrobials 49 (87.5%) 33 (89.2%) 16 (84.2%) 0.679
Previous antifungals 8 (14.3%) 1 (0.3%) 7 (36.8%) 0.001*
Days in ICU before positive culture 12.88 ± 14.4 13.05 ± 14.6 12.53 ± 14.3 0.898
Recent hospitalization 17 (30.4%) 11 (29.7%) 6 (31.6%) 0.887
Total parenteral nutrition 18 (32.1%) 15 (40.5%) 3 (15.8%) 0.076
Candida score (≥3) 29 (51.8%) 15 (40.5%) 14 (73.7%) 0.025*
Presence of CVC 49 (87.5%) 31 (83.8%) 18 (94.7%) 0.403
Mechanical ventilation 36 (64.3%) 19 (51.4%) 17 (89.5%) 0.007*
Vasopressor support 30 (53.6%) 13 (35.1%) 17 (89.5%) 0.000*
Renal replacement therapy 23 (41.1%) 9 (24.3%) 14 (73.7%) 0.001*
Length of ICU stay (days) 22.86 ± 28 22.35 ± 31.4 23.84 ± 20.6 0.853
Length of hospital stay (days) 30.09 ± 30.2 33.19 ± 33.8 24.05 ± 21.1 0.288
*Statistically significant.
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Background: There is a high incidence of candiduria especially in ICU
patients. Candiduria may be a sign of a disseminated candida infection
and a marker for increased ICU mortality. However, there is always a
dilemma regarding which patient to treat, as in a majority of patients it
may only be a colonizer. Moreover, the choice of antifungal drug is also
controversial due to low urinary concentration of many antifungal drugs.
Hence, it becomes imperative to have knowledge of locally prevalent
species to guide treatment protocols. The aim of this study was to assess
the incidence of candiduria among patients admitted to a medical ICU of
an Indian hospital, to perform microbiological characterization and to
study their ICU course and outcome.
Methods: Data from 93 consecutive ICU patients with candiduria,
admitted during an 18-month period, were obtained retrospectively. Data
regarding patient demographics, ICU course and outcome were entered in
a pro forma.
Results: Out of 3,142 ICU admissions, the incidence of candidemia was
29.6/1,000 admissions. A high proportion of patients (80.6%) had an
indwelling urinary catheter with the mean duration of catheter days being
5.89 ± 3 days. Other associated risk factors such as diabetes mellitus and
antibiotic usage were seen in 74.2% and 86%, respectively. Concomitant
candidemia was seen in 19.4% of cases. Nonalbicans Candida spp. (66.7%)
emerged as the predominant pathogen causing candiduria. ICU mortality
was 29% (Table 1).
Conclusion: There is a high incidence of candiduria in ICU patients,
especially among those with indwelling catheters and those on antibiotic
therapy. Moreover, in our cohort, an increased proportion of patients with
candiduria had noncandida infection, emphasizing the need to have
localized regional surveillance studies to identify the locally prevalent
candida species and devise antifungal therapy protocols.
P20
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Background: Mesenchymal stem cells (MSCs) are able to reduce systemic
inflammatory response in an experimental sepsis. One of the limiting
factors of MSC therapy is a high degree of apoptosis of transplanted cells.
On the basis of recently detected receptors for erythropoietin (EPO) on
the surface of MSCs we hypothesized that introduction of EPO together
with MSCs may increase survival of grafted MSCs and improve the clinical
efficacy of cell transplantation.
Methods: Fifty Wistar male rats were randomized into five groups with
10 animals in each: Group 1 were healthy controls, Groups 2 to 5 were
intraperitoneally introduced bacterial LPS 20 mg/kg. Two hours later LPS
Table 1(abstract P18) Comparison among patients according to RIFLE criteria
Parameter of interest No acute kidney injury
(n = 362)
Risk class
(n = 165)
Injury class
(n = 71)
Failure class
(n = 80)
Loss or end-stage renal disease
(n = 44)
Mean age (years) ± SD 57.89 ± 18.2 59.68 ± 18.4 57.14 ± 16.7 56.51 ± 21.3 63.09 ± 14.7
Sex, males (%) 213 (58.8%) 96 (58.2%) 41 (57.7%) 41 (51.3%) 27 (61.4%)
Mean APACHE II score ±
SD
10.68 ± 6.9 14.64 ± 7.6 19.7 ± 8.2 24.34 ± 8.1 16.91 ± 8
Mean PDR ± SD 16.09 ± 15.8 24.33 ± 19.2 37.13 ± 23.7 49.45 ± 23.4 30.66 ± 21
Mean SOFA score ± SD 3.39 ± 2.4 5.27 ± 3.3 7.15 ± 3.7 8.95 ± 3.4 5.39 ± 3.7
Need for inotropic
support
56 (15.5%) 41 (24.8%) 28 (39.4%) 40 (50%) 14 (31.8%)
Need for renal support 4 (1.1%) 7 (4.2%) 19 (26.8%) 58 (72.5%) 34 (77.3%)
Need for mechanical
ventilation
66 (18.2%) 43 (26.1%) 28 (39.4%) 32 (40%) 15 (34.1%)
Length of ICU stay, days 4.53 ± 5.2 5.25 ± 5.1 4.46 ± 4.8 6.44 ± 6.5 5.68 ± 6.2
Length of hospital stay,
days
8.55 ± 7.1 9.2 ± 6.4 8.34 ± 7.1 10.76 ± 11.9 9.57 ± 7.1
ICU mortality 27 (7.5%) 26 (15.8%) 18 (25.4%) 31 (38.8%) 9 (20.5%)
Table 1(abstract P19) Patient demographics, ICU course
and outcome
Parameter of interest Frequency
Age (years) (± SD) 59.81 (± 19.5)
Sex, males (%) 54 (58.1%)
Days in ICU before positive culture (± SD) 10.11 (± 9.8)
Presence of urinary catheter (%) 75 (80.6%)
Days since urinary catheter was present (± SD) 5.89 (±-3)
Admission APACHE II score 17.13 (± 7.8)
Predicted death rate (%) 30.36 (± 21.1)
Previous antimicrobials (%) 80 (86%)
Recent hospitalization (%) 7 (7.5%)
Neutropenia (%) 3 (3.2%)
Nonalbicans infection (%) 62 (66.7%)
Blood culture positivity (%) 18 (19.4%)
Need for vasopressor support 52 (55.9%)
Need for renal replacement therapy 25 (26.9%)
Need for mechanical ventilation 60 (64.5%)
ICU length of stay (days) 21.34 (± 23.3)
Hospital length of stay (days) 27.38 (± 25.2)
ICU mortality (%) 27 (29%)
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Page 10 of 58injection animals received the following intravenous treatment: 4 × 10
5
allogeneic MSCs (Group 3), 8.5 μg recombinant EPO-b (Group 4), MSCs
and EPO in the same doses (Group 5). Surviving animals were euthanized
on the fourth day. The morphological study, white blood cell count (WBC)
and serum level of IL-1b,I L - 2 ,I L - 6 ,a n dT N F a measurement were
performed.
Results: The highest WBC was found in the group of combined treatment
E P O+M S C s .T h es e r u mI L - 1 b level in Groups 2 and 4 was significantly
higher than in healthy and treated with MSCs and EPO + MSCs animals. The
main results of the morphologic analysis of different tissues in the groups
are presented in Table 1. The most significant differences in the LPS + EPO
group were found in the lymphoid tissue - considerable hyperplasia of
spleen white pulp and thymus cortex (Figure 1).
Conclusion: Combined treatment with EPO and MSCs can reduce acute
lung injury and kidney damage, cause hyperplasia of lymphoid tissue and
enhance the immune response more than separate treatment in an
experimental model of endotoxemia in rats.
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Development and validation of a bedside prediction score for
nosocomial sepsis in the pediatric ICU: a prospective observational
cohort study
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Background: D i a g n o s i so fn o s o c o m i a ls e p s i s( N S )i sac h a l l e n g ei ne v e r y
pediatric ICU [1,2]. There are very few studies on NS prediction in children,
and those existing [3-8] have studied risk factors with emphasis on
admission variables. In contrast, our study attempts to simplify the decision-
making process using a dynamic scoring system based on objective criteria.
Methods: This was a prospective study where 428 consecutive admissions,
aged 1 month to 12 years, between January and October 2011 with PICU
stay >48 hours, were enrolled and followed-up during their ICU stay and
72 hours thereafter. Occurrence of culture-positive nosocomial infections
and relevant details were recorded. Patients with and without nosocomial
sepsis were compared by chi-square test or Fisher’s exact test for categorical
and unpaired t test or Kruskal-Wallis for continuous variables. Significant
predictors of NS (P < 0.05 on univariate analysis) were included in the binary
backward stepwise logistic regression. The resultant derivation model’s
discrimination and calibration were assessed using the receiver operator
characteristic (ROC) curve and Hosmer-Lemeshow test, respectively. The final
model was transformed into a score, based on the regression coefficients.
For internal validation, bootstrapping and shrinkage coefficients were used.
Results: Of the 428 enrolled, 17 were excluded (malignancies (14 cases),
burns (one case), polytrauma (one case) and missing data (one case)). A total
of 151 episodes (23.1%; 95 out of 411 children) of culture-positive NS were
seen giving an incidence rate of 4.5 per 100 patient-days. Age, PRISM III
score, device utilization, albumin, immunomodulator and prior antibiotic
use, and intubation were significant independent predictors on multivariate
analysis (Table 1). This model had an AUC-ROC of 0.87 (Figure 1). Also, the
Hosmer-Lemeshow chi-square was 5.06 (P = 0.75) indicating good fit of the
model. Based on the regression coefficients, a pediatric nosocomial sepsis
prediction score (Pe-NoSeP) was developed. Probability cutoffs versus
sensitivity and specificity plotting showed a cutoff of 0.38 corresponding to
a score of 15. The sensitivity, specificity, positive predictive value, negative
predictive value and positive likelihood ratio at this cutoff were 79.1%,
79.1%, 61.6%, 89.9% and 3.76, respectively. The accuracy of the model was
79.3% and reduced classification errors from 29.8% to 20.7%. All seven
predictors retained their statistical significance after bootstrapping,
confirming the validity of the score.
Conclusion: The Pe-NoSeP score is a simple, easy-to-use bedside prediction
model, which estimates the probability of NS in a child on a particular day
and assists clinical decision-making. This tool may have diagnostic,
therapeutic and preventive utilities based on its application.
References
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Table 1(abstract P20) Morphometric characteristics of the examined tissues in the experimental groups
Controls LPS LPS + MSCs LPS + EPO LPS + EPO +MSCs
Alveolar septal thickening (μM) 10.32 ± 2.05 31.25 ± 2.9 15.3 ± 2.29* 28.6 ± 4.1 10.82 ± 1.08**
Kidney tubular dystrophy (point) 0 2.54 ± 0.31 2.22 ± 0.29 1.90 ± 0.12* 0.74 ± 0.19**
T-lymphocyte volume in thymus cortex (%) 86.24 ± 2.88 34.59 ± 1.34 49.37 ± 2.16 38.21 ± 1.73 81.48 ± 2.63**
Spleen white pulp volume (%) 23.95 ± 2.8 11.15 ± 3.8 19.9 ± 2.92 22.8 ± 0.98 27.15 ± 2.89*
*P < 0.05, **P < 0.01 compared with LPS group.
Figure 1(abstract P20) Representative hematoxylin and eosin staining of thymus tissue 96 hours post LPS injection (×100).
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Table 1(abstract P23) Multivariate logistic regression analysis: independent predictors and the Pediatric Nosocomial
Sepsis Prediction Score (Pe-NoSeP)
Serial no. Variable B Coeff. Odds ratio (OR) OR 95% CI P value Category Score
1 PRISM III score 0.06 1.06 1.02 to 1.10 0.003 5 to 15 0
16 to 26 2
27 to 37 4
38 to 48 7
49 to 59 9
2 Indwelling catheter use 1.67 5.31 2.31 to 12.23 < 0.001 No 0
Yes 6
3 Albumin transfusion 1.35 3.87 1.58 to 9.50 0.003 No 0
Yes 5
4 Age (≤5 years/>5 years) 0.90 2.45 1.22 to 4.93 0.010 >5 years 0
≤5 years 3
5 Immunomodulator use 1.30 3.66 1.23 to 10.94 0.020 No 0
Yes 5
6 Intubation 1.70 5.48 2.53 to 11.88 < 0.001 No 0
Yes 6
7 Prior antibiotic use (<4/≥4) 0.58 1.79 1.03 to 3.11 0.040 <4 0
≥42
Figure 1(abstract P23) Receiver operator characteristic (ROC) curve for the prediction model.
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Background: Statins target several mechanisms involved in the path-
ophysiology of sepsis, leading to their consideration as an adjuvant therapy.
Ubiquinone is an important mitochondrial antioxidant and constituent of
the electron transport chain. Ubiquinone production is inhibited by statins,
whereas sepsis itself also affects mitochondrial activity. The impact of statins
on mitochondrial function in sepsis has not been previously explored.
Methods: Sepsis was induced in instrumented, awake, male Wistar rats by
i.p. injection of faecal slurry. Fluid resuscitation was provided by continuous
intravenous infusion. Simvastatin 20 mg/kg bd was administrated by gavage
commencing either 3 days pre-sepsis (pre-treatment) or from 6 hours post-
sepsis (post-treatment). A control group received only vehicle but no active
drug (vehicle). Survival was assessed at 72 hours (16 per group). In a second
set of experiments, rats were sacrificed at 24 hours post-sepsis (seven per
group) for measurement of: plasma biochemistry and simvastatin acid; heart
and muscle ubiquinone levels by HPLC; and oxygen consumption on
permeabilized soleus muscle fibers in a Clark electrode chamber. A fourth
group of naive animals was also used as healthy controls. Statistics were
performed using the Wilcoxon test and repeated-measures ANOVA and post
hoc Bonferroni test.
Results: Survival at 72 hours (Figure 1) was 43.7%, 25% and 12.5% for
pre-treatment, vehicle, and post-treatment groups, respectively (P < 0.05).
At 24 hours post sepsis, ubiquinone was significantly decreased only in
hearts taken from statin pre-treated animals (706 ± 222 vs. 1,217 ± 269
pmol/mg protein for vehicle hearts). Plasma simvastatin acid levels were
significantly increased in statin pre-treated animals (41 ± 3 ng/ml)
compared with naïve animals receiving the same dose (1 ± 0.4 ng/ml).
Compared with vehicle-treated animals, statin pre-treatment resulted in
significant decreases in urea and creatinine, and a trend towards
improvement for liver enzymes and creatine kinase. Plasma lipid levels were
not significantly affected by statins given either before or after the onset
of sepsis. Mean values of muscle oxygen consumption were 11.9 ± 5.3,
14.4 ± 2.9, 12.1 ± 1.5 and 5.9 ± 2.4 pmol/ml/second/mg for naïve, sepsis +
post-treatment, sepsis + pre-treatment and sepsis + vehicle groups,
respectively. The significant reduction in muscle oxygen consumption seen
in the sepsis + vehicle group was prevented in both groups receiving
simvastatin.
Conclusion: This study confirms the beneficial effect of statins when given
before the onset of sepsis, and this appear to be independent of its lipid-
lowering property. This beneficial effect is likely to be multifactorial but
could be attributed in part to a protective effect on mitochondrial
respiration.
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Background: Several low-molecular-weight phenolic acids are present in
the blood of septic patients at high levels [1,2]. The microbial origin of the
most of phenylcarboxylic acids in the human body was shown previously
[3], but the pathophysiological role of phenolic acids is not clear. It was
shown that microbial phenolic acids produce either the antioxidant or the
pro-oxidant action on mitochondria depending on the chemical structure
[4]. In this work the influence of phenolic acids on reactive oxygen species
(ROS) production in mitochondria and neutrophils was investigated.
Methods: Mitochondria were isolated from the liver of Wistar rats. The
difference of electric potentials on the inner mitochondrial membrane
(ΔψM) was determined from the distribution of the lipophilic cation
of tetraphenylphosphonium whose concentration in external medium
[TPP
+]out was registered using a TPP
+-selective electrode. The rate of
oxygen consumption by mitochondria was determined polarographically.
The production of ROS by mitochondria was determined by measuring the
chemiluminescence of the Cypridina luciferin. The generation of superoxide
anion was induced by 25 μM menadione. The production of ROS
by neutrophils was examined by the method of luminol-dependent
chemiluminescence. All reagents used were from Sigma (USA). Statistical
processing of the data was carried out using the program MS Excel 2003. The
differences were considered significant at P ≤ 0.05.
Results: ROS production by mitochondria was higher in the presence of
cinnamic acid, benzoic acid, 3-phenylpropionic acid and phenylacetic acid
than in the presence of menadione alone. The most effective activators
of ROS production in mitochondria were those phenolic acids whose
effect is mediated via the interaction with thiol (-SH) groups. ROS
production by mitochondria was lower in the presence of phenyllactate,
p-hydroxyphenylacetate or p-hydroxyphenyllactate compared with the
control. All phenolic acids inhibited ROS formation in neutrophils to
different degrees. The inhibition was related to the scavenging of the
superoxide anion.
Conclusion: Microbial metabolites from both the normal gut microbiota
and infection sources enter the circulation and can enhance or reduce
the inflammatory response. In healthy people phenyllactate and p-
hydroxyphenyllactate, which dec r e a s eR O Sp r o d u c t i o ni nb o t hi n
mitochondria and neutrophils, can have the protecting effect on organs
and tissues. They can play a role of natural antioxidants. But in septic
patients deficit phenolic acids producing the pro-oxidant effects on
mitochondria (for example, PPA an dP A A )a n dh i g hl e v e l so fo t h e r
phenols can led to mitochondrial dysfunction and multiorgan failure.
Acknowledgements: This work was supported by the Russian Ministry of
Education and Science (Project No. 16.512.11.2227).
Figure 1(abstract P24) Seventy-two-hour survival curves.
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Background: Sepsis and its common complication septic shock, are
generally induced by the action of lipopolysaccharide (LPS) and is
characterized by peripheral arteriolar vasodilatation which results in
hypotension and inadequate tissue perfusion. Nitric oxide (NO) is a free
radical gas, produced by the immune system in response to an immuno-
logical stimulus and is related to the pathogenesis of sepsis due to its
vasodilator and cytotoxic actions. One significant finding in clinics is that
man and woman respond differently to sepsis, with better prognosis related
to women [1].
Objective: This study was designed to investigate the role of estrogen on
immune response in an experimental model of septic shock.
Methods: In the first set of experiments male and female (ovariectomized
and sham surgery) rats were injected intraperitoneally (IP) for three
consecutive days with estradiol cypionate (ECP), 40 μg/kg or vehicle. In the
third day, after ECP injection, rats receive IP injection of 10 mg/kg of
bacterial LPS or saline solution. Plasma was collected 4 and 6 hours after
LPS. In the second set of experiments macrophage culture was performed
from peritoneal wash of male and female rats. Culture was stimulated with
b-estradiol (10
-9M) and LPS 1 μg/ml and medium collected 12 and 24 hours
after stimulation for NO measure.
Results: In vivo experiments showed that administration of LPS increased
NO plasma concentration in males and females. ECP pre-treatment
decreased NO concentration in sham females in the two studied periods
(4 and 6 hours); conversely, increased nitrate levels in ovariectomized and
had no effect in males. Results of in vitro experiments showed that
macrophages from males produced more NO than the ones from female,
either in basal conditions or after LPS stimulation; however, treatment of the
culture with b-estradiol, significantly increased the NO production in
macrophages from male but had no effect in female rats.
Conclusion: Our results indicate that estradiol may have pro or anti-
inflammatory actions depending on the gender; however, estradiol in
female seems to be protective, since it decreased NO plasma concentration.
These results may explain in part the better outcomes of woman during
sepsis.
Acknowledgements: FAPESP
Reference
1. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in
the United States from 1979 through 2000. N Engl J Med 2003,
348:1546-1554.
P28
Use of Centre for Disease Control criteria to classify infections in
critically ill patients: results from an interobserver agreement study
PMC Klein Klouwenberg
1*, DSY Ong
1, LD Bos
2, FM de Beer
2, MA Huson
2,
M Straat
2, LA van Vught
2, L Wieske
2, J Horn
2, MJ Schultz
2, T van der Poll
2,
MJM Bonten
1, OL Cremer
1
1University Medical Centre, Utrecht, the Netherlands;
2Academic Medical
Centre, Amsterdam, the Netherlands
Critical Care 2012, 16(Suppl 3):P28
Background: Correct classification of the source of infection is important
in observational and interventional studies of sepsis. The Centre for
Disease Control (CDC) criteria are most commonly used for this purpose,
but the robustness of these definitions in critically ill patients is not
known. We determined the interobserver agreement for classifying
infections in the ICU.
Methods: Data were collected as part of a prospective cohort of 1,214
critically ill patients admitted to two hospitals in the Netherlands between
January 2011 and June 2011. Eight observers assessed a random sample of
168 out of 554 patients who had experienced at least one infectious
episode in the ICU. Each patient was assessed by two randomly selected
observers who independently scored the source of infection (by affected
organ system or site), the plausibility of infection (rated as none, possible,
probable, or definite), and the most likely causative pathogen. Assessments
were based on a post hoc review of all available clinical, radiological and
microbiological evidence. The observed diagnostic agreement for source of
infection was classified as partial (that is, matching on organ system or site)
or complete (that is, matching on specific diagnostic terms), for plausibility
as partial (two-point scale) or complete (four-point scale), and for causative
pathogens as an approximate or exact pathogen match. Interobserver
agreement was expressed as percentage agreement and as a kappa statistic.
Results: A total of 206 infectious episodes were observed in 168 patients.
Agreement regarding the source of infection was 89% (183/206) and 69%
(142/206) for partial and complete diagnostic agreement, respectively
(Table 1). This resulted in an overall kappa of 0.85 (95% CI = 0.79 to 0.90).
Agreement varied from 70 to 100% within major diagnostic subgroups.
In the subgroup of 142 episodes with full diagnostic agreement on source
of infection, the interobserver agreement for plausibility of infection was
83% and 65% on a two-point and four-point scale, respectively. For
causative pathogen, agreement was 78% and 70% for an approximate and
exact pathogen match, respectively.
Conclusion: In this study, overall interobserver agreement of classifying
infections using CDC criteria was excellent, whereas an exact match on all
aspects of the diagnosis between independent observers was limited for
some infections.
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Background: Sepsis is one of the leading causes of admission to the ICU.
After the initial proinflammatory response a gradual change towards a
more anti-inflammatory pattern can be seen. In this latter stage, immune
Table 1(abstract P28) Agreement across the various
sources of infection
Source of infection Agreement/total number
Lower respiratory tract 86/90 (96%)
Community-acquired pneumonia 28/32 (88%)
Hospital-acquired pneumonia 32/39 (82%)
Ventilator-acquired pneumonia 12/17 (71%)
Abdominal 34/36 (91%)
Secondary peritonitis 21/24 (88%)
Primary peritonitis 2/2 (100%)
Intra-abdominal abscess 3/5 (70%)
Bloodstream 30/34 (94%)
Line infection 22/26 (85%)
Primary bloodstream infection 4/5 (80%)
Central nervous system 10/11 (91%)
Secondary meningitis 5/7 (79%)
Primary meningitis 4/4 (100%)
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immunoparalysis, lending the patient more vulnerable to deleterious
secondary infections. Mitochondrial dysfunction has been suggested to
play a role in this immunoparalytic state and we therefore investigated
mitochondrial respiratory function in peripheral blood immune cells
(PBICs) in patients with sepsis and its evolvement over time.
Methods: Twenty patients with severe sepsis or septic shock were
included. PBICs were isolated from freshly drawn blood via density
gradient centrifugation and analyzed three times during the first week
after admission to the ICU (within 48 hours, days 3 to 4 and days 6 to 7).
Mitochondrial respiration was examined with high-resolution respirometry
in intact and permeabilized cells in order to evaluate both whole cell
respiration as well as contribution of individual complexes. Mitochondrial
DNA (mtDNA), cytochrome c (Cyt c) and citrate synthase (CS) were
measured as indicators of change in cellular mitochondrial content.
Results: In intact PBICs from septic patients, with endogenous substrates,
there was a gradual increase in cellular respiration that was 73% higher
after 1 week compared with controls (P = 0.003). In permeabilized cells,
complex I, II and IV displayed increased respiration compared with controls
already at days 1 to 2 (37%, 30% and 73% respectively, P < 0.001) and
continued to increase to days 6 to 7 (68%, 68% and 108% respectively).
The rise in mitochondrial respiration was paralleled by higher levels of CS
activity and increased mtDNA and Cyt c content in cells from septic
patients (90%, 143% and 231% for the respective parameter at days 6 to 7
compared with controls, P < 0.0001). Mortality for the septic patients was
25% by day 7. There was no difference in respiratory capacity between
survivors and nonsurvivors at any of the time points measured.
Conclusion: In PBICs from patients with severe sepsis or septic shock there
is a gradual increase in mitochondrial respiratory capacity. This increase is
probably due to mitochondrial biogenesis as indicated by increases
in mitochondria-specific markers. Nonsurvivors displayed the same increase
in respiration as survivors arguing against mitochondrial respiratory
dysfunction and defect mitochondrial biogenesis, in PBICs, as a mediator of
increased mortality in the septic condition.
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Background: A compromising endothelial cell (EC) monolayer affects
vascular permeability and leads to fluid extravasation. Tight junctions and
more particularly Zonula occludens 1 (ZO-1) play a major role in maintaining
vascular barrier integrity and are regulated by cytoskeletal proteins. During
sepsis, endothelial barrier disruption occurs in most organs and contributes
to organ dysfunction. We and others have demonstrated that the a1 isoform
of AMP-activated protein kinase (a1AMPK) controls cytoskeleton organi-
sation in various cell types including endothelial cells. Therefore, we
hypothesised that a1AMPK preserves tight junction organisation and
vascular permeability during sepsis in the coronary microcirculation.
Methods: In vitro, tight junction organisation (ZO-1 staining), cytoskeleton
organisation (phalloïdin staining) and vascular permeability were measured
in endothelial cells in culture (HCAECs). Endothelial cells were pretreated
with 1 mM AICA riboside (AICAr) before LPS challenge (50 μg/ml O55:B5).
In vivo, wild-type (a1AMPK
+/+) mice were treated with LPS (O55:B5,10 mg/kg)
and compared with a1AMPK knockout animals (a1AMPK
-/-). ZO-1 localisation
was determined on frozen heart sections. Vascular permeability was
evaluated using Evans Blue dye leakage. In addition, myocardial wall
oedema was assessed by magnetic resonance imaging (MRI).
Results: In vitro, LPS-challenged cells displayed a significant disruption of
the ZO-1 linear configuration after 24 hours and exhibited a decrease in
peripheral actin filaments. Gap areas appeared in the cellular monolayer
exposed to LPS, unlike untreated cells for which the monolayer remained
unaltered. Consequently, LPS treatment gradually increased endothelial
cells monolayer permeability in a time-dependent manner. AMPK
activation by AICAr preserved the linear pattern of ZO-1 and prevented
gap areas in the monolayer. More interestingly, AMPK activation reduced
LPS-induced hyperpermeability. In vivo, according to the in vitro
experiments, a dramatic decrease in ZO-1 staining was observed in
a1AMPK
-/- hearts compared with a1AMPK
+/+, after LPS challenge. This
resulted in an increased Evans Blue extravasation and, more importantly,
in an exaggerated myocardial wall oedema observed by MRI. Finally,
treating C57Bl6 mice with AICAr reduced cardiac vascular hyper-
permeability in our model of sepsis.
Conclusion: The AMPK signalling pathway protects the endothelial barrier
during sepsis by preserving tight junction organisation. Since AMPK
counteracts the molecular events involved in the LPS-induced barrier
disruption in coronary microcirculation, it could consequently represent a
new therapeutic molecule during sepsis.
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Background: Gram-positive bacterial lung infection is commonly associated
with sepsis, and particularly important in older individuals. Systemic vascular
dysfunction associated with sepsis is characterized by vascular permeability
that can lead to tissue hypoxia. Our studies focus on angiopoietin-2 (Ang-2),
whose increased plasma concentration is associated with severity of lung
injury and with mortality. Ang-2 is stored in the Weibel-Palade body (WPB),
an endothelial-specific secretory organelle. Here, we examine the release of
Ang-2 from primary human pulmonary microvascular endothelial cells
(HPMECs) in vitro stimulated with Gram-positive bacterial cell wall
components. We then used our model of pulmonary infection to investigate
the use of an inhibitor of WPB exocytosis to prevent systemic inflammation
and hemodynamic instability.
Methods: HPMECs were treated with lipoteichoic acid (LTA; 50 to 100 μg/ml)
and peptidoglycan (PGN; 167 to 333 μg/ml) in the presence or absence of
TAT-NSF700 fusion peptide (10 μM) to inhibit WPB exocytosis. Ang-2 in
culture medium was measured by ELISA, and WPB exocytosis assessed using
immunofluorescent (IF) staining of Ang-2. HPMEC monolayer permeability
was measured using FITC-dextran. Male C57/Bl6 mice, 8 to 10 weeks old
(n = 6/group), were pretreated with TAT-NSF700 (0.5 mg/kg) or saline
intraperitoneally. Thirty minutes later, LTA (150 μg) and PGN (500 μg) or
saline alone were instilled intratracheally. Pulse oximetry was assessed in
a w a k em i c ep r i o rt oa n d6h o u r sp o s ti n s t i l l a t i o n .T h em i c ew e r et h e n
euthanized by exsanguination under anesthesia and bronchoalveolar lavage
(BAL) was performed. BAL fluid total and differential counts were evaluated
and protein and cytokine concentrations in plasma and BAL were assessed
using commercial assays.
Results: LTA-PGN increased Ang-2 levels dose dependently (up to
ninefold, P = 0.003) in HPMEC culture medium within 30 minutes, which
was blocked by TAT-NSF700 pretreatment. IF staining showed aggregation
and localization of Ang-2 in the cytoplasm suggesting WPB exocytosis
within 30 minutes. LTA-PGN also induced HPMEC permeability. LTA-PGN
induced both local and systemic inflammation resulting in decreased heart
and breath rates and oxygen saturation (94% vs. 97%, P = 0.038) at
6 hours. These physiological changes were prevented in mice pretreated
with TAT-NSF700.
Conclusion: LTA-PGN induced rapid Ang-2 secretion via WPB exocytosis
and this release is associated with significant changes in permeability.
In vivo, LTA-PGN induces significant changes in heart and breath rates
and oxygen saturation that was prevented by inhibition of WPB
exocytosis. Thus, we have defined WPB, a storage organelle for multiple
proinflammatory mediators, as a potential target to control overwhelming
inflammation in Gram-positive sepsis and improve tissue oxygenation and
hemodynamics.
Critical Care 2012, Volume 16 Suppl 3
http://ccforum.com/supplements/16/S3
Page 15 of 58P32
Effectiveness of nebulized amphotericin B to eradicate Candida
colonization from the lower respiratory tracts of ICU patients
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Background: Candida species are opportunistic pathogens that are
ordinarily found in the human gastrointestinal tract. In critically ill
patients receiving mechanical ventilation, colonization of the lower
respiratory tract (LRT) with Candida may occur in 25 to 55% of patients.
Nebulized amphotericin B (NAB) is commonly used to eradicate Candida
from the LRT, for example as part of selective decontamination of the
digestive tract protocols. However, the clinical effectiveness of this
approach is unknown. Our aim was to determine the time to eradication
of Candida from the LRT in mechanically ventilated ICU patients receiving
and not receiving inhalation therapy with NAB.
Methods: We included patients admitted to the ICU of the University
Medical Center Utrecht from November 2007 until February 2012. We
excluded patients with a length of stay <72 hours and patients receiving
systemic antifungal treatment. Microbiological screening for Candida
colonization was performed on admission and twice weekly, and samples
were processed according to a standardized protocol. Samples obtained in
the first 72 hours of ICU admission were discarded since positive samples
obtained on admission were not an indication to start amphotericin B.
Colonization was defined as the presence of Candida in two or more
consecutive samples obtained on different days. Decolonization was
defined as the absence of Candida in two consecutive samples, or as the
absence of Candida in the last availab l es a m p l eb e f o r ee x t u b a t i o no r
discharge. Only the first episode of Candida colonization per admission
was used for analysis. Hazard ratios of eradication of Candida colonization
in treated patients compared with nontreated patients were determined
using Cox regression analysis.
Results: Out of a total of 2,948 patients who were admitted for at least
72 hours, 288 were colonized with Candida. Concurrent systemic
antifungal treatment during the colonization period was administered to
27 of these patients, who subsequently were excluded, leaving 261
patients for analysis. Decolonization occurred in 36 of 48 (75%) and 112
of 213 (53%) patients who received or did not receive NAB, respectively
(HR 1.51; 95% CI = 1.03 to 2.20). Median time to decolonization was 6.0
( I Q R5 . 6t o6 . 4 )a n d9 . 0d a y s( I Q R8 . 1t o1 0 . 9 )i np a t i e n t sr e c e i v i n ga n d
not receiving NAB, respectively (log-rank test, P = 0.03) (Figure 1).
Adjustment for age, sex and time from ICU admission to acquirement of
Candida did not alter the results.
Conclusion: Inhaled amphotericin B treatment in mechanically ventilated
patients with acquired Candida colonization of the lower respiratory tract
significantly increases the rate of decolonization.
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of neutropenia and bacterial complications in newborns with
respiratory distress syndrome
M Puchtinskaya
Research Institute of Obstetrics and Pediatrics, Rostov-on-Don, Russia
Critical Care 2012, 16(Suppl 3):P33
Background: The development of neutropenia with neonates with RDS on
mechanical ventilation is a sign of the realization of bacterial complications
[1,2]. The purpose of this study was the optimization of prevention of
neonatal sepsis.
Methods: With permission of the Ethics Committee 64 full-term newborns
with RDS on mechanical ventilation, without clinical signs of infection,
were retrospectively divided into two groups: with a decrease in absolute
neutrophil count (M <2,000 cells/mm
3) after 3 to 5 days of hospitalization
(I, n = 30) and non-neutropenic (II, n = 34). The survey was conducted at
admission and 3 to 5 days. They were studied on the content of
lymphocytes in the early (AnnexinV-FITC
+PI
-) and late (AnnexinV-FITC
+PI
+)
apoptosis by flow cytometry (AnnexinV
+-labeled FITK and propidium
iodide (PI
+)-labeled PE; Saltag, USA), taking into account results on the
cytometer (Beckman Coulter Epics XL, USA); the plasma level of
granulocyte colony-stimulating factor (GCSF), fibroblast growth factor
(FGF), anti-apoptosis soluble sFas-ligand (sFas-L) by ELISA (Victor, Finland;
test system Cytimmune Sciences Inc., USA and Bender MedSystems GmbH,
Austria). Points of cutoff were determined by ROC analysis. The statistical
power of the study is 80% (a ≤ 0.05).
Results: At admission, it was revealed that the patients in group I have a
high content of lymphocytes in the early and late apoptosis, and low levels
of GCSF, FGF, sFas-L in reference to group II (a ≤ 0.05). In group I, 27
patients at 3 to 5 days developed neutropenia (M <2,000 cells/mm
3) and a
reduction in plasma levels of GCSF, FGF, sFas-L and an increase in
lymphocyte apoptosis (a ≤ 0.05). Sepsis developed in 22 children of group I
and in only five patients of group II (a ≤ 0.05). The values of cutoff
(sensitivity, specificity, accuracy) for prediction of neutropenia in neonates
with RDS at admission to the ICU were: for GCSF - 1,556 pg/ml (85.1%,
75.6%, 79.6%, respectively); for sFAS-L - 5,870 pg/ml (69.56%, 74.4%, 71.9%);
for FGF - 25.7 pg/ml (68%, 82%, 74.4%); for early apoptosis - 9.59% (82%,
93%, 74%); and for late apoptosis - 0.56% (94.1%, 98%, 85.3%).
Conclusion: Reduction of proliferative factors (GCSF, FGF, sFas-L) and
activation of apoptotic lymphocytes are markers of neutropenia and are
associated with the high incidence of sepsis in infants with RDS.
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Background: In sepsis, the sympathetic nerve activity (SNA) is differentially
increased to individual organs [1]. It has been suggested that inhibition of
central sympathetic outflow with clonidine would improve outcome in
sepsis [2] but the cardiovascular and renal effects of clonidine in sepsis are
unknown. Accordingly, we sought to assess the effect of the central a2-
agonist clonidine on renal function in an ovine model of severe sepsis.
Methods: Animals had renal and cardiac flow probes implanted to
continuously measure the cardiac index (CI) and renal blood flow (RBF).
Mean arterial pressure (MAP) was continuously monitored and hourly
Figure 1(abstract P32)
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animal was randomly and blindly allocated to receive vehicle or clonidine
0.25 μg/kg/hour for 8 hours. Animals were followed for further 40 hours
during recovery and, at least 2 weeks later, crossed over to the other arm
of the study. Two-way repeated-measures ANOVA was performed and
P < 0.05 was considered significant. Data are mean ± standard error of
the average of 4 hours preceding each time point.
Results: Eight animals per group were studied. Two animals per group
died during the first experiment, leaving six animals for crossover. Values
presented refer to all eight animals. Animals in both groups had similar
baseline values and developed a similar hyperdynamic state with 50%
increase in CI, 15 mmHg drop in MAP and threefold increase in arterial
lactate. Clonidine (Figure 1) reduced the HR by 23(7) bpm (P = 0.013) but
did not affect MAP, RBF and lactate levels. Clonidine increased urine
output from 23(4) to 71(23) ml/hour (P = 0.004), but did not improve
creatinine clearance (from 44(6) to 42(4) ml/minute).
Conclusion: In experimental hyperdynamic sepsis, treatment with clonidine
appears safe, but it does not improve the glomerular filtration rate.
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Background: The pathophysiology of septic acute kidney injury (AKI) is
poorly understood. Renal medullary hypoxia has been proposed as a
cause of AKI, but the changes in intrarenal oxygenation in hyperdynamic
sepsis are unknown. Accordingly, we sought to determine the changes in
regional renal perfusion and tissue oxygenation in the cortex and in the
medulla in an ovine model of severe sepsis.
Methods: Mean arterial pressure (MAP), cardiac index (CI) and renal
blood flow (RBF) were continuously monitored in conscious sheep. Fibre
optic probes (Oxford Optronix) were used to measure tissue perfusion
and oxygen partial pressure at 30-second intervals. Arterial and renal
venous blood samples were collected for oximetry. After 24 hour of
baseline data collection, sepsis was induced with live Escherichia coli
infusion for 24 hours. Gentamycin was given to terminate sepsis. The
animals were followed for a further 24 hours of recovery. Histology was
performed to confirm the position of the catheter tips and to assess
tissue viability around the probes. Data are mean (± standard error) of
the average of the periods. One-way repeated-measures ANOVA was
used and P < 0.05 considered significant.
Results: Eight animals were studied. All animals developed a
hyperdynamic state with a doubling in heart rate and CI, and a 50%
increase in RBF. MAP decreased by 15 mmHg, with a fourfold increase in
arterial lactate. Urine output halved, serum creatinine doubled and
creatinine clearance decreased by one-third. Two animals died 28 hours after
induction of sepsis. Baseline cortical and medullar pO2 were 29.6 (± 4.3) and
29.1 (± 4.1) mmHg, respectively. During sepsis (see Figure 1), cortical
perfusion and oxygenation did not change significantly. In contrast,
medullary perfusion showed an early trend towards reduction, while
medullary tissue pO2 had decreased by 53 ± 11% at 24 hours of sepsis (P <
0.05). Calculated total renal oxygen consumption did not change
significantly (from 33 to 32 ml O2/minute).
Figure 1(abstract P34) Haemodynamic and renal effects of clonidine in sepsis. Data are mean ± standard error. Rectangle: 8 hours of clonidine
infusion.
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oxygenation in hyperdynamic sepsis. In a conscious large animal model
of septic AKI, we showed decreased medullary oxygenation, possibly due
to mismatched local perfusion and oxygen consumption.
P36
Abstract withdrawn
Critical Care 2012, 16(Suppl 3):P36
P37
Simplified selective decontamination of the digestive tract reduces
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Background: Selective decontamination of the digestive tract (SDD) was
shown to reduce acquisition of resistant bacteria and mortality in ICUs. A
significant reduction of bacteremia, candidemia, ventilator-associated
pneumonia, respiratory tract and rectal colonization have been found in
multicenter, randomized studies. SDD was proven to be clinically safe and
cost-effective in multiple clinical studies but has not been accepted by
the critical care community as a standard of care. Reluctance to use SDD
despite proof to the contrary is mostly explained by its perceived
potential to raise bacterial resistance to parenteral and enteral antibiotics
or rebound infection after their cessation. We studied the effect of a
simplified SDD protocol on Gram-negative colonization of the respiratory
tract and bloodstream infection.
Methods: During 2011, all adult ICU patients on mechanical ventilation
for more than 3 days were included. Enteral medication of neomycin and
polymixin-E was given four times daily until gastric tube removal or ICU
discharge. Blood, sputum cultures and rectal screening were taken on
admission and biweekly until 3 days after ICU discharge. The emergence
of multidrug-resistant (MDR) bacteria was investigated and compared
with 2010. The in-hospital length of stay and 28-day mortality were
compared.
Results: Out of 506 patients, 277 (74% of eligible) received SDD during
2011, compared with none of 458 patients in 2010. There was a 40%
reduction of positive blood cultures (P = 0.01) and a 27.3% reduction of
positive sputum cultures with MDR bacteria (P =0 . 0 4 ) .T h e r ew a sas h i f t
from MDR towards sensitive bacteria. This was mostly prominent in the
Acinetobacter, Klebsiella and Pseudomonas species. There was no
concomitant elevation of other pathogenes as MRSA, VRE, Clostridium or
Candida. There was an 18.4% relative reduction in 28-day mortality and a
2-day reduction in median hospital length of stay (P = 0.006).
Conclusion: The simplified SDD protocol reduced ICU acquisition of Gram-
negative resistant infections without a rise in Gram-positives or fungi. The
bacterial epidemiology of the unit changed shifting to sensitive bacteria,
and the 28-day mortality and hospital length of stay have improved. This
study supports the safety and efficacy of this SDD protocol and justifies its
further investigation in more ICUs.
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Decreased incidence of SIRS and sepsis by acupuncture in severe
multiple traumatic patients via facilitation of vagal activity
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*,JQ u
Research Institute of Surgery, Daping Hospital, Daping, Chongqing, China
Critical Care 2012, 16(Suppl 3):P38
Background: Acupuncture could increase vagal activity. We hypothesize
that acupuncture could activate the cholinergic anti-inflammatory
Figure 1(abstract P35) Haemodynamic and regional perfusion/oxygenation changes. Data are mean (standard error). Rectangle: 24-hour sepsis
period.
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prognosis in severe multiple trauma patients.
Methods: The design was a prospective, randomized intervention trial.
The setting was the Trauma Center, Department of Emergency Medicine,
Southwest Hospital, Chongqing, P.R. China. Consecutive multiple trauma
patients with an Injury Severity Score (ISS) of more than 16 points
meeting the criteria between January 2007 and December 2008 were
included. The intervention acupuncture was applied to the ST-36 and PC-
6 acupoint twice a day until day 7 after injury or sham acupuncture was
applied to non-acupoints. One hundred and fifty severe multiple
traumatic patients were randomly divided into three groups: acupuncture
group (group A; n = 50), sham acupuncture group (group B; n = 50), and
control group (group C; n = 50).
Results: Acupuncture at ST-36 and PC-6 acupoints significantly increased
the normalized unit of the high-frequency component (HFnu; P < 0.01)
and decreased the ratio of low-frequency and high-frequency component
(LF/HF; P < 0.05), which indicated an increased vagal activity and a tilt of
the sympathovagal balance. Serum TNFa and IL-6 concentrations
significantly decreased after stimulation at ST-36 and PC-6 acupoints (P <
0.01 and P < 0.05, respectively), but remained unchanged following
stimulation at the non-acupoint area. During the whole study period,
much lower concentrations of TNFa and IL-6 were detected in severe
traumatic patients with acupuncture intervention in comparison with
those in sham acupuncture and control patients (P < 0.05). Most
importantly, we observed that the incidences of SIRS, and some clinical
complications, such as ARDS, sepsis or MOF, and mortality in the
acupuncture group were much lower in comparison with the other two
groups.
Conclusion: Acupuncture has beneficial effects on modulation of
inflammatory response and will improve the clinical outcomes in severe
m u l t i p l et r a u m a t i cp a t i e n t s .W es u g g e s tt h a tl a r g e rc o h o r ts t u d i e so r
multiple center studies are needed to validate whether acupuncture is
another effective stimulation pattern to activate the cholinergic anti-
inflammatory pathway. The detailed mechanisms are worth further
investigation.
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Background: Advances in modern medicine and patient management
have seen increased use of prosthetic materials, leading to biofilm
formation, and the constituent organisms are different in their growth
rates and susceptibility patterns and cause many complications. Candida
species are increasingly seen to be important nosocomial pathogens and
are major causes of morbidity and mortality in immunocompromised
patients of intensive care and postoperative wards. Hence our aims were
to isolate and identify specific Candida species associated with the
luminal biofilm in endotracheal tubes/i.v. catheters in ICU patients and to
study the pathogenicity of Candida species by testing for virulence
mechanisms including biofilm formation and antifungal susceptibility.
Methods: One hundred and twenty-five medical/postoperative patients
admitted to the ICU for more than 48 hours were studied. Tracheal tubes
at the time of extubation and intravenous/other catheters removed from
patients and blood samples and other relevant samples from potentially
infected sites were collected and processed. Direct microscopy done by
KOH mount and Gram staining and cultures were done on blood agar,
brain heart infusion agar, and Sabouraud’s Dextose agar with antibiotics
and were incubated at 25 and 37°C. Antifungal susceptibility and virulence
testing of Candida species was done by phospholipase, proteinase
estimation and adherence assay.
Results: The patients ranged from 13 to 90 years with a male pre-
dominance seen in most ages. A total of 86.29% were admitted for less than
1 week followed by 9.68% for 1 to 2 weeks. The most common organ
system involved was the GIT followed by the CNS, respiratory and multiple
organ systems. In total, 356 samples including indwelling devices, blood and
urine samples were processed. A total of 253 samples were sterile while
fungal isolations were obtained in 103 samples with 51.4% from indwelling
devices and 39.8% from urine samples. Candida tropicalis (40%) and Candida
albicans (39%) were the commonest followed by Candida glabrata (11%),
Candida parapsilosis (4%) and Candida krusei, Candida kefyr and Candida
sphaerica (each 2%). Candida biofilm formation was elicited in 53 indwelling
devices. A total of 58.25% Candida species were resistant to fluconazole.
Phospholipase and proteinase activities were seen in 73.8% and 55.3%
Candida isolates with different species showing a wide range of activities,
while 71 Candida isolates showed (4+) adherence activity.
Conclusion: Candida species continue to be important fungal pathogens in
the formation of biofilms in ICU patients and knowing drug susceptibility
and virulence characteristics will help in reducing associated complications,
device control strategies and consequently reducing morbidity, mortality
and treatment costs.
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Background: Differentiating the systemic inflammatory response
syndrome (SIRS) from sepsis is very important to clinicians. Procalcitonin
(PCT) has been studied extensively as a marker of sepsis; however, its
clinical utility remains uncertain [1]. Alternative approaches involving
analysis of circulating biomarkers using gene expression (GE) show
promise [2]. The primary objective of this study was to compare the
diagnostic performance of a GE biomarker set, SeptiCyte® Triage, with
PCT in a mixed patient population.
Methods: The dataset was derived from two clinical trials conducted
across four tertiary care settings in Australia between 2008 and 2011
(ACTRN12610000465055). Critical care patients (n = 87) were enrolled if
they fulfilled the 1992 Consensus Statement [3] for sepsis, severe sepsis or
septic shock. Postsurgical patients were included as an infection-negative
systemic inflammatory cohort (n = 31), with 71 healthy controls (HC) for
comparison. Blood samples were collected within 24 hours of the surgical
procedure or upon admission to ICU for sepsis patients. PCT was measured
using a commercially available assay kit (Brahms PCT) and GE assessed
using Affymetrix GeneChip Human Exon 1.0 ST arrays, where a set of
biomarkers were identified ap r i o r i .AS u p p o r tV e c t o rM a c h i n ea l g o r i t h m
was used to calibrate the molecular biomarkers with respect to specific
clinical groups. Bootstrap and permutation tests were performed on the
difference in area under the receiver operating characteristic curves (AUC
ROC) for PCT and crossvalidated posterior probabilities.
Results: The SeptiCyte® Triage molecular biomarker set was significantly
better than PCT at differentiating non-infectious systemic inflammation from
all sepsis groups with an AUC ROC of 99.1% versus 90.8% (95% CI of
difference = 4%, 16%), respectively. The differentiating ability of PCT and the
SeptiCyte® Triage biomarker set is demonstrated in Figure 1. The 99.1% AUC
ROC of the biomarker set could be maintained when using a set of less than
10 genes, important for transferring the biomarkers to a rapid assay format.
As a quality step, a classifier was developed that differentiated HC from
sepsis with an AUC ROC of 100%.
Conclusion: In comparison with the diagnostic performance of PCT, a
limited set (<10) of molecular biomarkers potentially has a significantly
better sensitivity and specificity profile for the detection of sepsis within
a mixed systemic inflammatory patient group.
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Background: Leukocyte immunophenotyping could improve sepsis
diagnostics [1,2]. Our hypothesis was that monocytic and neutrophilic
CD11b and CD64 antigen fluorescence intensities differ between severe
sepsis, non-inflammatory ICU patients and nonseptic inflammation (off-
pump coronary artery bypass (OPCABG)).
Methods: Monocytic and neutrophilic CD11b and CD64 expressions were
analyzed from 27 patients with severe sepsis, seven OPCABG patients and
from eight ICU patients who did not fulfill any SIRS criteria. Blood
samples were collected within 48 hours from the beginning of severe
sepsis or in non-SIRS patients from ICU admission and two consecutive
days (D0, D1, D2). From surgical patients, the first samples were taken on
the day of surgery before the skin incision and two consecutive days (D0,
D1, D2). In addition 10 healthy individuals served as controls. Samples
Figure 1(abstract P40) Plot of log PCT (y axis) and index of SeptiCyte® Triage gene expression biomarkers (x axis) for 31 SIRS (black) and 87
sepsis (white) patients demonstrating the ability of each technology to differentiate these conditions.
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previously described [3].
Results: The maximum fluorescence intensities of monocytic and
neutrophilic CD11b and CD64 were highest in septic patients compared
with the other groups (P < 0.05) (Figure 1). In severe sepsis, fluorescence
intensities decreased over time (P < 0.05). In OPCABG the fluorescence
intensities of other antigens increased from D0 to D1 except neutrophilic
CD11b (P < 0.05). The intensities of other antigens except neutrophilic
CD64 were lower in the healthy than in all the other groups (P < 0.05).
Neutrophilic CD64, as well as other antigens, were lower in healthy
controls compared with severe sepsis at all time points (P < 0.05).
Conclusion: Based on this study, monocytic CD11b and neutrophilic
CD64 could be helpful in distinguishing severe sepsis from nonseptic
inflammation and healthy controls.
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Background: Invasive candidiasis is an important cause of morbidity and
mortality among hospitalized patient s .Ar a p i dd i a g n o s i si se x t r e m e l y
important for a successful outcome. Standard diagnostic methods (culture
and direct examination) often lack a satisfying sensitivity and require a
long growth period. The aim of the study was to assess the performance
of a new real-time PCR multiplex technique to rapidly detect Candida
DNA in clinical samples compared with culture-based methods.
Methods: Between November 2011 and May 2012, 142 blood samples
from 71 pediatric critical or hematological patients were studied both by
culture and PCR. The Magicplex Sepsis Real-time Test (Magicplex™ system;
Seegene) was used to detect Candida albicans, Candida parapsilosis,
Candida glabrata, Candida tropicalis and Candida krusei. Prior to DNA
extraction (EZ1 automatic system; Qiagen) at least 1 ml of blood sample
was inoculated into a VersaTREK REDOX1 bottle, which was incubated at
37°C for ≥3 hours. The PCR technique was performed according to the
manufacturer’s instructions. Culture-based methods were conduced
simultaneously in all specimens using the BacT/ALERT system (BioMérieux).
Results: A total of 131 of the 142 samples were both culture and PCR
negative. Nine blood samples (belonging to eight patients) were positive
by PCR, two of them were also positive by culture and the remaining
seven were not; two of the unfitting samples (28.5%) belonged to patients
with other multiple positive cultures for Candida spp. (urine and/or
catheter devices); the others belonged to patients with high clinical
suspicion and risk factors for invasive candidiasis. On the other hand, two
culture-proven and PCR-negative samples were considered false negative
results. Blood culture allowed the diagnosis of four patients (two of them
were also positive for PCR), while the evaluated PCR technique permitted
the detection of six additional cases (one of them with two positive
samples).
Conclusion: In this study the evaluated PCR system provides a rapid
technique for Candida detection. It can be considered an effective diagnostic
tool for diagnosing invasive candidiasis along with conventional cultures.
Figure 1(abstract P41) Antigen fluorescence intensities in four groups in 3 days.
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Background: Diagnostic and prognostic markers are of outmost importance
in the critical patient referred to the ICU. The aim of the present study was
the evaluation of procalcitonin (PCT), IL-10 and soluble CD25 (sCD25) as
potential markers in the diagnosis and prognosis of cohorts of critical
patients evaluated following a prospective design in a tertiary-center
university hospital.
Methods: We studied 52 consecutive SIRS patients with suspected sepsis
that were firstly stratified based on culture results (culture-positive and
culture-negative), then subsequently divided into survivors and
nonsurvivors. Venous blood samples were obtained from each patient
within 6 hours of hospital/ICU admission (T-0) and at the end of first week of
hospital/ICU stay (T-1). Serum samples were collected and used for
simultaneous determination of IL-10 and sCD25, using a cytokine biochip
array on the Evidence Investigator analyser (Randox Laboratories Ltd,
Crumlin, UK), while PCT was assayed by an enzyme-linked fluorescent assay
(VIDAS BRAHMS PCT; bioMerieux, France). Statistically significant differences
between groups were established by the Mann-Whitney U test. The
receiver-operating characteristic (ROC) curve was used to evaluate the
diagnostic accuracy (defined by the area under the ROC curve (AUROCC)) of
the analyzed cytokines and to determine the sensitivity and specificity at
selected cutoff values. The statistical analyses were performed using SPSS
14.0 software (SPSS, Chicago, IL, USA).
Results: PCT, IL-10 and sCD25 were significantly (P <0 . 0 5 )i n c r e a s e di n
infectious versus non-infectious SIRS patients at hospital admission (T-0)
and after 1 week of hospital stay (T-1). Diagnostic accuracy of PCT, IL-10
and sCD25 was evaluated by AUROCC and exhibited a significance index
of 0.0001, 0.0021 and 0.0095 respectively at T-0, while at T-1 the P values
were 0.0011, 0.0016 and 0.0201 respectively. Regarding prognostic
markers, PCT showed a prognostic significance only at T-1 (P = 0.04).
However when IL-10 and sCD25 values from survivors were compared with
those from nonsurvivors, significant differences were found for the former
and the latter marker with P =0 . 0 0 1 4a n dP = 0.014 respectively at T-0, as
well as with P = 0.0002 and P = 0.014 respectively at T-1.
Conclusion: In our study, well-known PCT and IL-10 markers and novel
sCD25 significantly contributed to diagnosis and prognosis of SIRS and
septic patients.
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Background: Nerve injury induced protein 1 (Ninjurin 1 (Ninj1)) was first
identified in Schwann cells and neurons contributing to cell adhesion and
nerve regeneration. Recently, the role of Ninj1 has been linked to
inflammatory processes in the central nervous system where functional
repression reduced leukocyte infiltration and clinical disease activity during
experimental autoimmune encephalomyelitis in mice [1]. But Ninj1 is also
expressed outside the nervous system in various organs such as the liver
and kidney as well as on leukocytes [2,3]. Therefore, we hypothesized that
Ninj1 contributes to inflammation in general; that is, also outside the
nervous system, with special interest in the pathogenesis of sepsis.
Methods: Ninj1 was repressed by transfecting HMEC-1 cells, a human
dermal microvascular endothelial cell line with siRNA targeting Ninj1
(siNinj1) or a negative control (siC). Subsequently, cells were stimulated with
100 ng/ml LPS (TLR4 agonist), 3 μg/ml LTA (TLR2 agonist) or 100 n/ml poly(I:
C) (TLR3 agonist) for 3 hours. The inflammatory response was analyzed by
real-time PCR. In addition, transmigration of neutrophils across a HMEC-1
monolayer was measured using transwell plates (pore size 3 μm).
Results: Repression of Ninj1 by siRNA reduced Ninj1 mRNA expression in
HMEC about 90% (Figure 1A). Reduced Ninj1 expression decreased
neutrophil migration to 62.5% (Figure 1B) and TLR signaling. In detail,
knockdown of Ninj1 significantly reduced TLR-2 and TLR-4 triggered
expression of ICAM-1 and IL-6 (Figure 1C,D) while poly(I:C)-induced
Figure 1(abstract P44) Effect of Ninj1 on TLR-induced inflammation.
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target, we measured IP-10 mRNA expression, which was also significantly
reduced in siNinj1-transfected cells (Figure 1E).
Conclusion: Our in vitro data strongly indicated that Ninj1 is involved in
regulation of TLR signaling and therewith contributes to inflammation.
In vivo experiments will clarify its impact on systemic inflammation.
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Background: Sepsis, a common cause of morbidity and mortality in
critically ill patients, is associated with systemic inflammatory response
syndrome due to upregulation of cyclooxygenase-2 and increase in the
levels of PGE2. It is also associated with increase in the levels of
proinflammatory cytokines like TNFa and IL-1b. Calotropis procera is a plant
that grows in the wild producing latex. The aqueous and methanolic
extracts of dried latex of this plant (AqDL and MeDL) and proteins isolated
from the fresh latex (LP) have shown anti-inflammatory and anti-arthritic
properties. AqDL and MeDL are orally effective, LP is effective parenterally.
The current study was designed to evaluate the efficacy of these extracts
against yeast-induced pyrexia and the levels of TNFa and PGE2 in the
hypothalamus of rats.
Methods: Pyrexia was induced in rats by subcutaneous injection of yeast in
the nape of the neck and the rectal temperature was measured at 0 hours
(basal temperature), 3 hours and 6 hours. Rats were divided into groups
(n = 6) and were treated with AqDL and MeDL given orally and LP given
intravenously at 6 hours. Group I: NC (normal control); Group II: YC (yeast
control); Group III: AqDL (200 mg/kg); Group IV: AqDL (400 mg/kg); Group V:
MeDL (100 mg/kg); Group VI: MeDL (250 mg/kg); Group VII: LP (5 mg/kg);
Group VIII: LP (25 mg/kg); Group IX: paracetamol (PCM 100 mg/kg). Rectal
temperature was measured hourly until 9 hours. The levels of TNFa and
PGE2 were measured in the excised hypothalamus region of the brain using
ELISA kits.
Results: Subcutaneous injection of yeast produced a marked increase in
rectal temperature of rats with a maximum effect at 6 hours (101.17°C). Like
paracetamol, treatment of rats with AqDL and MeDL produced a significant
decrease in body temperature from 101.17°C at 6 hours to 97.9°C and 98.2°C
at 9 hours respectively at higher doses and their effect was dose dependent
while LP was found to be ineffective. The present study shows that
treatment with yeast increased the tissue levels of TNFa (23.78 pg/mg) and
PGE2 (66.48 pg/mg) as compared with the NC group (16.31 and 41.35
respectively). All of the fractions lowered the hypothalamic TNFa level while
a marked reduction in PGE2 levels was observed with orally effective
fractions, namely AqDL and MeDL.
Conclusion: Our results demonstrate that the orally administered fractions
of latex of C. procera are effective in attenuating yeast-induced pyrexia and
this effect is mediated through reduction in the levels of PGE2.
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Background: Natural killer (NK) and natural killer T (NKT) cells play a key
role in bacterial infection and sepsis since they contribute to the bridging
of innate and acquired immune responses. We have previously shown
that in vivo depletion of these cell populations in a murine pneumococcal
pneumonia sepsis model affected mortality.
Methods: Four groups of C57BL/6 mice (n = 5 to 15 mice/group) were
infected intratracheally with 5 × 10
5 CFU Streptococcus pneumoniae.
Twenty-four hours prior to bacterial inoculation, NK cell depletion was
achieved by intravenous (i.v.) administration of anti-asialoGM1 rabbit
polyclonal antibody in one group (NK
DEPL), or anti-CD1d monoclonal
antibody, clone 1B1 was given for NKT cell depletion in a second group
(NKT
DEPL). The control group received equal volume of isotype antibody
control i.v. (C) and a fourth group received sham intratracheal installation
of normal saline (S). All animals were euthanized 48 hours post infection.
Serum and tissue samples were analyzed for bacterial colony counts,
cytokine levels, splenocyte apoptosis rates and cell population analysis by
flow cytometry. In parallel, specific miRNA expression analyses in
splenocytes and lung histologic examination were also performed.
Comparisons of numeric data between groups were made using the one-
way ANOVA test for multiple groups.
Results: We found that upon NK cell depletion there was a significant
increase in the spleen NKT (CD3
+/CD1d
+) cell population compared with
NKT
DEPL,Ca n dS( P =0 . 0 1 4 ,P =0 . 0 2 1a n dP =0 . 0 3 3 ,r e s p e c t i v e l y ) .
Interestingly, upon NKT cell depletion, spleen NK (CD3
-/NK1.1
+) cells
increased significantly compared with NK
DEPL,Ca n dS( P < 0.0001, P <
0.0001 and P = 0.001, respectively). NKT depletion led to decreased
lymphocyte apoptosis compared with C (P = 0.035), higher bacterial load
in the lung compared with C and NK
DEPL (P =0 . 0 1 4a n dP = 0.022
respectively) and in the liver compared with C (P =0 . 0 1 2 ) .I na d d i t i o n ,
serum levels of IFNg were significantly increased and splenocytes from
NKT depleted animals, incubated ex vivo in the presence or absence of
IL-2, produced more IFNg in comparison with all other groups. Furthermore,
splenocyte miRNA analysis showed that miR-200c and miR-29a were
downregulated, while miR-125a-5p was upregulated, in the NKT depleted
animals compared with all other groups.
Conclusion: F o rt h ef i r s tt i m ew eh a v es h o w nt h a tN K Tc e l ld e p l e t i o n
resulted in an increase in spleen NK (CD3
-/NK1.1
+) cells and a higher IFNg
production, which were associated with specific changes in splenocyte
miRNA expression.
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Background: Undergoing systemic inflammation, the innate immune
system releases excessive proinflammatory mediators, which finally can
lead to organ failure. Pattern recognition receptors (PRRs), such as Toll-like
receptors (TLRs) and NOD-like receptors (NLRs), form the interface between
bacterial and viral toxins and innate immunity. During sepsis, patients with
diagnosed adrenal gland insufficiency are at high risk of developing a
multiorgan dysfunction syndrome, which dramatically increases the risk of
mortality. To date, little is known about the mechanisms leading to adrenal
dysfunction under septic conditions. Here, we investigated the sepsis-
related activation of the PRRs, cell inflammation, and apoptosis within
adrenal glands.
Methods: Two sepsis models were performed: the polymicrobial
sepsis model (caecal ligation and puncture (CLP)) and the LTA-induced
intoxication model. All experiments received institutional approval by the
Regierungspräsidium Darmstadt. CLP was performed as previously
described [1], wherein one-third of the caecum was ligated and punctured
with a 20-gauge needle. For LTA-induced systemic inflammation, TLR2
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-/-) and WT mice were injected intraperitoneally with pure
LTA (pLTA; 1 mg/kg) or PBS for 2 hours. To detect potential direct adrenal
dysfunction, mice were additionally injected with adrenocorticotropic
hormone (ACTH; 100 μg/kg) 1 hour after pLTA or PBS. Adrenals and plasma
samples were taken. Gene expressions in the adrenals (rt-PCR), cytokine
release (multiplex assay), and the apoptosis rate (TUNEL assay) within the
adrenals were determined.
Results: In both models, adrenals showed increased mRNA expression of
TLR2 and TLR4, various NLRs, cytokines as well as inflammasome
components, NADPH oxidase subunits, and nitric oxide synthases (data
not shown). In WT mice, ACTH alone had no effect on inflammation,
while pLTA or pLTA/ACTH administration showed increased levels of the
cytokines IL-1b, IL-6, and TNFa.T L R 2
-/- mice indicated no response as
expected (Figure 1, left). Interestingly, surviving CLP mice showed no
inflammatory adrenal response, whereas nonsurvivors had elevated
cytokine levels (Figure 1, right). Additionally, we identified a marked
increase in apoptosis of both chromaffin and steroid-producing cells in
a d r e n a lg l a n d so b t a i n e df r o mm i c ew i t hs e p s i sa sc o m p a r e dw i t ht h e i r
controls (Figure 2).
Conclusion: Taken together, sepsis-induced activation of the PRRs may
contribute to adrenal impairment by enhancing tissue inflammation,
oxidative stress and culminate in cellular apoptosis, while mortality seems
to be associated with adrenal inflammation.
Reference
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Figure 1(abstract P47) Cytokine concentrations of IL-1b, IL-6 and TNFa in plasma and adrenal lysates. From WT and TLR2
-/- mice treated with PBS
(2 hours), ACTH (100 μg/kg; 1 hour), pLTA (1 mg/kg; 2 hours) or PBS/ACTH and pLTA/ACTH (left) and from WT mice that underwent CLP sham operation
(sham), CLP with single (CLP-1P) or double (CLP-2P) puncture (right). Animals that survived after 24-hour CLP are labelled ‘s’ and deceased ones ‘ns’. Data
are presented as mean ± SEM (n ≥ 6). Statistical significance was determined by one-way ANOVA and Bonferroni’s post test (vs. PBS within one group) or
t test (WT vs. TLR2
-/-). *P < 0.05, **P < 0.01, +P < 0.005, ++P < 0.001, #P < 0.0005, ##P < 0.0001.
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Background: Triggering receptor expressed on myeloid cells-1 (TREM-1)
is expressed on innate immune cells and plays a crucial role during the
onset of sepsis by amplifying the host immune response. TREM-like
transcript-1 (TLT-1) belongs to the TREM family and is selectively
expressed on activated platelets. We recently showed that TLT-1 and a
TLT-1-derived peptide (LR12) exhibit anti-inflammatory properties by
dampening TREM-1 signalling and thus behave as naturally occurring
TREM-1 inhibitors [1]. We also, however, demonstrated that the same
peptide modulates in vivo the inflammatory cascade triggered by
infection, thus inhibiting hyper-responsiveness, organ damage and death
during sepsis in mice. As mouse models of septic shock are far from
recapitulating the human physiology, we investigated the effects of LR12
during peritonitis in adult mini-pigs. Here we show that sepsis-induced
cardiovascular dysfunction and organ failure was prevented by LR12
administration. The objective was to determine the effects of a TLT-1
derived peptide (LR12) administration during septic shock in pigs (13
adult male mini-pigs).
Methods: Two hours after induction of a fecal peritonitis, anesthetized
and mechanically ventilated mini-pigs were randomized to receive LR12
(n = 6) or its vehicle alone (normal saline, n =5 ) .T w oa n i m a l sw e r e
operated and instrumented without the induction of peritonitis and
served as controls (sham). Resuscitation was achieved using hydroxyethyl
starch (up to 20 ml/kg) and norepinephrine infusion (up to 10 μg/kg/
minute).
Results: Hemodynamic parameters were continuously recorded. Gas
exchange, acid-base status, organ function, and cytokines were measured
at regular intervals until 24 hours after the onset of peritonitis when
animals were sacrificed under anesthesia. Peritonitis induced profound
hypotension, myocardial dysfunction, lactic acidosis, coagulation
abnormalities, and multiple organ failure. These disorders were largely
attenuated by LR12. In particular, cardiovascular failure was prevented as
attested by better mean arterial pressure, cardiac index, cardiac power
index, and SvO2, despite lower norepinephrine requirements (Figure 1).
Finally, 24-hour mortality rates were respectively 60% and 0% for control
and LR12 groups.
Conclusion: LR12, a TLT-1 derived peptide, exhibits salutary properties
during septic shock in adult mini-pigs.
Reference
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Figure 2(abstract P47) Apoptosis in murine adrenal glands. From WT and TLR2
-/- mice treated with PBS (2 hours), pLTA (1 mg/kg; 2 hours) or pLTA/
ACTCH (left) and from WT mice that underwent CLP sham operation (sham), CLP with single (CLP-1P) or double (CLP-2P) puncture (right). TUNEL staining
in adrenal sections showing whole adrenals (inserted pictures; 100× magnification), cortex and medulla area (400× magnification). The apoptotic cells
appeared with brown nuclear staining.
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Background: Triggering receptor expressed on myeloid cells-1 (TREM-1)
is a receptor of the immunoglobulin superfamily expressed on the
surface of neutrophils and monocytes/macrophages. It plays an important
role during sepsis by amplifying the inflammatory response. Modulation
of TREM-1 through the administration of a short synthetic peptide (LR12)
increases survival during experimental sepsis. This study aimed to explore
the mechanisms by which LR12 prevented sepsis-induced cardiovascular
dysfunction.
Methods: We studied the effect of TREM-1 modulation by a synthetic
peptide LR12 (3 mg/kg) on MAP and blood lactate during experimental
sepsis (CLP). Aortic and mesenteric arterial vessels of these animals were
collected to study the vasoreactivity to phenylephrine (Phe) and
acetylcholine (Ach) ex vivo (Myograph). Alternatively, vasoreactivity was
studied in the vessels of healthy animals (with and without endothelial
lawyer) stimulated with LPS or with a specific agonist of TREM-1 (aTREM-
1, 10 μg/ml), with or without LR12 (20 mg/ml). The effect of LR12 on
arterial vessels was also studied through western blotting (eNOS, iNOS,
Akt, COX-1, COX-2) and qRT-PCR. Mouse lung microvascular endothelial
cells (LUMECs; CD146
+) were analyzed by flow cytometry, qRT-PCR, and
ELISA to decipher the effect of LR12 on LPS-induced endothelial
activation.
Results: CLP induced MAP decrease and lactate elevation were prevented
by the administration of LR12. Arterial vessels from septic animals treated
with LR12 showed better response to Phe and Ach compared with
controls. The reactivity of aortic and mesenteric vessels (contraction and
relaxation) stimulated in vitro with LPS or by aTREM-1 was altered: this
phenomenon was reversed by LR12. LR12 restored the phosphorylation of
Akt and eNOS while it reduced the activation of inducible pathways (iNOS,
COX-2). FACS analysis showed that TREM-1 is constitutively expressed by
LUMECs (CD146
+/VEGFR2
+). In vivo, the expression of Trem-1 was increased
in septic animals and was inducible in vitro upon stimulation with LPS.
Trem-1, Tnf-a and Il-6 expression was upregulated by LPS; once again LR12
attenuated this upregulation. Finally, the production of several cytokines
by LPS-stimulated LUMECs was decreased by LR12.
Conclusion: Here we show that TREM-1 is expressed on endothelial cells
from the aorta, mesenteric artery, and microvascular endothelial cells, and
that TREM-1 might be directly involved in endothelial dysfunction during
experimental sepsis.
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Background: In macrophages Toll-like receptor 4 (TLR4) is activated in
response to lipopolysaccharide (LPS) and induces proinflammatory cytokine
expression [1]. Therefore, mechanisms terminating proinflammatory gene
expression are important. Autophagy plays a central role in controlling
innate immune responses by lysosomal degradation of signaling proteins,
thus contributing to the resolution of inflammation [2]. Autophagic proteins
like p62 directly interact with molecules involved in the TLR4-signaling
pathway, but a correlation with the IRAK E3 ligase and scaffold protein
Pellino3 remains obscure [3,4]. Hence, we are interested in elucidating the
function of Pellino3 to prove our hypothesis that it is a key regulator in the
TLR4-signaling cascade [5].
Methods: We used the cecal ligation and puncture (CLP) mouse model
causing polymicrobial sepsis to analyze Pellino3 protein and mRNA
expression. Furthermore, we induced endotoxemia in RAW264.7 mouse
macrophages by LPS treatment to verify in vivo experiments. Lentiviral
Pellino3 knockdown in RAW264.7 macrophages was used for cytokine
measurements at mRNA level. To analyze potential Pellino3 binding
partners in TLR4-signaling by mass spectrometry (MS), we overexpressed
FLAG-tagged Pellino3 in RAW264.7 macrophages, treated cells for 3, 6
and 24 hours with LPS and immunoprecipitated Pellino3 via its FLAG-tag.
To consider Pellino3 degradation as a result of p62-mediated autophagy,
we transiently knocked down p62 by siRNA in RAW264.7 macrophages
and also pharmacologically blocked LPS-induced autophagy by
Bafilomycin A1.
Results: We demonstrated Pellino3 protein degradation in primary
CD11b
+ s p l e n o c y t e sa f t e r2 4h o u r sf ollowing CLP operation and
confirmed this in RAW264.7 macrophages after 24-hour LPS stimulation.
Knockdown of Pellino3 attenuates proinflammatory cytokines, for
example IL-6 mRNA, after 6 hours of LPS. Furthermore, we found by MS
and verifying immunoprecipitation experiments that p62 is a Pellino3
binding partner, thus targeting Pellino3 for degradation. In line, both p62
knockdown and Bafilomycin A1 treatment prevent Pellino3 degradation,
supporting an autophagic mechanism.
Conclusion: Our observations highlight a regulatory role of Pellino3 on
TLR4 signaling. Thus, antagonism of Pellino3 in the hyperinflammatory
Figure 1(abstract P48) LR12 protects from sepsis-induced hypotension. Evolution of mean arterial pressure (a) and norepinephrine requirements (b)
during the 24-hour study period. MAP was constantly higher and norepinephrine dose lower in LR12-treated animals than controls.
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stabilization of Pellino3 by inhibition of autophagy in the hypoinflammatory
phase of sepsis may improve immunity. In consideration of these two
conflictive sepsis phases, modulation of Pellino3 may provide a new strategy
for the development of a therapy approach in sepsis.
Acknowledgements: This research was supported by a grant from the
Deutsche Forschungsgemeinschaft (KN493/9-1 and SFB TP3).
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Background: The multicomponent phagocytic NADPH oxidase produces
reactive oxygen species (ROS) after activation by microorganisms or
inflammatory mediators [1]. In the hypoinflammatory phase of sepsis,
macrophages are alternatively activated by contact with apoptotic cells or
their secretion products. This inhibits NADPH oxidase and leads to
attenuated ROS production [2] and furthermore contributes among others
to a hyporeactive host defense. Due to this immune paralysis, sepsis
patients suffer from recurrent and secondary infections [3]. We focused on
the catalytic subunit of NADPH oxidase, the transmembrane protein NOX2
[4]. We assume that after induction of sepsis the expression of NOX2 is
reduced and hence ROS production is decreased.
Methods: We induced polymicrobial sepsis in mice by cecal ligation and
puncture. The ability of peritoneal macrophages (PMs) to produce ROS was
determined by FACS via hydroethidine assay. NOX2 expression of PMs was
determined by western blot and qPCR. To elucidate the mechanism
causing mRNA destabilization, we performed in vitro experiments using
J774 macrophages. To obtain an alternatively activated phenotype,
macrophages were stimulated with conditioned medium from apoptotic
T cells (CM). By luciferase assays we figured out a 3’UTR-dependent
regulation of NOX2 mRNA stability. Assuming that a protein is involved in
the mRNA degradation, we performed a RNA pulldown with biotinylated
NOX2-3’UTR constructs followed by mass spectrometry. We verified the
role of SYNCRIP by siRNA approach. Additionally, we overexpressed NOX2
in J774 cells and analyzed the ROS production (w/wo CM treatment) by
FACS.
Results: We found an impaired expression of NOX2 at RNA and protein
level along with decreased ROS production after induction of sepsis in mice
as well as stimulating J774 macrophages with CM of apoptotic T cells. This is
due to a time-dependent NOX2 mRNA degradation depending on SYNCRIP,
a RNA-binding protein, which stabilizes NOX2 mRNA through binding to its
3’UTR under normal conditions. In line, knockdown of SYNCRIP also
decreases NOX2 mRNA expression. We assume that a CM-dependent
modification or degradation of SYNCRIP prevents its stabilizing function. As
the overexpression of NOX2 restores ROS production of CM-treated J774
cells, we assume that NOX2 expression is crucial for maintaining NADPH
activity during the hypoinflammatory phase of sepsis.
Conclusion: Our data imply a regulatory impact of SYNCRIP on NOX2
stability during the late phase of sepsis. Therefore, further understanding
of the regulation of NADPH oxidase could lead to the design of a therapy
to reconstitute NADPH oxidase function, finally improving immune
function in sepsis patients.
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Background: The ligand-activated transcription factor, peroxisome-
proliferator-activated receptor gamma (PPARg), has been shown to play an
essential role in immunosuppression during sepsis. PPARg is upregulated in
T cells of septic patients, sensitizing these cells to PPARg-dependent
apoptosis and thus contributing to T-cell depletion [1,2]. In the polymicrobial
cecum ligation and puncture (CLP) sepsis model in mice, both T-cell-specific
gene knockout (Lck-Cre PPARg
fl/fl) and systemic pharmacological PPARg
antagonism by GW9662 improved survival [3]. Because GW9662 was only
effective when applied 3 hours after CLP, we were interested to extend this
time frame. For this reason we characterized the kinetics of SPPARgMs when
administered before or in combination with the agonist thiazolidinedione,
rosiglitazone.
Methods: AP P A R g-dependent transactivation assay was used in HEK293T
cells. It is based on the vector pFA-PPARg-LBD-GAL4-DBD encoding the
hybrid protein PPARg-LBD-GAL4-DBD and the reporter vector pFR-Luc,
carrying a GAL4-responsive element in front of the Firefly luciferase gene.
These two vectors were co-transfected, in combination with a control
vector encoding Renilla luciferase (pRL-CMV) to normalize Firefly luciferase
activity for transfection efficiency. Following transfection, cells were
incubated with the SPPARgMs F-MOC and MCC-555 and the PPARg
antagonist GW9662 for different times (2 to 48 hours) and at increasing
doses (0.01 to 10 μM), with or without rosiglitazone (0.01 to 10 μM).
Transactivation was analyzed using a 96-well plate format.
Results: Rosiglitazone transactivated PPARg in a time-dependent and dose-
dependent manner, the response gradually increasing to a maximum at
48 hours with 10 μM. Low concentrations (0.01 to 0.1 μM) of SPPARgMs
F-MOC and MCC-555 and the PPARg antagonist GW9662 all exerted dose-
independent antagonistic effects at an early incubation time point (2 hours).
From 10 hours onwards, MCC-555 and GW9662, given alone, both exerted
PPARg agonistic effects, MCC-555 in parallel to responses to rosiglitazone,
but GW9662 with characteristics of partial antagonism. F-MOC showed no
dose-dependent effect at any concentration at later time points. Only
GW9662 (1 to 10 μM) was able to inhibit rosiglitazone (0.1 to 1 μM)-induced
PPARg transactivation after 10 hours.
Conclusion: Our kinetic analysis reveals clear differences in the
modulatory characteristics of PPARg inhibitors, with previously unreported
early inhibitory effects and late agonistic or partial agonistic activity. New
SPPARgMs with extended inhibitory activity may prove useful in the
therapy of sepsis.
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Background: Fatal human critical cases associated with influenza A
subtype H5N1 have been documented in Bandung, Indonesia. Of four
children, three died. We determined the level of cytokines and chemokines
in those patients.
Methods: The Luminex method was used to look for the profile of
cytokine and chemokine gene expression induced by H5N1 influenza virus
from patient’s serum.
Results: We found that H5N1 influenza virus in the dead children was a
more potent inducer of IL-6, the level being higher (17.00, 74.31, 85.75)
than in the one child who survived (4.78). The IFNg level of the fatal
causes was also higher (21.43, 31.75, 384.38) than in the one child who
recovered (5.51). This suggested that a cytokine storm may play a role in
the pathogenesis of fatal H5N1 cases.
Conclusion: The H5N1 influenza A virus is a potent inducer of
proinflammatory cytokines and chemokines. This hyperinduction of
cytokines may be relevant to mortality of children with H5N1 infection.
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Background: Sepsis-induced organ damage is a leading cause of death in
critically ill patients. Thrombopoietin (TPO) is a humoral growth factor
mainly involved in regulation of platelet number and function. High
circulating levels of TPO are detectable in septic adults and children and
are related to sepsis severity. We have previously shown a correlation
between TPO levels and platelet activation in septic burned patients,
where circulating activated platelets may cause microthrombotic events
that lead to organ damage. Our aim was to evaluate the contribution of
TPO in organ injury in a murine model of polymicrobial sepsis. To this end,
we synthesized and used a chimeric fusion protein, named mouse TPO
Receptor-Maltose Binding Protein (mTPOR-MBP), able to inhibit TPO
biological activity.
Methods: Male C57BL/6 mice were randomized to cecal ligation and
puncture-induced sepsis (CLP) or to laparotomy (sham) surgery. CLP mice
received 40 μg mTPO-MBP or sterile saline 10 minutes after surgery.
Immediately after and 6 hours after surgery all animals received 0.08 mg/kg
buprenorfin in 1.5 ml sterile saline subcutaneously. After 18 hours blood was
collected from the cava vein and used for cell count, flow cytometric
analysis of leukocyte-platelet interaction and to obtain plasma. Plasma TPO
levels were determined by ELISA. The lung and liver were excised and fixed
in 4% paraformaldehyde solution. An expert pathologist blinded to
experimental groups quantified organ damage.
Results: Plasma TPO levels were significantly higher in septic mice (nine
mice in each group). Leukocyte and platelet counts did not significantly
differ in the CLP group treated with mTPOR-MBP compared with the CLP
control group. In contrast, the percentage of monocyte-platelet
aggregates, a marker of platelet activation, was significantly reduced after
treatment with mTPOR-MBP. Moreover, TPO blockade by mTPOR-MBP
administration induced a significant reduction of histological alterations
in the lung, as evaluated by neutrophil infiltration and thickening of the
alveolar-capillary membrane, and liver tissue samples, as evaluated by the
number of microabscesses.
Conclusion: Increased circulating levels of TPO during experimental
sepsis may have a role in the development of organ damage. Inhibition
of TPO biological activity may represent a novel promising therapeutic
approach to prevent organ failure in severe sepsis.
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Background: Cholecystokinin (CCK) was firstly described as a
gastrointestinal hormone, but immune cells express their receptors,
suggesting a possible involvement of this peptide in pathophysiological
processes. Our aims were to evaluate the role of CCK on resistance against
Gram-positive Staphylococcus aureus-induced sepsis, as well as cell influx to
infectious focus. Furthermore, since nitric oxide, TNFa and IL-10 play a key
role in the innate immune system controlling bacterial infection, we also
evaluated the synthesis of these inflammatory mediators during this sepsis
model.
Methods: Male Wistar rats (180 to 200 g) received an intraperitoneal
injection of proglumide (P) (nonselective CCK receptor antagonist; 30 or
50 mg/kg) 30 minutes before bacterial S. aureus inoculum (0.5 to 1 × 10
10
CFU/animal). At 4 and 24 hours after sepsis induction, blood and
peritoneal lavage fluid (PLF) were collected for microbiological analysis,
cytokines and nitrate quantifications and also differential cell counting.
Nitrate was detected by chemiluminescence, while TNFa and IL-10 were
determined by ELISA sandwich kits.
Results: The pretreatment with P at higher dose (50 mg/kg) increased
bacteremia in comparison with the saline-injected group (2,052 ± 810.7
vs. 154.3 ± 47.0 CFU/ml, P < 0.01) at 4 hours after sepsis induction. At the
same time point, the bacterial counting in PLF increased in a dose-
dependent manner in the P-treated rats (P < 0.05). On the other hand,
only the higher P dose elevated significantly the CFU/ml in the PLF at
24 hours (97.75 ± 12.77 × 10
4 vs. 35 ± 10.05 × 10
4 CFU/ml, P < 0.05). The
plasma TNFa and nitrate concentrations were not changed by treatment
or time after sepsis induction. However, the administration of CCK
receptors antagonist reduced the TNFa production in comparison with
the control group in PLF, at both time points. The plasma IL-10
concentration increased at 4 hours in P-treated rats, while at 24 hours it
was reduced (85.83 ± 48.0 vs. 1,698 ± 265.6 pg/ml, P < 0.001). In PLF, the
rats pretreated with P reduced the IL-10 measurements (P < 0.05) when
compared with the control group. In agreement, the macrophage influx
to peritoneal infectious focus was compromised by treatment with a high
P dose at 24 hours after S. aureus-induced sepsis (3,947.73 ± 269.99 vs.
5,629.61 ± 786.90 cells/μl; P < 0.05). Moreover, the neutrophil count did
not change among the experimental groups (6,860.59 ± 211.90 vs.
6,273.54 ± 798.91 cells/μl).
Conclusion: These data suggest a protective role for CCK peptide during
S. aureus-induced sepsis, modulating the systemic and local inflammatory
response, as well as increasing the macrophage influx to the infectious
focus.
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Background: Since 1994, Polymyxin B-direct hemoperfusion (PMX-DHP)
(Toraymyxin®; Toray Medical Co., Tokyo, Japan) has been approved as
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negative infection in Japan. However, its efficacy and indication are still
controversial issues. Recently, randomized controlled studies are ongoing
in other countries. Our hypothesis is that PMX-DHP therapy may improve
the hemodynamic status in septic patients.
Methods: From July 1994 to June 2010, all adult patients treated with
PMX-DHP and receiving a pulmonary arterial catheter (PAC) in our ICU
were included in this retrospective observational study. Patients’ clinical,
microbiological and PAC data were collected from medical archives. PAC
variables were compared between immediately before and immediately
after PMX-DHP therapy. Values were expressed as mean ± SD. Data were
analyzed by Wilcoxon signed-ranks test, chi-square test and Fisher’se x a c t
probability test. P < 0.05 was considered statistically significant.
Results: Sixty-three patients (36 men, 27 women; age range 24 to
89 years (mean 63.4 ± 14.8)) were studied. The mortality rate was 30.2%
at 28 days after PMX-DHP. The APACHE II score and SOFA score on the
day of PMX-DHP therapy were 20.2 ± 14.8 and 7.3 ± 3.8, respectively.
Mean arterial pressure (MAP; mmHg), cardiac index (CI; l/minute/m
2), and
oxygen delivery and consumption (DO2 and VO2; ml/minute) significantly
improved after PMX-DHP therapy (77.5 ± 22.5 vs. 84.1 ± 23.4, P =0 . 0 0 1 3 ;
3 . 9±1 . 5v s .4 . 3±1 . 2 ,P = 0.0006; 951.6 ± 403.5 vs. 1,002.5 ± 394.0, P =
0.013; 233.5 ± 80.6 vs. 248.0 ± 84.1, P = 0.004, respectively). The systemic
venous resistance index (SVRI) (dyn second m
2/cm
5) and mixed venous
oxygen saturation (SvO2; %) were not statistically different before and
after PMX-DHP therapy (1,573.6 ± 614.6 vs. 1,527.7 ± 575.5, P = 0.069;
71.9 ± 9.0 vs. 74.1 ± 7.5, P = 0.082). The inotropic score and P/F ratio
improved after the therapy (9.9 ± 15.9 vs. 7.5 ± 12.5, P = 0.018; 269.8 ±
108.5 vs. 300.6 ± 133.4, P = 0.003).
Conclusion: MAP, CI, DO2,V O 2, inotropic score and P/F ratio improved
after PMX-DHP therapy, while SVRI and SVO2 did not change. PMX-DHP
could contribute to oxygen delivery due to improve hemodynamic status,
while decreasing inotropic agents in septic patients.
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Background: Sepsis is a common condition in newborns, which has
significant morbidity and mortality worldwide. In recent years, multiple
factors have led to an increase in its incidence, such as the use of invasive
diagnostic procedures, broad-spectrum antimicrobial therapy and an
increase of immunocompromised patients. There have also been changes
in the profile of the agents causing sepsis. The aims of this study were the
determination of the annual incidence of neonatal sepsis (early-onset and
late-onset), analyzing their clinical course, significant microorganisms
isolated and the profile of antimicrobial resistance.
Methods: One hundred and ninety-eight cases of sepsis were studied,
collected over the past five years (2007 to 2011). Early-onset neonatal
sepsis was defined as that which appeared before 3 days of life and late-
onset neonatal sepsis if it happened later. Blood cultures were incubated
in the BACTEC FX System (Becton Dickinson), and identification and
antimicrobial susceptibility testing were done by the Wider system (Soria
Melguizo). Yeasts were identified by ID32C (bioMerieux).
Results: Of the 198 detected sepsis cases, 173 (87.4%) were late and 25
(12.6%) were early. While the annual incidence rate of early-onset sepsis
was uniform in each year, the late-onset sepsis has experienced an
increase in 2011. The mortality rate was similar throughout the study
(10.8%). Gram-negative bacilli are the most frequently isolated (48%),
with predominance of enterobacteria compared with nonfermenters (84
vs. 11 cases), followed by Gram-positive cocci (36%) and yeast (16%).
In candidemia most common are nonalbicans species of Candida (27 vs.
5c a s e s ) ,w i t hCandida parapsilosis more frequently isolated (65.6%).
Klebsiella pneumoniae (33 strains) was the more frequent microorganism,
followed by Escherichia coli, Staphylococcus epidermidis, C. parapsilosis and
Enterobacter cloacae. With respect to antibiotic resistance, 11.1% of
Staphylococcus aureus were MRSA and 19% (16 strains) of enterobacteria
were ESBL producing. Only one strain of Pseudomonas aeruginosa was
resistant to imipenem by metallobetalactamases.
Conclusion: K. pneumoniae was the organism responsible for more
episodes of sepsis in neonates. As in other studies in neonatology, this
study highlights the prevalence of nonalbicans species in candidemia due
to the frequency of C. parapsilosis. Late-onset sepsis has increased by
Gram-negative bacilli in the last year, probably due to the occurrence of
a nosocomial outbreak of ESBL-producing E. cloacae.H o w e v e r ,t h e
mortality rate from sepsis has remained stable. When clinically evaluated,
cases of sepsis can be detected as a predominance of enterobacteria
against S. epidermidis, highlighting the importance of careful analysis of
clinical outcomes.
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Background: Kidney injury molecule-1 (KIM-1) is a new biomarker
promising a better detection and diagnostic quality of acute kidney injury
(AKI).
Methods: This clinical prospective study - approved by the local ethics
committee - was performed to assess urinary levels of KIM-1 by ELISA
technique in 38 patients with septic shock (Table 1). They were prospectively
enrolled within 24 hours of onset of signs of infection, if they met the criteria
for septic shock as defined by the members of the ACCP/SCCM Consensus
Conference Committee. KIM-1 levels were quantified on admission (baseline,
day 0) and on days 4, 7 and 10 of the ICU stay. The patients were classified
by AKIN and RIFLE criteria. Data were analyzed with regard to the prognostic
value of survival, need for renal replacement therapy (RRT) and correlation
with renal function parameters (plasmatic urea and creatinine, creatinine
elimination and clearance, free water clearance, fractional sodium excretion)
or hepatic laboratory findings (albumin, total bilirubin, ASAT, ALAT, g-GT).
Data are given as mean ± SEM.
Results: The urinary KIM-1 concentration on admission showed no
significant difference with respect to survival of patients. However, the
urinary KIM-1 concentration determined on days 4, 7 and 10 was higher in
patients surviving septic shock (P < 0.001 on days 4 and 7). Elimination
displayed lower levels in deceased patients (P < 0.05 on days 0 and 4),
whereas urinary output was higher in survivors during the whole ICU stay
(P < 0.05 on day 7). Urinary KIM-1 concentration did not differ between AKIN
and RIFLE classification groups. Urinary KIM-1 elimination per 24 hours on
days 0, 4 and 7 was higher in stage 1 than in stage 2 or 3 of the AKIN
classification, respectively (both P < 0.05). If patients were classified by RIFLE
criteria, urinary KIM-1 elimination was also higher in the risk group as
compared with the injury or failure group without reaching significance.
However, the need for RRT was reflected by a higher urinary KIM-1
concentration after admission (P < 0.05 on days 4 and 10), a lower KIM-1
elimination and urinary output during the whole ICU stay (KIM-1 elimination:
Table 1(abstract P59) Demographic data
Age (years) 57.2 ± 2.6
Gender (male/female) 27/11
BMI (kg/m
2) 29.7 ± 1.5
Length of ICU stay (days) 19.5 ± 2.7
Mortality (%) 13.2 (5 out of 38 patients)
SAPS score 63.4 ± 2.7
APACHE II score 28.8 ± 1.3
SOFA score 12.7 ± 0.5
MOD score 10.4 ± 0.6
RIFLE (number per group) no AKI = 28; risk = 4; injury = 3;
failure = 3;
AKIN (number per group) no AKI = 25; stage 1 = 1; stage 2 = 1;
stage 3 = 11
Need for RRT (yes/no) 16/22
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day 7; Figure 1A,B,C). Neither urinary KIM-1 concentration or elimination
correlated with any renal and hepatic function parameter.
Conclusion: Urinary KIM-1 can be used as a prognostic factor for survival
and need for RRT in septic shock patients.
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Background: Necrotizing fasciitis (NF) is one of the most severe diseases
among surgical infections. There is always severe sepsis, multiple organ
dysfunction, septic shock with NF and high mortality rates from 50% to 80
to 100%. Progressive severe sepsis with a lack of local inflammatory
symptoms is being characterized as a modern clinical view of NF.
Methods: A 5-year retrospective analysis of 12,907 admitted patients to the
Department of Surgical Infections and Sepsis from 2007 until 2011 years was
performed. All patients were admitted by the emergency service. The
duration of admitting to the hospital from disease onset was 1 to 7 days,
with a mean of 2 to 3 days.
Results: There were 86 patients with NF in 2007 to 2011. All patients had
severe sepsis or septic shock with multiple organ dysfunction proved by
laboratory tests and were treated in the ICU. The most frequent
accompanying immunodeficient disorders are diabetes, oncology, alcohol
and drug addiction, and extensive contusion of soft tissues. There were six
patients in 2007 with NF (2 discharged/4 died), 13 patients in 2008 (7/6),
18 patients in 2009 (6/12), 16 patients in 2010 (12/4), and 33 patients in
2011 (15/18) correspondingly. Obtained results show a stable increase of
patients with NF. The amount of patients with NF by 2011 was extended
5.5 times compared with 2006. The mortality rates fluctuated between 55
and 66%, less mortality rate was seen in 2010 (25%). On average the
mortality rate was 51.5%; this corresponds to the modern literature
reviews. The most common organisms isolated were: Enterococcus faecalis
(18.5%), Staphylococcus aureus (15.5%), Streptococcus (14%) and anaerobic
cultures (6.6%). All admitted patients had been treated immediately with
high doses of intravenous antibiotics and extensive surgical treatment of
the infection lesions; following intensive treatment in the ICU was made.
Serious attention to immunotherapy was made. Severe reduction of the
lymphocytes and hemoglobin seemed clinically significant in prediction of
inflammation severity.
Conclusion: Accompanying immunodeficient disorders influence rising
NF. Early diagnostics and active treatment make better treatment results
and decrease mortality rates. Progressive decrease of lymphocytes and
hemoglobin is extremely adverse to predict. Using immunotherapy makes
clinical results much better. Regular microbiological monitoring of wound
infection should make adequate antibiotic therapy.
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Background: Erysipelas in some patients can be complicated with SIRS
and sepsis, even with septic shock that may be explained by the
hyperactivity of the complement system. The complement system in
erysipelas has not been explored thoroughly. Previously a reduction of the
general hemolytic activity of different complement components was
reported. The study of the complement system is absolutely required to
determine the functional state of the immune system and inflammation
process in erysipelas.
Methods: Plasma samples from 38 patients with different clinical
erysipelas forms (two primary erysipelas, 12 recurrent erysipelas) were
obtained in 2010. The erythematous form was diagnosed in 10 patients
with primary infection and in four patients with recurrent infection, the
erythematous-hemorrhagic form in eight and seven patients, and the
bullous-hemorrhagic form in seven and two patients accordingly. Blood
samples were taken on day 1 (admission to the hospital) and on days 7 to
10 (on discharge from the hospital). The evaluation of the concentration of
the complement components was performed by commercial solid-phase
ELISA. The components studied were: C1-inhibitor (C1-INH) (μg/ml),
C4 (mg/ml), C3 (mg/ml), C5 (μg/ml), anafilatoxins C3a (ng/ml) and C5a (ng/
ml), and a hydrolysed form of the C3 component C3[H2O] (mg/ml and % of
total C3) that is triggered by the alternative pathway.
Results: There were significantly increased concentrations of anafilatoxins
C3a and C5a, C1-INH and C3[H2O] in erysipelas patients compared with
healthy individuals. Correlations were found between serum concen-
trations of C4 and C3 (r = 0.89; P < 0.01) and anafilatoxins C3a and C5a (r =
0.55; P < 0.01). Significant differences were found in different clinical
erysipelas forms: patients with primary erysipelas (erythematous form) had
significantly higher concentrations of anafilatoxin C3a than patients with
the more severe bullous-hemorrhagic form (P = 0.02). These data support
t h eh y p o t h e s i st h a tC 3 ah a sr e g u l a t o r y anti-inflammatory features that
make it differ from the definitely proinflammatory C5a component. The
portion of C3[H2O] was significantly lower in the group of patients with
recurrent erysipelas (erythematous form) than in the combined group of
erythematous-hemorrhagic and bullous-hemorrhagic erysipelas forms (P =
0.04). This suggests that spontaneous complement activation via an
alternative pathway is less frequent in patients with mild erysipelas forms.
After the treatment period we observed a significantly decreased
Figure 1(abstract P59) Urinary KIM-1 concentration (A) and elimination (B) in comparison with urinary output (C) per 24 hours in patients with
(blue line) and without (yellow line) RRT at baseline and on days 4, 7 and 10.* P < 0.05, **P < 0.001.
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form) erysipelas (P = 0.02) and in patients with recurrent erysipelas
(erythematous-hemorrhagic and bullous-hemorrhagic forms) erysipelas
(P = 0.02). This proves modern knowledge about decreasing complement
activity during reduction of inflammation.
Conclusion: It was shown that the complement system is significantly
activated in erysipelas patients due to increased concentrations of C3a
(~3 to 5 times), C5a (~1.5 times), C1-INH (~1.5 times) and % C3[H2O]
(~100 times) compared with healthy individuals. We suggest that
investigation of the complement activity may allow one to improve the
estimation of inflammation severity, and predict development of SIRS and
effectiveness of therapy.
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Background: Infection and sepsis are serious postoperative complications,
which have to be recognized and treated by appropriate therapeutic
options in the ICU. Pancreatic stone protein (PSP/reg) is synthesized and
secreted by the pancreas, the stomach and the small intestine. In this
study we evaluated whether PSP/reg predicts sepsis-related postoperative
complications and death in patients with peritonitis.
Methods: A prospective cohort study of postoperative patients admitted to
the ICU in an adult surgical teaching hospital in Germany. Ninety-one
consecutive postoperative patients with proven diagnosis of secondary
peritonitis admitted to the ICU were included in the study. Blood samples
were taken within 3 hours from admission to the ICU for analysis of PSP/reg,
white blood cell counts (WCC), C-reactive protein (CRP), IL-6, and
procalcitonin (PCT). The Mannheim Peritonitis Index and APACHE II clinical
scores were also determined. Univariate and multivariate analyses were
performed to determine the diagnostic accuracy and independent
predictors of death in the ICU.
Results: Univariate analysis demonstrated that PSP/reg has the highest
diagnostic accuracy for complications such as organ failure and is the
best predictor for death in the ICU. PSP/reg had the highest overall
efficacy in predicting death with an odds ratio (OR) of 4.0 versus PCT (OR
3.2), IL-6 (OR 2.8), CRP (OR 1.3), and WCC (OR 1.4). By multivariate
analysis, PSP/reg was the only independent predictor of death.
Conclusion: Patients with sepsis-related complications showed elevated
serum-PSP/reg levels. PSP/reg demonstrated a high diagnostic accuracy to
discriminate the severity of peritonitis and to predict death in the ICU.
This test could be used in clinical diagnosis and therapeutic decision-
making in the ICU.
Acknowledgements: This study was supported by the Gebert Rüf
Foundation, Switzerland.
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Background: The Acute Physiology and Chronic Health Evaluation
(APACHE II) score is widely used in the ICU and has been well validated
against the other critical illness scoring systems in predicting ICU mortality.
The aim of this audit was to determine survival to hospital discharge for
patients admitted to our ICU during a period of 6 months.
Methods: We performed a prospective audit of 80 consecutive patients
admitted to our 16-bed respiratory intensive care unit (RICU) in a university
teaching hospital. Patients were excluded if the observation period was
less than 24 hours and age less than 12 years. An audit form was
completed by a fellow intensivist who followed up the patients until they
were discharged from the RICU. Patient data were stratified according to
the outcome (S, survivors; E, expired) and compared for different age
groups (12 to 29 years, 30 to 60 years, >60 years), gender (males vs.
females) and diagnostic disease groups. Student’s t test, chi-square test/
Fisher’s exact test and analysis of variance were used for comparison of
data as appropriate and P < 0.05 was considered significant.
Results: The mean APACHE II score, mean age and duration of ICU stay
were 12.4 ± 10.8, 42.1 ± 20.6 years and 12.8 ± 12.2 days respectively. The
patients’ number of days of ICU stay was independent of patients’
outcome (S or E) (P = 0.476). Similarly the gender distribution did not
affect the mean APACHE II score on admission (P = 0.273) and duration of
ICU stay (P = 0.166). The survival rate among the eight different diagnostic
groups was similar (P = 0.064). A higher APACHE II score and a higher age
was associated with increased mortality (P <0 . 0 0 1a n dP = 0.001
respectively).
Conclusion: Our RICU had a mortality of 32% (26/80 patients) and
patients who died belonged to the higher age group and had high mean
APACHE II score. Although our audit is small and may not represent the
cohort adequately, our mortality rate was similar to that obtained from a
large cohort [1]. The higher mortality rate was probably because our
centre is a tertiary-care referral hospital and many referred cases reached
us late.
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Introduction: Central venous catheterization (CVC) is a frequently
performed procedure in ICUs for both monitoring and definitive central
venous access. Although the apical approach is the most preferred
technique in our practice, a modified landmark guided technique that uses
only the carotid artery pulsation as a landmark (paracarotid approach) to
locate the puncture site for internal jugular venous (IJV) catheterization
attained a high success rate with few complications. The aim of the study
was to compare two approaches used for IJV cannulation: the apical
approach and the paracarotid approach. The primary endpoint was the
rate of success. The secondary endpoints were the related adverse events
and the difficulty factors (number of attempts).
Methods: A prospective, randomized clinical trial in a tertiary-care university
teaching hospital. After obtaining approval from the Hospital Ethics
Committee, 50 adult patients admitted to our ICU with an absolute
indication for CVC were randomized to undergo one of the two techniques.
We compared the demographics, success rates, difficulty factors and adverse
events.
Results: The first-attempt success rate (80% vs. 60%, P < 0.05) and overall
success rate (92% vs. 88%) was higher in the paracarotid group, with fewer
attempts (1.08 ± 0.5 vs. 1.16 ± 0.6). There were no pneumothorax (0 vs.
5%), and less accidental arterial punctures (5% vs. 18%) in the paracarotid
group, but the difference was not significant statistically.
Conclusion: This study shows that the paracarotid approach of IJV
cannulation is a better technique in providing a higher first-attempt
success rate and has fewer complications.
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Background: Regional citrate anticoagulation has emerged in critically ill
patients to safely treat patients with risk of bleeding. However, liver
dysfunction may lead to citrate accumulation and change patients’ acid-
base status. In 10 years, 100 septic shock patients were treated with CPFA,
an extracorporeal therapy that combines unselective plasma adsorption
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from liver dysfunction (total bilirubin ≥2 mg/dl) and we treated them with
our citrate protocol. The aim of this study is to evaluated the safety of
citrate-like anticoagulation on patients with liver dysfunction.
Methods: Four consecutive mechanically ventilated patients (three male,
one female) with septic shock and liver dysfunction were treated.
Prescribed CPFA parameters were: Qb 150 ml/minute, plasma flow rate
(Qp) 30 ml/minute, predilution solution (Na
+ 136 mmol/l, citrate 10 mmol/l,
citric acid 2 mmol/l) infused to keep inlet citratemia at 3 mmol/l,
postdilution solution (Na
+ 139 mmol/l, K
+ 1.5 mmol/l, Ca
2+ 2 mmol/l, Mg
2+
0.75 mmol/l, HCO3
- 35 mmol/l, glucose 5.55 mmol/l) and postdilution CaCl2
at a rate restoring the plasma Ca
2+ to 1.1 mmol/l (Table 1) and adjusted
according to patients’ need. We evaluated five clinical parameters pre and
post CPFA: pH, bicarbonate, lactate, Ca
2+/iCa
2+, total bilirubin.
Results: Twenty-two treatments were performed accounting for 163 hours,
mean duration 10.2 ± 2.1 hours, mean plasma volume of 16.4 ± 5.4 l, Qb
150 ml/minute, Qp 28.4 ± 1.8 ml/minute, and a treated plasma dose/kg
body weight of 0.8 ± 0.4 l/kg. Mean CaCl2 10% infusion of 4.5 ± 1.3ml/hour,
with citratemia, evaluated as total Ca
2+/iCa
2+ ratio (Figure 1), was always
<2.5 (mean 1.8 ± 0.2). For pH (mean pre 7.45 ± 0.06 vs. mean post 7.39 ±
0.07), bicarbonate (24.6 ± 3.5 vs. 24.8 ± 4.7), and lactate (2.9 ± 1.5 vs. 2.1 ±
1.6) there are no statistically significant differences between pre and post
treatment. Instead we observed a decrease of bilirubin (Figure 2). Mean
SOFA and SAPS II pre CPFA were 14 ± 3 and 54 ± 17, respectively. During
treatment, the acid-base patients’ status were kept under control with no
significant electrolyte correction (Mg
2+,K
+, Thamesol 3.6%, NaHCO3 8.4%).
Conclusion: In these four patients treated with CPFA and citrate in liver
dysfunction, we have observed the absence of alteration: pH, bicarbonate,
lactate and Ca
2+/iCa
2+. We also observed a decrease of bilirubin.
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Background: As mortality of patients with severe sepsis and septic shock is
still inappropriately high [1], innovative therapeutic approaches are urgently
needed. In the presence of hypovolemia, fluid therapy is typically initiated to
compensate for intravascular volume deficits [2]. However, administration of
fluids may not necessarily correct a disturbed blood flow on the
microcirculatory level [3]. Microcirculatory failure during sepsis is, at least in
part, caused by pathological nitric oxide (NO) levels [4,5]. To achieve an
optimal NO availability, approaches including NO donors or inhibitors may
be useful. The aim of the present study was to assess the ability of our test
substance S-nitrosothiol-HES (S-NO-HES) to act as NO donor and exert a
pharmacological activity.
Methods: The investigated test substance S-NO-HES is a novel molecule
consisting of NO coupled to a thiolated derivative of hydroxyethyl starch
(HES). The ability of S-NO-HES to release NO was demonstrated.
Furthermore, the effect of S-NO-HES on myocardial function was studied in
isolated Langendorff-perfused hearts from guinea pigs and compared with
that of the reference substance sodium nitroprusside. The thiolated HES
derivative (SH-HES) served as negative control. In addition, isolated aortic
rings from rats were pre-contracted by phenylephrine. After defined
incubation periods with reference, test, or control items, the NO-induced
relaxation was determined. S-nitrosoglutathione served as reference
compound, HES and in one experiment also SH-HES as control substances.
Table 1(abstract P65) Protocol scheme for citrate-calcium chloride infusion
kg 50 55 60 65 70 75 80 85 90 95 100
Pre ml/hour 2,250 2,250 2,250 2,250 2,250 2,250 2,250 2,250 2,250 2,250 2,250
Post ml/hour 100 150 200 250 300 350 400 450 500 550 600
CaCl 10% ml/hour 4 4433333222
Figure 1(abstract P65) Ca
2+/iCa
2+ ratio for each patient to verify
the nontoxicity of the citrate and the end of CPFA.
Figure 2(abstract P65) Comparison of total bilirubin pre and post
CPFA.
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to completely relax the aortic rings and to define the 100% relaxation level.
Results: S-NO-HES significantly increased the heart rate of Langendorff-
perfused guinea pig hearts and additionally reduced both the QT interval
and QTc-B values. In addition, S-NO-HES exerted a significant vasodilatory
effect on phenylephrine pre-contracted rat aortic rings that was dose
dependent. The effect was not only observed under light, which is known
to trigger NO release from S-nitroso compounds, but also under exclusion
of light and therefore more physiological conditions.
Conclusion: We demonstrated for the first time that the S-NO-HES
molecule released NO and exhibited corresponding pharmacological
properties. In future experiments, the effectiveness of S-NO-HES to
substitute NO deficiency under septic conditions has to be studied.
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Background: Bacterial sepsis is a very severe infection, potentially lethal,
that requires an etiologic diagnosis and fairly complex treatment, quickly
set. Plex-ID is the newest method in etiologic diagnoses of bacterial
infections. It can detect bacterial DNA found in various pathological
products: blood, CSF, joint fluid, pleural liquid.
Methods: We conducted a 6-month study from January to June 2012 on
children admitted to our pediatric ICU of the National Institute of
Infectious Diseases for severe forms of bacterial sepsis. In these children
we monitored the following parameters: sex, age and origin (nosocomial
or community-acquired infection). Positive diagnosis of sepsis was
established on clinical and laboratory criteria (hemocultures, CSF cultures).
As well as classical cultures, we found causal agents through the newest
modern technique - Plex-ID. We watched for correlation of data obtained
by classical methods versus molecular methods and the clinical and
biological evolution of patients under treatment
Results: In the 6 months of study, 21 children met the clinical and
biological criteria for bacterial sepsis. Seventy-six percent of patients
came from other hospitals, the reason for which we consider that the
etiology is most probably nosocomial pathogens. Sex distribution was
approximately equal boys and girls, and in terms of distribution by age
group prevailed in children aged 0 to 3 years (80%). We obtained 15
positive results (71%) by molecular methods that were correlated with
conventional methods of diagnosis. The seat in the distribution of case
etiology was as follows: Niessiera meningitides (four cases), Streptococcus
pneumoniae (two cases), Staphylococcus spp. (four cases), Klebsiella
pneumoniae (one case), Acinetobacter baumannii (one case), Pseudomonas
aeruginosa (one case), Propionibacterium acnes (one case), and
Haemophilus influenzae (one case).
Conclusion: Bacterial sepsis in children is a serious condition resulting in
four deaths (19%) with septic shock and multiple organ failure in our
study. The patients require rapid etiologic diagnosis and establishment of
appropriate emergency treatment. Plex-ID is an effective and rapid
diagnosis method, identifying casual agent in 71% of cases.
The major advantage of this new method is the possibility to establish
the etiological diagnosis in the early hours of patient admission. Also the
speed and specificity of the modern diagnosis methods increase the
survival index of the hospitalized patients with severe bacterial sepsis.
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Background: During the onset of sepsis, the inflammatory system
becomes hyperactive, leading to an overproduction of proinflammatory
mediators, which contribute to septic shock, multiple organ failure, and
death. Animal studies indicate that insulin may have direct anti-
inflammatory effects, independent of its effect on hyperglycemia.
However, the mechanism by which insulin reduces inflammation in the
absence of hyperglycemia is unknown. The aim of the present study was
to investigate of the molecular mechanisms of action and response of
i n s u l i na d m i n i s t r a t i o ni nr e l a t i o nt oi t sa n t i - i n f l a m m a t o r ye f f e c ti ns e p t i c
animals. We analyzed the modulation of IKK/IB/NF-B pathways and
insulin signaling pathway (IR, IRS-1 and Akt) and the expression of NF-B
p65 DNA binding in liver, muscle and adipose tissue in septic animals.
Methods: For the experiment, diffuse sepsis was induced by cecal ligation
and puncture surgery in male adult Wistar rats. The septic animals were
randomly divided into four different groups. Three of them were submitted
to insulin injection in the portal vein and were stimulated for 1, 3 and
5 minutes, and the other group (control) was not stimulated (saline). After
the stimulation time, insulin sensitive tissues were extracted and the
expression and phosphorylation of the proteins were analyzed through
western blot. NF-B p65 activation was determined in nuclear extracts from
muscle, liver and adipose tissue from septic rats by ELISA.
Results: In a time-course experiment we observed an increase in insulin-
induced phosphorylation of IR-b,I R S 1t y r o s i n ep h o s p h o r y l a t i o n ,a n dA k t
serine phosphorylation that reached a peak at 3 minutes post injection in
muscle, liver and adipose tissue in septic animals. In parallel, there was a
r e d u c t i o ni nt h ep h o s p h o r y l a t i o no fI K Ki nt h et i m e1a n d3m i n u t e sa f t e r
stimulation by insulin returned to basal levels at 5 minutes. There was also
a reduction in the phosphorylation of IB in the time 3 and 5 minutes after
insulin injection. The DNA binding of NF-B p65 in the cell nucleus showed
a reduction in expression levels of NF-B at all times investigated, in
accordance with the reduction of IKK and IB phosphorylation after insulin
injection in liver, muscle and adipose tissue of septic animals.
Conclusion: In summary, we report evidence indicating that the acute
infusion of insulin activated the PI3K-Akt pathway and reduced IKK/IB/
NF-B indicate an important molecular mechanism to the anti-inflammatory
effect of the hormone in liver, muscle and adipose tissue of septic animals.
This helps explain a correlation between activation of insulin signaling and
its effect on the inflammatory pathway.
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Introduction: Pseudomonas aeruginosa is a Gram-negative bacillus, which
can cause severe infections especially in immunocompromised patients.
Most infections caused by this germ are nosocomial because of increased
antibiotic and antiseptic resistance but in rare cases we talk about
community infections. Severe infection in immunocompetent patients
caused by this microbe is extremely rare. The mortality rate in sepsis
caused by P. aeruginosa is very high (up to 60%).
Methods: We present the case of a 2-year-old boy admitted to our clinic
for fever, diarrhea, impaired general condition, vesiculobullous and
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mention: untreated perianal fissure and excised warts on terminal
phalanges of his third finger of the left hand, big toe and the fifth toe of
his left leg as the overgrowth and necrosis at the site of excision. Shortly
after admission the patient presents an episode of acute respiratory failure
followed by apnea and he is tracheal intubated and mechanically
ventilated.
Results: During admission the general condition remains serious, the
patient remains sedated and respiratory assisted with petechial
exanthema, with hypotension, oligo-anuria, anal fissure, and necrotic
lesions in the distal finger phalanges. Biological: severe pancytopenia
(WBC = 700/mmc, Hb = 8.2 g/dl, platelets = 34.000/mmc), coagulation
disorders, nitrogen retention syndrome, hypoalbuminemia, hepatic
cytolysis syndrome, procalcitonin and inflammatory tests intensely
positive. On smears made from the skin lesions, Gram-negative bacilli
were visualized. The cultures of skin lesions weres u g g e s t i v ef o r
P. aeruginosa, confirmed after 48 hours by blood culture identification
and PCR determination (Plex-ID). We established comprehensive
treatment: antibiotic (meropenem, ciprofloxacin, linezolid), antifungal,
inotropic drugs (dobutamine, norepinephrine), ENP (rebalance acid-base
and electrolyte), human immunoglobulin, blood and blood products
transfusions and Neupogen. The evolution was favorable to the
resumption of diuresis after 24 hours, increasing white blood cells and
the lesions diminished.
Conclusion: Positive diagnosis of severe sepsis was based on clinical and
laboratory findings. We have established the likely starting point of the
patient’s severe condition to be the multiple skin lesions and untreated anal
fissure. Although the patient was immunocompetent, he developed a severe
form of sepsis with septic shock caused by P. aeruginosa hardly responsive
to treatment. We believe that the patient’s favorable development was due
to this germ’s increased sensitivity to antibiotics, most probably community
acquired.
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Background: Polymicrobial infection is associated with systemic
inflammatory response, which is involved in the pathogenesis and
development of acute kidney injury (AKI) [1,2]. In this study, we examined
the effect of sesamol against AKI in cecal-ligation-and-puncture (CLP)-
treated rats.
Methods: Rats were given two subcutaneous doses of sesamol (10 mg/kg)
0 and 6 hours after CLP. Serum and kidney tissue were sampled 12 hours
after CLP. Renal function and proinflammatory mediators, such as IL-1b,
IL-6, and nitrite production were detected. Systemic oxidative stress was
assessed by determining nitric oxide, superoxide anion, and xanthine
oxidase activities. In addition, inducible nitric oxide synthase (iNOS)
expression was also assessed in leukocytes from rats with AKI.
Results: The levels of serum BUN, CRE, IL-1b, IL-6, nitrite, iNOS expression,
superoxide anion, and xanthine oxidase activity were significantly higher in
rats after CLP. Sesamol significantly inhibited all parameters in CLP-treated
rats.
Conclusion: Sesamol attenuated AKI by inhibiting neutrophil-initiated
systemic inflammation and oxidative stress in CLP-treated rats.
Acknowledgements: This study was supported by grants from the
National Science Council, Taiwan.
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Background: Neurotransmitters derived from the autonomic nervous
system can regulate inflammatory cytokine secretion. This has been
extensively studied in the parasympathetic nervous system, where
acetylcholine regulates the secretion of TNF from splenic macrophages
during LPS-induced inflammation. However, the role of noradrenergic
neurons during mouse models of infection has not been characterized.
The goal of these experiments was to study the influence of noradrenergic
neurons on the immune response during Gram-negative septic peritonitis
in mice.
Methods: Peripheral noradrenergic nerves were ablated using 6-
hydroxydopamine (6-OHDA), a commonly employed method for studying
noradrenergic neurons. Four days later, septic peritonitis was induced by i.p.
injection of 150 CFU Klebsiella pneumoniae. Survival, serum and peritoneal
bacterial loads, inflammatory cytokine production and leukocyte recruitment
were studied at multiple time points after infection. To assess the
importance of the NE containing splenic nerve, survival experiments on
splenectomized mice with or without 6-OHDA treatment were performed.
Figure 1(abstract P71) Nonadrenergic nerve ablation with 6-OHDA improves survival during K. pneumonia intraperitoneal sepsis (A).
Nonadrenergic nerve ablation leads to improved bacterial killing (B) and enhanced monocyte recruitment 4 hours after infection (D). The survival benefit
of 6-OHDA treatment required the spleen because splenectomy (SPLX) prior to 6-OHDA treatment abolishes this survival benefit (C). Peritoneal
monocytes were quantified 4 hours after infection in 6-OHDA-treated mice with or without spleens (D). 6-OHDA treatment enhanced the recruitment of
splenic monocytes to the peritoneum during infection (D). *P < 0.05.
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K. pneumoniae septic peritonitis (Figure 1A). Mice in which noradrenergic
nerves had been ablated showed a more robust immune response
4 hours after infection with higher systemic IL-6, higher intraperitoneal
MCP-1 and a fourfold increase in monocyte recruitment into the
peritoneum. Bacterial loads were lower 24 and 48 hours after infection in
mice in which noradrenergic nerves had been ablated (Figure 1B). Four
hours after infection, 6-OHDA-treated mice recruited more inflammatory
monocytes to the infected peritoneum (Figure 1D, CTRL vs. 6-OHDA).
Splenectomy prior to noradrenergic nerve ablation abrogated the
beneficial effects of 6-OHDA during infection (Figure 1C) and reduced the
recruitment of monocytes to the infected peritoneum (Figure 1D, 6-OHDA
vs. SPLX + 6-OHDA).
Conclusion: These results suggest that splenic nerve-derived catechola-
mines regulate the egress of splenic monocytes during infection and that
altering this pathway can alter survival during septic peritonitis in mice.
These data highlight the emerging role of splenic monocytes during
inflammation and infection [1] and add to the body of evidence that the
immunosuppressive effects of catecholamines can impair innate immune
responses during infection [2]. These experiments may have important
implications for patients receiving vasopressors in the ICU.
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Background: Staphylococcus aureus is a major cause of bloodstream
infections (BSI), and is associated with a higher morbidity and mortality
compared with other BSI pathogens. Innate pattern recognition receptors
like mannose-binding lectin (MBL) of the complement system and NOD2
(nucleotide-binding oligomerization domain-containing protein 2), an
intracellular sensor for a variety of pathogens, have been shown to be
crucially involved in the immune response against S. aureus in knockout
animal models [1,2], but human data are lacking. Low MBL levels and
N O D 2m u t a t i o n sc a nb ef o u n di nu pt o3 0 %a n d1 0 %i nt h eg e n e r a l
population, respectively [3,4]. This study aimed to investigate whether
MBL deficiency and NOD2 mutations predispose to and influence the
severity of S. aureus BSI.
Methods: A matched case-control study was undertaken involving 70
patients with S. aureus BSI and 70 age-matched and sex-matched
hospitalized controls recruited prospectively at two major tertiary
hospitals. Participant blood samples were analyzed for MBL levels by
mannan-binding ELISA and for four MBL2 and three NOD2 polymorphisms
by real-time PCR. Clinical and microbiological data were reviewed. MBL
deficiency was defined as functional MBL level ≤0.1 μg/ml. Univariate and
multivariate conditional logistic regression was used to investigate the
risk of BSI in matched controls and cases.
Results: S. aureus BSI were nosocomially acquired (60%) and intravenous
c a t h e t e ra s s o c i a t e d( 5 0 % )i nt h em a j o r i t yo fc a s e sw i t ha ni n - h o s p i t a l
mortality of 10%. After adjusting for diabetes, immunosuppression,
chronic kidney disease and long-term intravenous catheters, MBL
deficiency was found less frequently in cases than controls (8.6% vs. 20%,
OR = 0.38, P = 0.07) as were low-producing MBL genotypes (11% vs. 23%,
OR = 0.37, P = 0.05), whereas NOD2 polymorphisms were similarly
distributed (14% vs. 10%, P = 0.4). In line with MBL2 genotypic results,
MBL levels were significantly higher in cases than in controls (adjusted
OR = 1.35 per 1 μg/ml increase, P = 0.002; Figure 1). Cases with NOD2
polymorphisms had less severe disease manifestations as shown by a
l o w e rS O F As c o r e( m e a n2 . 1v s .4 . 4 ,P = 0.04) and a reduced rate of
multiorgan dysfunction and death (40% vs. 60%, P = 0.06), whereas MBL
deficiency had no influence on the severity of S. aureus BSI.
Conclusion: Neither MBL deficiency nor NOD2 polymorphisms were
associated with an increased risk of S. aureus BSI. In fact, contrary to
experimental data, MBL deficiency seemed to confer protection in acquiring
S. aureus BSI, and NOD2 mutations were less frequently associated with
multiorgan dysfunction in this matched case-control study.
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Background: Plasminogen activator inhibitor type 1 (PAI-1) inhibits
fibrinolysis and its plasma increases correlate with exacerbated sepsis
mortality. However, its exact role in abdominal sepsis outcomes
Figure 1(abstract P72) Differences in MBL serum concentrations in
cases (S. aureus BSI) and controls. Horizontal lines represent medians.
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survival during acute polymicrobial sepsis using a custom-developed anti-
PAI-1 monoclonal antibody. We specifically studied whether the effects of
the treatment vary between all-inclusive populations and homogeneous
cohorts stratified based on the risk of death.
Methods: Mice underwent cecal ligation and puncture (CLP) and received
a single intravenous injection of either anti-PAI-1 (10 mg/kg; MA-MP6H6)
or control antibody (MA-Control). Three approaches were used: approach I,
co-treatment (CLP and MA-MP6H6 administered at 0 hours) without
stratification; approach II, post treatment (MA-MP6H6 at 18 hours post CLP)
without stratification; and approach III, post treatment (MA-MP6H6 at
30 hours) with prospective stratification. Then 20 μl blood (facial vein) was
sampled daily from all mice until day 5 and survival was followed for
28 days. In approach I, a group of mice was sampled at 6 hours and
sacrificed at 24 hours to test the MA-MP6H6 efficacy. In approach III, mice
were stratified into either predicted to survive (P-SUR) or die (P-DIE) based
on circulating IL-6 measured at 24 hours post CLP.
Results: MA-MP6H6 co-treatment blocked 60 to 100% of active plasma
PAI-1 and restored fibrinolysis (fibrin plate assay) in septic animals at
24 hours post application. Without stratification, MA-MP6H6 co-treatment
and 18-hour (also 30-hour) post treatment neither conferred benefit nor
was detrimental. Post treatment with MA-MP6H6 after prospective IL-6
stratification at 14 ng/ml cutoff (48% sensitivity for P-DIE and 100%
specificity for P-SUR) showed 15% exacerbation of mortality (P > 0.05).
Cutoff readjustment to 3.3 ng/ml maximized P-DIE cohort homogeneity
(82% sensitivity; 100% specificity) revealing harmful MA-MP6H6 effects: in
P-SUR, no MA-Control-treated mice ever died, but 30% of MA-MP6H6-
treated did (P < 0.05). In P-DIE, all MA-MP6H6-treated mice died within
72 hours, while MA-Control mice lived up to 8 days (P <0 . 0 5 ) .I nc o -
treatment, MA-MP6H6 increased circulating IL-6 and CXCL-1/KC by
threefold and twofold at 24 hours (MCP-1, MIP-1a,I L - 1 b,I L - 1 0a n dT N F a
unaffected), but had no effect in post treatment (24 to 96 hours).
Regardless of the treatment approach, MA-MP6H6 did not significantly
alter hematological and/or organ function parameters.
Conclusion: Restoration of fibrinolysis by neutralization of PAI-1 in acute
sepsis lacks benefit and may prove fatal. Remarkably, the detrimental effect
of MA-MP6H6 became apparent only after a maximally homogeneous
separation of high/low risk-of-death cohorts. A prospective separation of
septic patients into various well-defined, homogenous cohorts is critical in
revealing negative side effects of tested anti-sepsis therapeutics.
Acknowledgements: Supported by WWTF Grant LS07-065.
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Background: Disseminated intravascular coagulation plays an important
role in the pathogenesis of severe sepsis. Current treatment of sepsis is not
possible without the use of extracorporeal blood purification methods; the
use of heparin is one of the measures of stabilization circuit. Intravenous
administration of heparin can cause a decrease in platelet count. A reliable
Figure 1(abstract P74) Dynamics of platelets in the patient groups.
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is using 4T scales [1].
Methods: An observational retrospective cohort study of 106 patients in
the period from 2010 to 2011. The aim of the study was to determine
the effect of heparin on the severity of clinical signs of heparin-induced
thrombocytopenia in patients with severe sepsis. Inclusion criteria were the
presence of severe sepsis in a patient (Surviving Sepsis Campaign 2008),
the need for extracorporeal blood purification, and thrombocytopenia. The
mean age of all the patients was 54 ± 15.91, mean SOFA score was 7.4 ± 0.9
(2 to 13). Reduced platelet counts were observed in 23 patients. Patients at
high risk for heparin-induced thrombocytopenia type II (4 to 5 points for the
4T scale) in the study were not included. Ten of the patients (9.4%)
conducted a session intermittent high-volume hemofiltration (group IHVH)
within 4 hours, c volume replacement of 100 ml/kg/hour. Eleven patients
(10.4%) did not receive extracorporeal blood purification (group Stand),
because of uncontrolled bleeding. All patients received therapy according to
Surviving Sepsis Campaign 2008. The standard dose of heparin was 8 to
15 units/kg/hour.
Results: In group IHVH the increase in platelet count at the end of the
second day treatment was 105.75 ± 52.8 × 10
9/l (Figure 1). This level is
significantly different from the number of platelets in group Stand to the
same phase of the study (10.7 ± 4.0 × 10
9/l). During treatment in the
groups studied there were no thromboses. The 28-day period mortality in
group IHVH was 20% (two patients), and in group Stand was 9% (one
patient).
Conclusion: The use of heparin, including the extracorporeal blood
purification, can be safe with heparin-induced thrombocytopenia type I in
patients with severe sepsis.
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Background: Recent improvements in the treatment of severe Gram-
negative sepsis have not resulted in a substantial decrease in mortality. LPS,
originating from Gram-negative bacteria, is a major mediator in the
development of septic shock [1]. Decreasing the load of LPS in these
patients may be beneficial for these patients. The Alteco LPS Adsorber®
selectively binds the lipid A moiety of LPS. Positive effects of the adsorber
have been reported [2-4].
Methods: Nineteen patients with Gram-negative sepsis were treated with
the Alteco LPS Adsorber®, in addition to standard therapy according to
SSC Guidelines 2008. All patients needed inotropic support and
mechanical lung ventilation. The mean APACHE II score at the start of
treatment was 25.9 ± 1.8. The time to initiating the perfusion varied
between 1.7 and 8.6 hours after the diagnosis of septic shock. The
treatment lasted 120 minutes and was repeated after 24 hours. The SOFA
score, oxygenation index (PaO2/FiO2) and the dose of dopamine was
noted before and 48 hours after the treatment.
Results: At baseline, the severity of MODS was SOFA score 9.2 ± 2.8. At
48 hours the mean score SOFA was 4.3 ± 2.7, at the expense of an
increase in the index of oxygenation from 128.6 ± 36.2 to 253.5 ± 44.8;
and a decrease in doses of inotropic support (dopamine) from 17.1 ±
1.8 mkg/kg/minute to 4.2 ± 1.8 mkg/kg/minute. We found an inverse
correlation between the time to initiate treatment with the adsorbtion
and the decrease in SOFA score (R = -0.69; P < 0.1) (Figure 1). The degree
Figure 1(abstract P75) Correlation between the SOFA score after 48 hours observation and the time of LPS adsorption start.
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shown in Figure 2. The 28-day mortality was 26.3% in this patient group.
There were no adverse events related to use of the adsorber.
Conclusion: Since LPS is a major mediator in Gram-negative sepsis, there
is a rationale for rapid removal of LPS from patients with sepsis. Early
initiation of LPS adsorption is most effective for reducing the signs of
MODS. Our experiences with the use of Alteco LPS Adsorber® are
promising as shown by our data above and are in support of previous
findings [2-4]. The results are limited by the lack of controls; however, we
believe that further randomized controlled clinical studies using this
therapy are warranted, more so in view of the fact that no specific
treatment against septic shock is available.
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Background: The Surviving Sepsis 6-hour bundle [1] was created to
promote effective identification and management of patients with severe
sepsis and septic shock. Efficient and timely implementation of the 6-hour
bundle including early intravenous antibiotics has been shown to improve
patient outcome [2]. We aimed to determine the efficiency of severe sepsis
identification, implementation of the 6-hour bundle and overall manage-
ment of ward-based patients.
Methods: During a 4-month period, ward-based patients with severe
sepsis were identified by nurse practitioners and the critical care outreach
team at a large teaching hospital in North West England. Analysis of
patient medical records was performed to assess the efficiency and quality
of care received compared with the gold standard sepsis 6-hour bundle.
Promptness of doctor attendance and patient 30-day outcome were also
analysed.
Results: Twenty-eight patients with severe sepsis were identified and
analysed. Suspicion of sepsis was documented in medical records for all
patients; however, the 6-hour sepsis bundle was completed in only one
case. Appropriate i.v. antibiotics were prescribed to all patients. Median
duration from the documented onset of severe sepsis (time 0) until review
by a doctor was 90 minutes (0 to 19 hours). The median Modified Early
Warning Score (MEWS), determined from patients’ vital signs, at
documented onset of severe sepsis was 3.5 (1 to 9) with a subsequent
increase of median MEWS to 4 by the time of doctors’ first attendance. The
30-day patient outcome showed 13 patients discharged home and seven
patients deceased. Comparison of deceased patients with patients who
were discharged alive (see Table 1) demonstrated an increased median
duration from time 0 until doctor attendance in the deceased group.
However, interestingly, timely antibiotics (given within 1 hour of patient
assessment by a doctor) were administered with greater frequency in the
deceased patient group.
Conclusion: Despite the widespread recognition of patients with severe
sepsis, underperformance of the 6-hour bundle remains a major factor in
Figure 2(abstract P75) Reducing the degree of MODS as compared with the starting time of LPS adsorption (% of baseline).
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the onset of severe sepsis until doctor review is associated with increased
risk of mortality despite better adherence to the 6-hour bundle. Further
education of doctors and nursing staff, regarding the importance of the
6-hour sepsis bundle, in addition to the implementation of strategies to
improve the early identification and timely review of ward-based patients
with severe sepsis are recommended.
Acknowledgements: Olivia O’Gara and Jonathan Walker are contributing
authors.
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Background: Bacterial infections are a significant cause of morbidity and
mortality in newborn infants. Successful treatment of neonatal infection
depends on the early initiation of antibiotic therapy; however, unnecessary
use of antibiotics increases bacterial resistance and has been associated
with increased rates of necrotizing enterocolitis and death in premature
infants. Unfortunately, the early clinical signs and symptoms of neonatal
infection are often confused with other non-infectious conditions in
premature infants such as apnea of prematurity and chronic lung disease.
Neonatologists have traditionally relied on white blood cell counts (CBC)
and bacterial cultures to help identify infected infants, but the CBC is an
unreliable marker of infection in the neonatal population and bacterial
cultures are too slow to be useful in the immediate evaluation of an infant.
Methods: Therefore, in order to overcome these obstacles and improve
the identification of infected infants, we incorporated neutrophil CD64
levels into the infection evaluations in our newborn ICU and evaluated
the impact of this change on clinical care.
Results: A total of 405 evaluations were performed in 268 infants (ages 1
to 293 days) from 2005 to 2009. Twenty-nine infants had culture-positive
sepsis. The sensitivity and negative predictive value of the neutrophil CD64
assay was consistently ≥90% in identifying infected and non-infected
infants. In fact, during the 3-year analysis period only three infants were
identified with positive blood cultures that had a normal CD64 index. Two
of these infants had blood cultures that were positive for Staphylococcus
epidermidis and one had a positive blood culture that was obtained from a
colonized central line. Although absolute CD64 levels did not correlate
with severity of illness in our population (as determined by the need for
ventilation (P = 0.87) or inotropic support (P = 0.90)), relative decreasing
CD64 levels did correlate well with the resolution of infection within
a given infant. When compared with infants with an elevated CD64 level, a
normal CD64level decreased unnecessary antibiotic exposure by 3.9 days.
By comparison, in infants evaluated with the traditional methods that did
not include a CD64 level, a normal CBC only decreased antibiotic exposure
by 1 day when compared with infants with an abnormal CBC.
Conclusion: In summary, the clinical care that we provide our infants has
improved with the use of neutrophil CD64 levels in our infectious
evaluations.
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Background: Early-onset sepsis (EOS) represents one of the main causes
for ICU admission in newborns and therefore imposes a considerable
burden on the healthcare system. Performance of traditional infection
markers to diagnose EOS is poor and therefore insufficient to guide the
decision to start or stop antibiotic treatment. While procalcitonin (PCT) has
become an established sepsis marker in adults and children, sensitivity and
specificity of PCT are only moderate in EOS due to the physiologic PCT
increase during the first days of life. Pancreatic stone protein (PSP) is a
promising sepsis marker in adults. This study investigated whether
determining PSP improves diagnosis of EOS in comparison with other
infection markers.
Methods: A prospective multicentre study including 137 infants >34
weeks gestational age admitted with suspected EOS. PSP, PCT, soluble
human triggering receptor expressed on myeloid cells-1 (sTREM-1),
macrophage migration inhibitory factor (MIF) and C-reactive protein
(CRP) were measured at admission. Receiver-operating characteristics
(ROC) curve analysis and multivariate logistic regression were
performed. Bioscores were constructed using two, three and four sepsis
markers.
Results: PSP was significantly higher in infected compared with uninfected
infants (median 11.3 vs. 7.5 ng/ml, P = 0.001). The ROC area under the
curve resulted at 0.69 (95% CI = 0.59 to 0.80, P < 0.001) for PSP, at 0.77
(95% CI = 0.66 to 0.87, P < 0.001) for PCT, at 0.66 (95% CI = 0.55 to 0.77,
P = 0.006) for CRP, at 0.62 (0.51 to 0.73, P = 0.055) for sTREM-1 and at 0.54
(0.41 to 0.67, P = 0.54) for MIF. In multivariate models, increased PSP levels
showed the strongest association of all markers with EOS and PSP >9 ng/ml
independently of PCT predicted EOS (odds ratio = 26.4, 95% CI = 4.0 to
172.5, P < 0.001). Combining both markers significantly increased the ability
to diagnose EOS (P < 0.001). The bioscore based on PSP and PCT performed
best with an AUC of 0.83 (95% CI = 0.74 to 0.93, P < 0.001) and was superior
Table 1(abstract P76) Characteristics and management data for patients with severe sepsis comparing patients who
were deceased with patients discharged home at 30 days
Patients discharged home at 30 days
(n = 13)
Patients deceased at 30 days
(n =7 )
Median age (years) 77 68
Median time taken to be seen by doctor after time 0 (minutes) 90 240
Median MEWS at time 0 3 3
Median MEWS at doctors’ attendance 3 4
Timely antibiotics given 15% 43%
Basic resuscitation undertaken (oxygen, i.v. fluids, urinary
catheter, ABG)
90% 93%
Time 0 = time of initial documented evidence of severe sepsis.
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Page 39 of 58to PCT or PSP alone. The combined PSP/PCT score had a NPV of 100%
if both markers were below cutoff and a PPV of 71% if both were positive.
Conclusion: In this prospective study, the diagnostic performance of PSP
and PCT was far superior compared with traditional markers and a
combination bioscore improved diagnosis of sepsis. Our findings suggest
that PSP is a valuable biomarker in combination with PCT in EOS. To the
best of our knowledge, this is the first study investigating PSP in neonatal
sepsis.
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Introduction: High morbidity and mortality rates are associated with
sepsis in newborns, as well as low recovery rates, extended recovery times,
and delayed culture times of blood culture. To surmount these parameters,
new molecular techniques are required by the clinical laboratory. The
LightCycler Septifast® technique, which identifies up to 25 microorganisms
known to cause over 90% of admissions to ICUs due to infection, has
proven its usefulness in adult patients in several countries. The objective
was to standardize the Septifast® Roche technique for diagnostic use in
newborns with suspected sepsis.
Methods: Eighty-six newborn samples with suspected sepsis (according to
the NOSEP-1 scale) were included. We analyzed two blood samples per
patient, the first one collected in an EDTA-anticoagulated tube (0.5 to
1.0 ml), and a second sample of 1 cm
3 in a hemoculture tube for automated
hemoculture procedure using BacT/ALERT®3D (Biomerieux). Briefly, the
w h o l es a m p l ew a sl y s e dw i t hM a g N AL y s e r( R o c h e ) ,a n dn u c l e i ca c i d
purification was performed with Septifast prep M
grade (Roche). DNA from
Gram-negative, Gram-positive, and fungi was detected using multiplex
LightCycler 2.0 real-time methodology with LightCycler SeptiFast M
grade kit
(Roche). Finally, results analysis was performed with Roche Septifast
identification software (SIS).
Results: Of the 86 samples analyzed, 31 (36.04%) were positive in at least
one of the identification procedures. Thirteen samples (15.11%) were
rendered positive by hemoculture, and 27 (31.39%) by Septifast® protocol.
Fifty-seven samples (66.20%) were negative by both analytic procedures,
and a total of 31 pathogens (15 Gram-negative, 11 Gram-positive and five
fungi species) were identified by Septifast® (four of them in combination)
versus nine species recovered from hemocultures. The response time
ranged from 6 to 24 hours by Septifast® procedure, compared with 4 to
7 days by hemoculture detection.
Conclusion: The use of the multiplex real-time PCR Septifast® technique
allows one to detect a wider number of pathogenic species and a faster
response time than hemoculture, with a small quantity of blood sample
(1 ml).
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Background: Endotoxic shock during infection by Gram-negative bacteria
could frequently lead to mortality. Bacterial endotoxins (lipopolysaccharides
(LPS)) play a major role in pathogenesis of Gram-negative sepsis. The
infection after injury, burn or surgery could lead to accumulation of released
endotoxins in the bloodstream. LPS are able to interact with specific
receptors on the surface of target host cells (monocytes/macrophages,
neutrophils, endothelial cells, and so forth). After interaction with LPS,
phagocytes change their morphological and functional properties, namely
receptor expression, synthesis of proinflammatory cytokines and phagocytic
activity. In the LPS signaling pathway, Toll-like receptor 4 (TLR4, CD284) is
the main cell surface molecule inducing activation of NF-B-dependent
genes. Recent reports suggest that TLRs are involved in phagocytosis as the
assistance receptors of phagocytes helping them to recognize invading
bacteria or their molecular patterns [1,2]. Intensity of phagocytosis is
potentiated by prior neutrophil exposure to endotoxins [3]. TLRs ligation by
endotoxin molecules induces adaptor protein MyD88-dependent signaling
involving IL-1 receptor-associated kinase (IRAK) and p38 mitogen-activated
protein kinase leading finally to upregulation of phagocytosis-inducing
genes. The integrated collaboration between TLR4 and phagocytosis has
been shown early [4]. As shown during phagocytosis, TLR4 was only
integrated in this functional property of the cells but not involved as the
primary receptor [5]. It is well known that appropriate cell response to LPS is
Figure 1(abstract P80) Influence of antibodies against TLR4, CD14
and CD11b on neutrophil phagocytic activity in whole blood.
Control cells without any incentives (C), cells activated by S-LPS (C1) and
cells activated by Re-LPS (C2).
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have studied the functional role of these receptors in phagocytosis of
fluorescein-labeled Escherichia coli by human neutrophils in whole blood
activated by S-form or Re-form endotoxins from E. coli.
Methods: S-LPS from E. coli O55:B5 (Sigma) and Re-LPS from E. coli
JM103 were obtained in our laboratory according to standard procedure.
Fluorescein-labeled bioparticles E. coli K12 (Molecular Probes), mouse anti-
h u m a nT L R 4m A b sH T A 1 2 5( I g G 2 ai s o t y p e ;S e r o t e c ) ,a n t i - h u m a nC D 1 4
clone UCHM-1 mAbs (IgG2a isotype; Sigma), and anti-human CD11b
mAbs clone 44 (IgG1 isotype; Sigma). LPS were dissolved in pyrogen-free
water to make 10 μg/ml stock solution, and sonicated vigorously for 20
minutes to increase LPS solubility. Experiments were performed in whole
blood from nine donors (male, female, age 20 to 27). Blood was collected
in sterile conditions into Monovette heparin-treated tubes 10 U/ml
(Sarsted, Germany). Each tube contained 90 μl whole blood and 50 μl
suspension of FITC-labeled bacteria (2 × 10
7 cells/ml; 1:10 leukocytes:
bacteria ratio) was gently mixed and incubated for 30 minutes at 37°C.
Then erythrocytes were lysed by hypotonic buffer for 5 minutes at room
temperature. Samples were centrifuged (5 minutes, 200 × g,2 1 ° C )a n d
washed twice by cooled PBS containing 0.02% EDTA. The pellet was
resuspended in 400 μl PBS-EDTA solution. To assess the influence of cell
activation on phagocytosis the 100 ng/ml of S-LPS or Re-LPS were added
before FITC-labeled bacteria and incubated during 30 minutes at 37°C. To
determine the role of CD14, TLR4 and CD11b receptors in phagocytic
activity, corresponding mAbs (1 μg, 30 minutes) were added to whole
blood before cell activation by LPS and induction of phagocytosis. The
phagocytic activity was monitored using the EPICS XL-MCL flow
cytometer (Beckman Coulter). Results given as median fluorescence
intensity. Phagocytic activity of cells without LPS activation or mAb
treatment was established as 100%. Experiments were done two times
using duplicate determinations in each experiment. The mean ± standard
error was calculated using standard calculations available in the OriginPro
spreadsheet. Statistically significant differences were determined by
Student’s t test.
Results: Phagocytic activity of leukocytes was increased by pre-exposure
of whole blood to S-LPS or Re-LPS (Figure 1). Pretreatment of whole blood
by anti-CD14 or anti-TLR4 mAbs decreased to some extent the phagocytic
activity of leukocytes activated by endotoxins independently of their
glycoform (Figure 1). Significant inhibition of phagocytosis using anti-
CD11b mAbs was achieved (Figure 1). Abs against CD11b more pro-
nounced decreased S-LPS activated phagocytosis by 30% but were less
effective in the case of Re-LPS (by 15%). It is known that CD11b receptors
play an important role during phagocytosis of opsonized bacteria.
Conclusion: LPS activate phagocytosis of Gram-negative bacteria
independently of their glycoforms (Figure 1). The effect of HTA125 mAbs
may be explained by their interaction with TLR4 leading to inhibition of
LPS-induced signaling into the nucleus and blocking synthesis and
surface expression additional recep t o r ss u c ha sc l a s sAm a c r o p h a g e
scavenger receptor (SR-A) [6] and CD11b [7] involved in phagocytosis.
Activation of integrin-dependent signaling pathways can also be blocked
by these HTA125 mAbs [8]. Anti-CD11b decreased most pronounced LPS-
activated phagocytosis. Taking these results into consideration one can
speculate that the Fc-chain of anti-CD11b (IgG1) mAbs through
interaction with CD32A may mediate downregulation of TLR4 responses.
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Background: Delayed neutrophil apoptosis is often detected in
inflammatory pathologies, includings e p s i s[ 1 ] .C D 2 4i sas m a l lh e a v i l y
glycosylated cell-surface protein, linked to the membrane by a glycosyl-
phosphatidylinositol (GPI) anchor in a wide variety of cells [2]. Cross-ligation
of CD24 triggers apoptosis in a human B-cell subset during the early
activation stage [3]. Since CD24 is also expressed on neutrophils, we aimed
to study its expression in sepsis and its putative role in apoptosis.
Methods: Blood samples were either collected from healthy donors or
from sepsis patients at the onset of sepsis and the two following days and
surface CD24 expression on neutrophils was analyzed by flow cytometry.
Peripheral blood neutrophils were purified from sepsis patients and
healthy individuals by positive selection. Whole blood or neutrophils were
challenged with lipopoplysaccharide (LPS), TNF, granulocyte-macrophage
colony-stimulating factor (GM-CSF), heat-killed Staphylococcus aureus or
heat-killed Escherichia coli and CD24 expression assessed by flow
cytometry. Neutrophils were cross-linked with anti-human CD24 and
assessed for apoptosis after 24 hours of culture. In some experiments,
neutrophils were preincubated with caspase inhibitor (z-VAD-fmk) before
crosslinking.
Results: Surface expression of CD24 assessed by flow cytometry was
significantly altered in neutrophils from sepsis patients compared with
healthy controls. Activation of neutrophils with LPS or heat-killed bacteria in
whole blood triggers a strong upregulation of CD24 at surface level despite
no enhanced expression being observed when the activation was carried
out in purified neutrophils. In contrast, TNF and GM-CSG upregulated CD24
in whole blood and in purified neutrophils. CD24 cross-ligation induces
caspase-independent apoptosis in human neutrophils. Ex vivo death
responses after CD24 ligation in neutrophils from sepsis patients are
currently under study.
Conclusion: This is the first report studying the role of CD24 in sepsis
patients, linking homeostasis and apoptosis.
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Background: Escherichia coli is a leading cause of bloodstream infections
worldwide and its associated rate of mortality is high. It is found in its
primary habitat, the digestive tract, as a commensal but is also involved in
Critical Care 2012, Volume 16 Suppl 3
http://ccforum.com/supplements/16/S3
Page 41 of 58various intestinal and extraintestinal diseases. It is a known fact that the
digestive tract may serve as a portal of entry into the bloodstream.
Therefore, the presence of highly resistant E. coli strains in the gut presents
a threat to the patients with predispositions such as chronic illnesses and
poor immune status.
Methods: This study was undertaken with the aim to determine the
resistance pattern among the E. coli strains isolated from the gut of
chronically ill patients across wide clinical settings. The study was conducted
over a period of 1 year from 1 January 2011 to 31 December 2011. Stool
samples from patients admitted for more than 14 days in wards of all major
clinical specialities were collected after proper counselling and informed
consent. E. coli were identified on the basis of cultural characteristics and
biochemical reactions. Strains isolated from pediatric patients were
subjected to serotyping by the slide agglutination test with specific antisera
(Denka Seiken Co., Ltd, Tokyo, Japan) to identify the enterovirulent strains.
All E. coli strains were subjected to antimicrobial susceptibility testing and
ESBL identification by the disk diffusion methods in accordance with the
CLSI guidelines.
Results: Two hundred and fifty-four patients were included in the study with
the following distribution: 71 from a pediatrics ward, 62 from a general
medicine ward, 54 from a general surgery ward, 42 from a gynaecology ward,
16 from an orthopaedics ward and nine from an ENT ward. E. coli was isolated
from 112 samples. Out of 34 E. coli strains isolated from paediatric patients, 14
were determined to be enterovirulent E. coli by serotyping. Antimicrobial
susceptibility testing of all E. coli strains showed 100% resistance to nalidixic
acid and a high degree of resistance to ampicillin (87.5%), doxycyline
(83.0%), cotrimoxazole (75.9%), ciprofloxacin (73.2%) and third-generation
cephalosporins (71.4%). ESBL production was detected in 71 strains (63.4%).
However, no resistance was found for carbapenems and tigecycline.
Conclusion: A large population of chronically ill patients who were tested
was found to be carrying highly resistant E. coli in their guts. These usually
commensal strains may serve as a source of bloodstream infection especially
in cases of immunosuppression. Whether these strains were acquired in the
hospital or from the community needs to be studied further.
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Background: One hallmark contributing to immune suppression during the
l a t ep h a s eo fs e p s i si sm a c r o p h a g ep o l arization to an anti-inflammatory
phenotype upon contact with apoptotic cells (AC). Taking the important role
of the nuclear receptor PPARg for this phenotype switch into consideration,
it remains elusive how AC activate PPARg in macrophages. Therefore, we
were interested to characterize the underlying principle.
Methods: Apoptosis was induced by treatment of Jurkat T cells for
3 hours with 0.5 μg/ml staurosporine. Necrotic cells (NC) were prepared
by heating cells for 20 minutes to 65°C. PPARg activation was followed by
stably transducing RAW264.7 macrophages with a vector encoding the
red fluorescent protein mRuby after PPARg binding to 4 × PPRE sites
downstream of the reporter gene sequence. This readout was established
by treatment with the PPARg agonist rosiglitazone (1 μM) and AC (5:1).
Twenty-four hours after stimulation, mRuby expression was analysed by
fluorescence microscopy. Lipid rafts of AC, NC, as well as living cells (LC)
were enriched by sucrose gradient centrifugation. Fractions were
analysed for lipid raft-associated marker proteins. Lipid rafts were
incubated with transduced RAW264.7 macrophages as described above.
5-Lipoxygenase (5-LO) involvement was verified by pharmacological
inhibition (MK-866, 1 μM) and overexpression.
Results: Assuming that the molecule responsible for PPARg activation in
macrophages is localized in the cell membrane of AC, most probably
associated to lipid rafts, we isolated lipid rafts from AC, NC and LC. Mass
spectrometric analysis of lipid rafts of AC showed the expression of 5-LO,
whereas lipid rafts of LC did not. Moreover, incubating macrophages with
lipid rafts of AC induced mRuby expression. In contrast, lipid rafts of NC and
LC did not. To verify the involvement of 5-LO in activating PPARg in
macrophages, Jurkat T cells were incubated for 30 minutes with the 5-LO
inhibitor MK-866 (1 μM) before apoptosis induction. In line with our
hypothesis, these AC did not induce mRuby expression. Finally, although
living Jurkat T cells overexpressing 5-LO did not activate PPARg in
macrophages, mRuby expression was significantly increased when AC were
generated from 5-LO overexpressing compared with wild-type Jurkat cells.
Conclusion: Our results suggest that induction of apoptosis activates 5-LO,
localizing to lipid rafts, necessary for PPARg activation in macrophages.
Therefore, it will be challenging to determine whether 5-LO activity in AC,
generated from other cell types, correlates with PPARg activation,
contributing to an immune-suppressed phenotype in macrophages.
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Background: As sensors of infection, innate immune cells are able to
recognize pathogen-associated molecular patterns by receptors such as Toll-
like receptors (TLRs). Natural killer (NK) cells contribute to inflammatory
processes by producing proinflammatory cytokines such as IFNg and GM-
CSF [1]. Our aim was to characterize the immune status of NK cells in a
murine model of sepsis and in patients with systemic inflammatory
response syndrome (SIRS) and sepsis.
Methods: Cecal puncture (CP) was employed as a murine model of
polymicrobial sepsis. TLR expression in murine and human NK cells was
studied by flow cytometry. Ex vivo IFNg production was analyzed either by
ELISA or by flow cytometry.
Results: In mice, the expression of TLR2 and TLR4 in spleen NK cells is
mainly intracellular, similarly to TLR9. In vitro cell responsiveness of purified
NK cells to TLR2, TLR4 or TLR9 agonists, in synergy with accessory cytokines
(IL-2, IL-15 and IL-18), allowed a significant production of IFNg and GM-CSF.
In contrast, NK cells, purified from spleen of mice with sepsis, showed a
dramatic reduction of their capacity to produce cytokines in response to TLR
agonists. Depletion of regulatory T cells (Tregs) before CP led to a complete
reversion of NK cell tolerance to TLR agonists. IL-10 and TGF-b1a r et w o
main inhibitory cytokines produced by Tregs. We showed in vivo, using IL-10
knockout mice and by inhibiting TGF-bR signaling, that the tolerization
mechanism of NK cells was mostly mediated by TGF-b [2]. In humans, the
expression of TLR2, TLR4 and TLR9 in peripheral blood NK cells (both CD3
-
CD56
high and CD3
-CD56
dim subsets) was mainly intracellular. The ex vivo
responsiveness of the blood NK cells to their agonists in synergy with
accessory cytokines (IL-15 and IL-18), allowed a significant secretion of IFNg.
Similar to the murine model of sepsis, in SIRS and sepsis patients the
secretion of IFNg by NK cells was significantly decreased.
Conclusion: NK cells express TLR2 and TLR4 intracellularly, as already
reported for other cell types (epithelial, endothelial, and dendritic cells).
Furthermore, NK cells undergo tolerance to TLR agonists during SIRS or
sepsis, as already described for monocytes in these clinical settings.
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Page 42 of 58Background: Enterococcus faecalis gained importance in the last years for
causing tough and troublesome nosocomial infections especially in the
urinary tract, sometimes even leading to sepsis. Causes of concern are
increasing resistances of enterococci. Therefore, it is of utmost interest to
identify resistance patterns of bacteria within a very short timeframe to
select the right therapy and efficiently prevent spreading. Within our
junior research group we want to develop an on-chip device to probe
antibiotic susceptibility patterns of sepsis pathogens based on optical
spectroscopy without the need for time-consuming bacterial cultivation.
In this contribution, we present our first results with a focus on E. faecalis.
Methods: E. faecalis was grown in liquid culture and characterized in the
presence and absence of vancomycin by means of Raman spectroscopy.
Multivariate statistical analysis was applied to extract the spectral differences
due to antibiotic treatment. To enable the spectroscopic analysis directly
with patient samples (such as urine) Raman spectroscopy was combined
with dielectrophoresis. Bacteria from suspensions were captured and kept at
well-defined positions in a nonuniform electric field for the time of Raman
measurement. Currently, bacteria-spiked model urine is used. However, the
investigations shall be extended to urine from patients.
Results: A clear distinction between Raman spectra of E. faecalis with and
without antibiotic treatment is possible even 30 minutes after incubation
with vancomycin. A quadrupole electrode design is presented that allows
the efficient capturing of E. faecalis and Escherichia coli,b ym e a n so f
negative dielectrophoresis [1] (Figure 1a). From the captured bacteria in
solution on the dielectrophoretic chip, high-quality Raman spectra have
been recorded within 1 second (Figure 1b). These spectra allowed a
reliable differentiation of the two commonly encountered bacterial
species in urinary tract infections: E. faecalis and E. coli. First steps have
been undertaken to implement such dielectrophoretic capturing
structures into a microfluidic device for simplified sample handling.
Conclusion: Raman spectroscopy in combination with statistical analysis
holds the potential for a fast evaluation of bacterial antibiotic susceptibility
without the need of time-consuming cultivation.
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Background: Hemodynamic monitoring plays a key role in the early
recognition, optimization of interventions and monitoring of therapeutic
response in children with septic shock. Assessing the need for fluids
followed by rapid and timely fluid resuscitation is crucial for improved
outcomes. It is in this context that fluid responsiveness, defined as an
increase in cardiac output in response to a fluid challenge, assumes
importance. We have done this prospective clinical study to evaluate the
degree of IVC diameter variability in predicting fluid responsiveness
(increment in stroke index ≥15%) in children with septic shock post
20 ml/kg of crystalloid (0.9% saline) resuscitation.
Methods: A total of 166 episodes of preload responsiveness check were
echocardiographically evaluated in 41 children with septic shock. In each
episode, IVC diameter variability ((maximum - minimum IVC diameter)/
maximum IVC diameter), stroke index and ejection fraction were assessed
at two points (before preload T0 and after preload T1). Adequate
sedation was ensured before each echocardiographic assessment. Infants
<1 month of completed age, any clinical evidence of increased intra-
abdominal pressure, children with previously diagnosed heart disease,
requiring high-frequency ventilation, and for whom family did not give
consent were excluded from the study.
Results: Of the 166 episodes, 120 (72%) were fluid responsive and 46
(28%) were nonresponsive. One hundred and twenty-five episodes
occurred on patients who were on positive pressure ventilation, whilst 41
occurred during spontaneous breathing. The decrease in the heart rate
with preload was significant in the responsive as compared with the
nonresponsive group (24 ± 9 vs. 4 ± 7; P = 0.001) independent of the
ventilator support. IVC diameter variability at T0 correlated significantly
(r =0 . 3 9 ;P = 0.001) with stroke index increment following preload. The
AUC of ROC for IVC diameter variability was 0.75 (0.66 to 0.85). A cutoff
value of 14% variability showed 84.4% sensitivity and 65.9% specificity to
positively predict fluid responsiveness in ventilated as well in spontaneously
breathing children.
Conclusion: IVC diameter variability showed a significant correlation with
stroke index increment after preload and can act as a useful bedside tool
in predicting preload responsiveness in children with septic shock. Utility
of a serial ΔIVC percentage instead of a single measurement to assess
volume changes needs to be explored.
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Figure 1(abstract P85) (a) E. faecalis trapped between the electrodes on a quadrupole dielectrophoretic chip. (b) R a m a nm e a ns p e c t r aw i t h
standard deviation taken from 1,000 spectra of the trapped E. faecalis.
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Page 43 of 58Background: Rapid and timely fluid resuscitation is key to improved
outcomes in septic shock. Hemodynamic monitoring is vital for preload
assessment. Central venous pressure (CVP) is one such traditional tool
that is currently falling out of favor as adult data have shown it to be less
reliable in predicting preload responsiveness. Pediatric data are, however,
limited. We conducted this study to assess the predictive utility of CVP in
determining the preload responsive status defined as a stroke index
increment (≥15%) after preload (20 ml/kg 0.9% saline) administration.
Methods: A total of 166 episodes of preload administrations were included.
Hemodynamic variables (heart rate, mean arterial blood pressure, CVP) were
measured before (T0) and after (T1) preload administration in all. Both
spontaneously breathing and mechanically ventilated children were
enrolled. HR decrement and CVP increment as response to preload were
calculated using T1 and T0 measurements. The stroke index was measured
by transthoracic echocardiography at T0 and T1. Infants <1 month of age,
improper position of central venous catheter tip, clinical evidence of
increased intra-abdominal pressure, previously diagnosed heart disease,
need for high-frequency ventilation, and children in whom family had
declined consent were excluded from the study.
Results: Of the 166 episodes, 120 (72%) were fluid responsive and 46 (28%)
were nonresponsive. One hundred and twenty-five episodes occurred in
patients on positive pressure ventilation and 41 during spontaneous
breathing. The internal jugular vein was catheterized in 34 (142 episodes;
85%) and the femoral vein in seven patients (24 episodes; 14.5%). There was
a significant decrease in heart rate independent of ventilator support in the
preload responsive as compared with the nonresponsive group (24 ± 9 vs.
4±7 ;P = 0.001). However, there was no significant difference in CVP
between the fluid responsive and nonresponsive episodes (6.2 ± 1.5 vs.
6.0 ± 1.4; P = 0.71), although CVP was significantly higher in mechanical
ventilation as compared with episodes on spontaneous breathing (6.5 ±
1.3 vs. 5.2 ± 1.6; P =0 . 0 0 1 ) .B a s e l i n eC V P( T 0 )( r = 0.01; P = 0.10) and CVP
increment at T1 (r = 0.18; P = 0.14) showed a poor correlation with stroke
index increment.
Conclusion: CVP increment with preload showed a poor correlation with
stroke index increment, suggesting that CVP measurements are not
useful in predicting a preload responsiveness state in critically ill children.
Decrement in heart rate was the only conventional hemodynamic
variable that signified preload response but that also in retrospect, thus
limiting its utility as a predictive tool.
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Background: Nosocomial bloodstream infections, especially by Gram-
negative bacterial species, contribute to substantial morbidity and
mortality in critically ill children. In this context, emerging carbapenem
resistance further complicates patient management, as these isolates are
often resistant to all b-lactam antibiotics and frequently co-resistant to
most other antibiotics, leaving very few treatment options. We conducted
this study to identify the microbiologic spectrum of Gram-negative
nosocomial bloodstream infections (BSI) in a PICU of a tertiary care
hospital and to determine the changing antibiotic sensitivity pattern.
Methods: Data from prospectively maintained records of patients with
more than 48 hours of PICU stay and a Gram-negative bloodstream
isolate from January 2009 to December 2011 were analyzed. The study
period was divided into Group 1 (January 2009 to December 2009),
Group 2 (January 2010 to December 2010), and Group 3 (January 2011 to
December 2011) to look for any change in antibiotic sensitivity pattern.
Results: There were 102 episodes of Gram-negative BSI (Group 1: 51,
Group 2: 33, Group 3: 18) in 1,601 patients, corresponding to 8.2 episodes
per 1,000 patient-days. Among the Gram-negative isolates, commonest
was Acinetobacter species (n = 44; 43%) followed by Klebsiella pneumonia
(n = 16; 16%). All three groups were similar with respect to age, sex ratio,
device utilization, grade of infection and outcome. When antibiograms
were compared between Groups 1 and 3, there was a significant increase
in carbapenem resistance (19% vs. 55%; P =0 . 0 1 )o v e rt i m e .
Carbapenem-resistant isolates remained resistant to most of the other
antibiotics (third-generation cephalosporins (98%), aminoglycosides (98%),
b-lactam with b-lactamase inhibitor (94%), ciprofloxacin (90%)). However,
sensitivity to colistin (100%) was retained in all carbapenem-resistant
Gram-negative isolates. Although Gram-negatives were predominant
organisms isolated in all three time periods, a significant increase in
fungal isolates (3 vs. 12; P = 0.0003) was observed over the study period.
A l lf u n g a li s o l a t e sw e r ec a n d i d as p e c ies; nonalbicans candida species
(13/19) were commoner than Candida albicans.
Conclusion: Gram-negative bacteria are the commonest cause for
n o s o c o m i a lB S Ii no u rP I C U .A ni n c r e a s i n gt r e n do fc a r b a p e n e m
(imipenam, meropenem) resistance was noted over the study period.
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Background: Sepsis is a daily challenge in ICUs. Today various therapeutic
strategies are known to improve survival in patients with sepsis. Early
assessment is important for determination of the appropriate treatment. PCT
has been proposed as a specific infection maker for this purpose.
Methods: A fluorescence dye-incorporated immunochromatographic assay
(FICA) was developed for detection of the PCT concentration in serum.
Serum mixed with fluorescence-conjugated detector was loaded onto a
cartridge and incubated for 12 minutes. The fluorescence intensity of the
cartridge was then measured in a laser fluorescence scanner. The analytical
performance of the FICA system was evaluated by precision and recovery
tests. The comparability of the new method was examined with an
automated analyzer.
Results: A reliable correlation between area ratio (AT/AC), reflecting
fluorescence intensity of test/control line, and PCT concentration was
observed (r = 0.999). The CVs of intra-assay and inter-assay precision in a
range of 0.26 to 2.09 ng/ml were 7.8% and 4.5%, respectively, and analytical
recovery of the FICA system fell within 6.4% at the tested samples. When
the FICA method was compared with Roche Elecsys analyzers, there were
strong correlations (r = 0.993, n = 80).
Conclusion: The FICA system with point-of-care-testing appeared to be an
easy, fast and suitable method for measurement of the PCT concentration
in serum.
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Background: Indian data from the Management of Sepsis in Asia’s
Intensive Care Units (MOSAICS) study are presented. The primary objective
of the MOSAICS study was to assess the compliance of Asian ICUs and
hospitals to the Surviving Sepsis Campaign’s 6-hour resuscitation bundle
and 24-hour management bundle.
Methods: This was prospective cohort study of 162 adult patients with
severe sepsis who were admitted to 17 ICUs in India in July 2009. Patients’
baseline characteristics, the achievement of targets within the resuscitation
and management bundles, and out c o m ed a t aw e r er e c o r d e d .M a i n
outcome measures were compliance tot h eS u r v i v i n gS e p s i sC a m p a i g n ’s
resuscitation and management bundles. Secondary objectives were to
evaluate the impact of compliance on mortality.
Results: The mean age of patients was 53.3 ± 17 years. The mean APACHE II
SCORE was 21.9 ± 8.4, and was significantly higher in nonsurvivors (26.3 ±
8.5) than survivors (19.2 ± 7.3). Hospital mortality was 38.3% (62/162).
Achievement rates for the bundle targets were: lactate measurement, 40.1%
(65/162); blood cultures, 52.4% (85/162); broad-spectrum antibiotics, 62.3%
(101/162); fluids ± vasopressors, 84.4% (103/122); central venous pressure,
49.6% (56/113); central or mixed venous oxygen saturation, 16.8% (19/113);
low-dose steroids, 52.4% (55/105); glucose control, 27.2% (44/162);
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resuscitation and management bundles were 6.8% (11/162) and 8% (13/162)
respectively. There was a trend to improving survival with bundle
compliance. Compliance with the resuscitation and management bundles
was associated with mortality rates of 18.2% and 19%, respectively, while
mortality rates with noncompliance were 39.7% and 41.1%. Of the
resuscitation bundle elements, achieving targets for fluid resuscitation and
vasopressors was associated with survival, but this disappeared when
adjusted for APACHE II score. Of the elements in the management bundle,
achieving glucose target and low tidal volume ventilation in patients with
acute lung injury as well as the APACHE II score were independently
associated with survival.
Conclusion: While mortality from severe sepsis is high, compliance to the
resuscitation and management bundles is generally poor in ICUs in India.
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Background: Nosocomial infections are important sources of morbidity
and mortality in ICUs. Surveillance of nosocomial infection is an integral
feature of infection control and quality assurance in hospitals.
Methods: Our ICU is a nine-bed ICU of a tertiary cancer centre in
Mumbai, India. Over a 1-year period, between March 2009 and February
2010 (period 1), we prospectively determined the rates of ventilator-
associated pneumonia (VAP) and central line associated bloodstream
infection (CLABSI) based on CDC definitions. We also carried out daily
process surveillance including compliance to hand hygiene, the ventilator
bundle and the central line care bundle. We then introduced the
following interventions: routine use of heat-moisture exchanger filters
and closed suction systems to reduce VAP, and use of antibiotic-coated
central venous catheters to reduce CLABSI. We also reinforced general
hygiene practices for all ICU personnel and use of checklists. We then
remeasured VAP and CLABSI rates and process compliance over the next
1 year, from March 2010 to February 2011 (period 2).
Results: In period 1, VAP comprised 61% and CLABSI 35% of all device-
related nosocomial infections in the ICU. The CLABSI and VAP rates were
33 and 58 per 1,000 device-days, respectively. VAP and CLABSI accounted
for 20% and 7.7% increase in mortality, respectively. The hand hygiene
compliance rate was 68% for physicians and 82% for nurses, and
compliance with vascular catheter care and ventilator bundles was 65%
and 70% respectively. After introduction of the interventions, in period 2,
the incidence of VAP was reduced from 58/1,000 ventilator-days to 30.9/
1,000 ventilator-days; the CLABSI rate fell to 26.7/1,000 device-days. There
was no significant difference in compliance with hand hygiene or the
central line and ventilator bundles compared with the previous period.
Conclusion: Our rates of VAP and CLABSI were much higher than those
reported for developing countries and the US NHSN. This may be partly
due to the immunosuppressed nature of cancer patients with neutropenia
and prior chemotherapy. Our interventions resulted in a significant
reduction in the rate of VAP, and to a lesser extent for CLABSI. Process
compliance did not change. It is essential to improve process compliance
to further reduce the incidence of nosocomial infections in our ICU.
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Background: Herein we examined the hypothesis that preserving
splanchnic microcirculation with lasting visceral parasympathetic
vasodilatation plus a rapid hyperfluid therapy, during the early phase of
severe sepsis (DL60), could delay and/or reduce the acutely exacerbating
inflammatory feature of sepsis and modify its progression to death. In our
previous work, this sepsis determined splanchnic tissue hypoxia, gut
bacterial overgrowth, and bacterial translocation (BT) and these events
were inflammatory amplification causal factors.
Methods: Adult Wistar-EPM rats (n = 86) were anesthetized and
submitted to: sepsis (S) (2 ml Escherichia coli 10
8 CFU/ml i.v.) and/or
thoracic epidural analgesia (E) (0.2 ml of 0.05% bupivacaine) and/or
hyperfluid therapy (H) (30 ml/kg/20 minutes of Ringer lactate) according
to the group (G) design: SG; SEG; SHG; SEHG; EG and; NG (naive). Epidural
analgesia and fluid therapy were initiated 30 minutes after sepsis. At
the 24-hour period, animals were monitored to: microcirculatory
hemodynamics (duodenum, jejunum, ileum, liver and kidney) with
Figure 1(abstract P92) SDF images of organs. Liver (1 to 4) and ileum
(9 to 12). Arrows indicate altered microvessels and perivascular tissue
areas.
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(duodenum, jejunum and ileum) and BT event in mesenteric lymph node
(MLN), liver and spleen. Mortality was followed for 30 days.
Results: SDF findings showed that both EG and EHG preserved the
microvascular and perivascular tissue architecture following sepsis
induction in all organs. However, the SEH combination group showed
larger microvessel diameter as compared with SEG, suggesting a better
withholding of the intravascular blood volume subsequently improved
tissue perfusion (Figure 1). A significant gut bacterial overgrowth was
observed only in SG as compared with NG, EG, HG and EHG. The BT index
to MLN was proportional to bacterial overgrowth, being higher in SG
(67%), lower in SHG (33%) and SEG (17%), and absent in SEHG and EG. The
mortality rate was 60% (SG), 30% (SEG) and 10% (HG). All animals with
sepsis survived with E + H combination therapy.
Conclusion: The splanchnic sympathetic blockage by epidural analgesia
attenuated abdominal organs’ microcirculatory dysfunction by augmen-
tation of the parasympathetic vasodilatation effect, which might have
preserved gut microcirculation, minimizing bacterial overgrowth, BT and
subsequent gut immune activation. In addition, vigorous fluid therapy in
the early phase of sepsis might have modulated the host systemic
inflammatory response by ensuing better tissue perfusion. The combined
therapy, by acting differently via an inflammation trigger, might have
promoted a synergistic effect. Studies are in progress to verify the
combined therapy potentials in the later phase of sepsis.
Acknowledgements: Supported by FAPESP.
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Background: The microcirculation dysfunction sequence in sepsis has not
been well acknowledged to support therapy and prognosis. Herein, the
abdominal organs’ microcirculation and their perivascular tissue
derangements captured by SDF microscopy were correlated with the
whole organ histological findings in severe sepsis.
Methods: Adult Wistar-EPM rats (n = 54) were distributed into: sepsis
group (n = 36), animals submitted to 10
9 CFU/ml Escherichia coli
inoculation through the jugular vein; and sham group (n = 18), animals
with physiologic saline 0.9%. At 0, 2, 6 and 24 hours, liver, kidney and
ileum microvascular and perivascular images were monitored by SDF
in vivo and also by histology.
Results: The liver and kidney surface SDF images showed that
microcirculation and perivascular tissue alterations are a concomitant
event, which were a focal event initially that turned progressively
generalized in proportion to sepsis worsening. Vascular patterns were
from complete absence to hyperflow and narrowed to dilated venules,
showing that altered and nonaltered microvessels occur simultaneously in
sepsis. The expansion of perivascular tissue fuzziness with narrowed or
vanished microvessels in sepsis suggested local dysfunction in
progression. Confronting these areas with histology, the enlarged
perivascular areas were composed mostly of cytoplasm edema at the
early sepsis phase and of varying stages of the cell necrosis process at
the further periods. These processes were very similar in both the liver
and kidney and occurred throughout the organ, showing that the surface
findings can be extensive to deeper areas (Figure 1). In contrast, the
small bowel SDF images showed that gut surface microcirculation was
composed primarily of high-flow capillaries and only the vascular density
was focally reduced in sepsis; besides, the perivascular tissues could not
be identified, showing that the vascular and tissue architectural pattern in
the gut differs substantially from solid organs, suggesting a different
pathophysiology response of the intestinal microcirculation in sepsis. The
gut histology showed generalized cell edema and varying necrosis phases
in muscle layers of the intestine in sepsis, and such events could not be
suspected by SDF.
Conclusion: Organ dysfunction in sepsis is better detectable in solid
organs by SDF imaging as compared with gut muscular compartment.
These results demonstrated the importance of the solid organ SDF
monitoring in experimental sepsis treatment studies.
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Background: The management of the uncontrolled systemic inflammatory
response in the early phase of severe sepsis is still a challenge. Herein we
aimed to minimize the acute inflammation phase of sepsis by clarithromycin
associated with intravascular volume r e s t o r a t i o nw i t ha na g g r e s s i v ef l u i d
therapy.
Methods: Wistar rats were distributed into five groups: S, animals
submitted to sepsis (DL80;3m lEscherichia coli 10
9 CFU/ml, i.v., n = 6); SCH,
animals induced to sepsis after clarithromycin (14 mg/kg, i.v., given 24 and
0 hours before sepsis) and hyperhydration (Ringer lactate 40 ml/kg, i.v., in
20 minutes after the sepsis induction) (n = 6); SC, animals induced to
sepsis and treated with clarithromycin (n = 6); SH, animals induced to
sepsis and treated with hyperhydration (n = 6); and Sham, animals induced
to sham sepsis (n = 4). All invasive procedures were undergone after
general anesthesia. The liver, kidney and ileum microcirculation were
monitored by Laser Doppler and sidestream darkfield imaging at 2-hour
and 26-hour periods. The mortality index was observed for 30 days.
Results: All animals of the SCH and Sham groups survived while the S, SC
and SH groups showed 20% survival. Hyperhydration or clarithromycin in
sepsis showed a partial and transient improvement of the microcirculation
of the abdominal organs, although the association of hyperhydration with
clarithromycin (SCH group) showed better effects. In addition, the beneficial
microhemodynamic effect under combined therapy was better evidenced in
the liver and intestine as compared with the kidney.
Conclusion: The association of clarithromycin and hyperhydration
showed a beneficial effect in severe sepsis, possibly by modulating
inflammatory response and microcirculation damage, respectively,
resulting in subsequent survival; nevertheless, their individual effects were
not efficient to inhibit severe sepsis mortality and microcirculation
dysfunction.
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Background: The effect of Alteco LPS Adsorber® to remove LPS from the
circulation is based on the incorporation of a synthetic peptide that binds
to the lipid A moiety of LPS, the binding capacity in one adsorber
exceeding 7.5 μg LPS. Positive clinical effects of the adsorber when used in
patients with Gram-negative sepsis have been reported [1]. Measurement
of LPS in human blood, however, is hampered by difficulties such as
contamination and interference. The aim of this pilot study was to evaluate
a method to release LPS from the LPS adsorber after perfusion with LPS
containing blood.
Methods: Two adsorbers (A1, A2) containing the active peptide and one
dummy adsorber (D) with no peptide were used. Whole blood (500 ml) from
healthy pigs was collected in a bag containing heparin, 37 μgL P Sw a s
added. A roller pump was used to recirculate the blood through the
adsorber. The pump flow was set at 150 ml/minute and the duration of the
perfusion was 2 hours. After the end of perfusion the adsorbers were rinsed
with 500 ml Krebs solution. A solution of 20 mg proteinase K in 50 ml Tris
buffer with pH 7.4 was prepared and 2.5 ml CaCl2 was added. The adsorbers
were kept at 37°C and the proteinase K solution [2] was perfused through
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(chromogenic LAL) [3] were drawn before the perfusion and then after 30,
240 and 360 minutes. The enzyme activity was checked using a synthetic
substrate [4].
Results: The concentrations of LPS before and during perfusion with
proteinase K are shown in Table 1.
Conclusion: The LPS values found before the start of the perfusion indicate
contamination of the solution. The increase in LPS seen in all adsorbers after
30 minutes is probably due to traces of blood components. The later
increase in LPS after treatment with proteinase K in the active adsorbers
indicates that the adsorber is effective in capturing LPS from whole blood
and that proteinase K is able to dislodge LPS bound to the adsorber.
Figure 1(abstract P93) Organ SDF and histological findings in sham and sepsis groups at the 6-hour period. Arrows indicate vascular and
perivascular tissue derangements.
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Background: Major trauma is characterized by a proinflammatory
response, followed by an immunosuppression, increasing the risk for ICU-
acquired infection. Several prognostic markers of sepsis in ICU patients
have been identified and need to be assessed. Recently, Pancreatic Stone
Protein/regenerating protein (PSP/reg) was shown to be increased during
post-traumatic sepsis [1]. The N-terminal fragment of the C-type
natriuretic peptide precursor (NT-proCNP) was assessed as a predictor of
sepsis in multiple traumatized patients without brain injury [2]. The main
objective of this study was to determine whether measurements of those
biomarkers could help in the prediction of sepsis in severe trauma
patients.
Methods: This retrospective observational study was carried over 24
months in a trauma ICU at a university hospital. Trauma patients under
mechanical ventilation with an Injury Severity Score (ISS) >25 and age >18
were included. Patients dying in the first 48 hours after trauma, having
pulmonary inhalation/gut perforation during trauma or after the onset of
infection, were excluded. We used already described ELISA protocols for the
detection of PSP/reg [1] and NT-proCNP (Biomedica, BI-20872). Both
biomarkers have been measured every 2 days from day 1 to day 4 after
trauma. After descriptive analysis of clinical data (using medians with
interquartile ranges), we evaluated the standard fold-change (SFC) and the
area under the curve (AUC) between patients being infected (sepsis group)
and patients not being (nonsepsis group).
Results: We analyzed 61 trauma patients: age 37 (25; 50), ISS 38 (33; 45).
Among them, 24 developed sepsis in the first week after trauma
(pneumonia; median delay 4 days). There were no differences between
sepsis and nonsepsis groups at admission regarding demographic data.
Neither PSP/reg nor NT-proCNP showed significant differences between
sepsis and nonsepsis groups, whatever time point was considered
(respectively days 1 to 2 and days 3 to 4; Table 1). The computed values for
SFC and AUC were lower than the minimal detectable values.
Conclusion: In this pilot study, neither PSP/reg nor NT-proCNP can help
in the prediction of sepsis in severe trauma patients. Contrary to the
results published by Bahrami and colleagues [2], we did not show
significant difference between sepsis and nonsepsis groups in patients
without brain injury. Our study illustrates the complexity of validating
biomarkers for sepsis prediction in independent cohort of patients.
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Background: Time is precious for patients and clinicians facing septic
events. In recent past years, many efforts have been made to develop
rapid and reliable tests, especially by molecular methods, which still have
several limits in determining antimicrobial susceptibility. Nowadays,
MALDI-TOF mass spectrometry allows almost instantaneous bacterial
identification, but antibiotic susceptibility results are usually delayed 24 to
48 hours, compared with the timing of microorganism identification.
Methods: In this work, two short procedures, one for Gram-negative and
one for Gram-positive bacteria, were developed. The two methods were
employed to purify bacteria from positive blood cultures (Becton
Dickinson) after microscopic examination, and to prepare bacterial cells for
identification. Bacteria were then identified by MALDI-TOF mass
spectrometry (Bruker Daltonics) with excellent scores, similar to those
obtained from agar plate colonies. After identification, short-term broth
cultures were inoculated with an aliquot of the recovered bacteria, with or
without (growth controls) antibiotics and incubated in an HB&L (Alifax
SpA) instrument, which monitored each vial for bacterial growth during
the following 3 hours. Absence or reduction in growth in a vial containing
a certain antibiotic was interpreted as sensibility, while resistance was
assessed by a bacterial growth comparable with the control vial.
Results: In these pilot experiments 32 Gram-negative (10 Klebsiella
pneumoniae,s i xEscherichia coli,f o u rEnterobacter aerogenes,f o u r
Pseudomonas aeruginosa,t w oKlebsiella oxytoca,t w oAcinetobacter
baumannii,o n eCitrobacter freundii,o n eProteus mirabilis,o n eSerratia
Table 1(abstract P95)
LPS Before 30 minutes 240 minutes 360 minutes
A1 (EU/ml) 3.65 5.29 27.04 50.68
A2 (EU/ml) 2.74 4.65 10.45 18.04
D (EU/ml) 3.94 4.16 6.78 5.82
Enzyme activity (%), A1, A2, D 100, 100, 100 104, 110, 110 96, 102, 104 92, 95, 102
Table 1(abstract P96) PSP/reg and NT-proCNP doses (ng/ml) in function of patient groups
Sepsis Nonsepsis
PSP/reg Days 1 to 2 (n = 38) (n = 16) 30.1 (15.9; 51.4) (n = 22) 27.8 (18.0; 41.3)
Days 3 to 4 (n = 36) (n = 7) 57.9 (21.7; 131.1) (n = 29) 38.5 (15.8; 71.2)
NT-proCNP Days 1 to 2 (n = 37) (n = 16) 4.5 (3.6; 5.7) (n = 21) 5 (3.8; 8.8)
Days 3 to 4 (n = 36) (n = 7) 3.6 (3.3; 3.9) (n = 29) 4.7 (3.3; 5.6)
Data presented as median (Q1; Q3).
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Staphylococcus epidermidis, eight Staphylococcus hominis,t h r e e
Staphylococcus capitis, two Staphylococcus haemolyticus, two Staphylococcus
aureus,o n eStaphylococcus auricularis,o n eEnterococcus faecalis,o n e
Enterococcus faecium) bacterial isolates were correctly identified and 274
rapid susceptibility tests were performed. Among these, 259 were compared
with results from Vitek 2 (bioMérieux), obtained 48 hours later from agar-
plated cultures of routine analysis, with an overall agreement of 93% (1.5%
very major errors, 4% major errors, 1% minor errors; discrepancies resolved
by E-test). Antibiotics tested were chosen among cefotaxime, ceftazidime,
gentamicin, levofloxacin, meropenem, amikacin and colistin for Gram-
negative bacteria and cefoxitin, linezolid, teicoplanin and ampicillin for
Gram-positive bacteria. All but cefoxitin gave results in 3 hours.
Conclusion: These results show that rapid and reliable microbiological
answers can be given in a few hours, thus allowing clinicians to start a
proper and lifesaving antibiotic therapy.
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Background: NGAL appears to be a biomarker of acute kidney injury. It is
produced by neutrophils and renal tubular cells. In healthy patients, plasma
NGAL levels have been shown to vary with white blood cell concentrations.
The predictive ability of NGAL to predict AKI is attenuated by leucocytosis in
patients being treated with vancomycin. The relationship between NGAL
and white cell indices in the critically ill is poorly understood. The aim is to
explore the relationship between different measures of NGAL and white cell
count (WCC) and neutrophil count (NC) in critically ill patients at risk of AKI.
Methods: Patients with systemic inflammatory response syndrome and
oliguria, or a creatinine rise >25 μmol/l, or both, in a tertiary referral
university hospital ICU, within 48 hours of admission, were studied. We
measured kidney-specific monomeric urinary NGAL (muNGAL), plasma
(pNGAL) and urinary NGAL (ucNGAL) by commercial assay, and routine
haematological and biochemical parameters. Institutional ethics approval
was obtained.
Results: We studied 84 patients (51.2% male, median age 66.5 (52 to 74))
with a median APACHE III score of 61 (45 to76). Fifty-one patients had
WCC >10 × 10
9/l, 58 had NC >7.5 × 10
9/l. No useful correlations were
demonstrated between white cell indices and any form of NGAL
measurement. A stronger correlation existed between creatinine and
sNGAL than urinary indices. The strength of correlation between
creatinine and all measures of NGAL was greater in those patients with
high white cell indices (Table 1); the increase was significant for sNGAL in
those with elevated WCC (r = 0.27 in nonleucoytotic patients, r = 0.65 in
leucocytotic patients, P < 0.05).
Conclusion: The stronger correlation between creatinine and pNGAL
suggests systemic factors may be more important than local factors in
the pathophysiology of AKI. The increased strength of relationship in
those with leukocytosis suggests NGAL may be a general index of illness
severity. Multicentre and longitudinal studies are required to further
increase our understanding of the natural history of NGAL release and
the clinical utility of these tests.
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Background: Acquired glucocorticoid resistance frequently complicates
the therapy of sepsis. It leads to an exaggerated proinflammatory response
and has been related to altered expression profiles of glucocorticoid
receptor isoforms glucocorticoid receptor-a (mediating anti-inflammatory
effects) and glucocorticoid receptor-b (acting as a dominant negative
inhibitor). We investigated the impact of glucocorticoid receptor isoforms
on glucocorticoid effects in human T cells. We hypothesized that changes
of the ratio of glucocorticoid receptor isoforms impact glucocorticoid
resistance and that glucocorticoid receptor-a expression is controlled by
microRNA-mediated gene silencing.
Methods: First, T cells from healthy volunteers (native and CD3/CD28-
stimulated cells with or without addition of hydrocortisone) were analyzed
for the expression of glucocorticoid receptor isoforms by quantitative PCR.
Additionally, effects of gene silencing of glucocorticoid receptor-b by siRNA
transfection were determined. Secondly, microRNA-mediated silencing was
evaluated by cloning of a glucocorticoid receptor-a-specific 3’-untranslated-
region reporter construct and subsequent transfection experiments in cell
cultures. Effects of miRNA transfection on glucocorticoid receptor-a
expression were analyzed in Jurkat T cells and in T cells from healthy
volunteers (quantitative PCR and western blotting). Finally, expression of
glucocorticoid receptor-a, glucocorticoid receptor-b,a n dm i R - 1 2 4w a s
tested in T cells of sepsis patients (n =2 4 ) .
Results: Stimulation of T cells induced a significant upregulation of
glucocorticoid receptor-a (not glucocorticoid receptor-b), thereby possibly
rendering T cells more sensitive to glucocorticoids; this T-cell response was
hindered by hydrocortisone. Silencing of glucocorticoid receptor-b
doubled the inhibitory effects of glucocorticoids on IL-2 production.
MicroRNA-124 was proved to specifically downregulate glucocorticoid
receptor-a. Furthermore, a glucocorticoid-induced threefold upregulation
of microRNA-124 was found. T cells of sepsis patients exhibited slightly
decreased glucocorticoid receptor-a and slightly increased miR-124
expression levels, whereas glucocorticoid receptor-b expression was
twofold upregulated (P < 0.01) and exhibited a remarkable interindividual
variability.
Conclusion: Glucocorticoid treatment induces expression of miR-124,
which downregulates glucocorticoid receptor-a thereby limiting anti-
inflammatory effects of glucocorticoids. Steroid treatment might
aggravate glucocorticoid resistance in patients with high glucocorticoid
receptor-b levels.
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Care Med 2012 [Epub ahead of print].
© Society of Critical Care Medicine
and Lippincott Williams & Wilkins, and the presented excerpt for Sepsis
2012 Paris was permitted by Wolters Kluwer Health, 8 August 2012.
P100
Glucocorticoids control systemic inflammatory response by regulation
of energy metabolism and cytokine expression
A Kleyman
1,2*, S Hübner
2, M Bauer
1, JP Tuckermann
2,3
1Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany;
2Leibniz Institute for Age Research, Jena, Germany;
3University of Ulm,
Institute for General Zoology and Endocrinology, Ulm, Germany
Critical Care 2012, 16(Suppl 3):P100
Background: Endogenous glucocorticoids (GCs) are essential for survival
in systemic inflammatory response (SIRS). So far, their effect has been
attributed exclusively to anti-inflammatory activities of GCs in leukocytes.
GCs act through glucocorticoid receptor (GR), a ubiquitously expressed
Table 1(abstract P98) Spearman correlation for inclusion
creatinine
Group n pNGAL ucNGAL muNGAL
Undifferentiated 84 0.51 0.40 0.40
No leucocytosis (WCC <10 × 10
9/l) 33 0.27 0.22 0.21
Leucocytosis (WCC >10 × 10
9/l) 51 0.65 0.47 0.47
No neutrophilia (NC <7.5 × 10
9/l) 26 0.40 0.33 0.32
Neutrophilia (NC >7.5 × 10
9/l) 58 0.55 0.42 0.41
Critical Care 2012, Volume 16 Suppl 3
http://ccforum.com/supplements/16/S3
Page 49 of 58nuclear receptor. GR binds as a homodimer to the glucocorticoid
responsive element in the promoter of target genes and regulates their
transcription. Another mode of GR action is dimerization independent;
monomeric GR interacts with other transcriptional factors such as AP1,
NF-B, IRF3, modulates their activity and in this way regulates the
expression of target genes. Our study explored which cells mediate the
beneficial effects of GCs and identified GR target genes important for
survival in systemic inflammatory response.
Methods: Knock-in mice carrying a dimerization-deficient GR (GRdim
mice), leptin-deficient mice (ob/ob mice) and the respective wild-type
littermates were subjected to a LPS-induced shock model.
Results: After high-dose LPS (10 mg/kg) wild-type mice decreased oxygen
consumption and developed mild temporal hypothermia; however, in 6 to
12 hours they discontinued to decrease energy metabolism and recover
during 24 to 48 hours. Recovery of energy metabolism in wild-type mice
w a sa c c o m p a n i e db yu p r e g u l a t i o no fl e p t i ne x p r e s s i o ni nw h i t ea d i p o s e
tissue and an increase of leptin serum level as well as upregulation of
expression of the leptin target gene (proopiomelanocortin (POMC)) in the
hypothalamus. After LPS injection, mice with a dimerization-deficient GR
(GRdim mice) had normal TNFa and elevated IL-1b serum level compared
with wild-type littermates. GRdim mice developed a strong repression of
oxygen consumption, severe hypothermia and died during 48 hours after
LPS administration. Continued repression of energy metabolism in GRdim
mice was associated with the inability to increase leptin serum level and a
misregulation of leptin signaling in hypothalamus after LPS injection. Leptin-
deficient ob/ob mice demonstrate phenotype similar to GRdim mice: a
strong suppression of energy metabolism, low oxygen consumption, severe
hypothermia, and increased lethality in systemic inflammation. Importantly,
treatment with IL-1 receptor antagonist (IL-1RA) alone does not rescue
GRdim mice; however, simultaneous treatment with IL-1RA and leptin
significantly increase energy metabolism and rescue survival of GRdim mice
in LPS-induced SIRS.
Conclusion: We show that endogenous GCs fulfill their protective function
during systemic inflammation by different mechanisms: repression of
cytokine expression and regulation of energy metabolism via upregulation
of leptin expression.
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Background: The PRE-SHOCK population, ED sepsis patients with tissue
hypoperfusion (lactate of 2.0 to 3.9 mM), commonly deteriorates after
admission and requires transfer to critical care. The objective was to
determine the physiologic parameters and disease severity indices in the
ED PRE-SHOCK sepsis population that predict clinical deterioration. We
hypothesized that neither initial physiologic parameters nor organ function
scores will be predictive.
Methods: A retrospective analysis of a prospectively maintained registry of
sepsis patients with lactate measurements in an urban, academic medical
center. The PRE-SHOCK population was defined as adult ED sepsis patients
with either elevated lactate (2.0 to 3.9 mM) or transient hypotension (any
sBP <90 mmHg) receiving intravenous antibiotics and admitted to a medical
floor. Consecutive patients meeting PRE-SHOCK criteria were enrolled over a
1-year period. Patients with overt shock in the ED, pregnancy, or acute
trauma were excluded. The primary patient-centered outcome was
increased organ failure (Sequential Organ Failure Assessment (SOFA) score
increase >1 point, mechanical ventilation or vasopressor utilization) within
72 hours of admission or in-hospital mortality.
Results: We identified 248 PRE-SHOCK patients from 2,649 screened. The
primary outcome was met in 54% of the cohort and 44% were transferred
to the ICU from a medical floor. Patients meeting the outcome of
increased organ failure had a greater shock index (1.02 vs. 0.93, P =0 . 0 4 2 )
and HR (115 vs. 105, P < 0.001) with no difference in initial lactate, age,
MAP or exposure to hypotension (sBP <100 mmHg). There was no
difference in the Predisposition, Infection, Response, and Organ
dysfunction (PIRO) score between groups (6.4 vs. 5.7, P = 0.052). Outcome
patients had similar initial levels of organ dysfunction but had higher SOFA
scores at 24, 48, and 72 hours, a higher ICU transfer rate (60 vs. 24%, P <
0.001) and increased ICU and hospital lengths of stay.
Conclusion: The PRE-SHOCK sepsis population has a high incidence of
clinical deterioration, progressive organ failure, and ICU transfer.
Physiologic data in the ED were unable to differentiate the PRE-SHOCK
sepsis patients who developed increased organ failure. This study
supports the need for an objective organ failure assessment in the
emergency department to supplement clinical decision-making.
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Background: Increasing levels of endotoxin activity are associated with
increasing mortality in ICU patients. The removal of endotoxin through
polymyxin B hemoperfusion has been shown to decrease organ dysfunction
and reduce mortality in septic shock patients. Our objective was to
determine the ability of endotoxin measurement and its change over
24 hours in normotensive sepsis patients to predict clinical deterioration.
Methods: A prospective observational study in a single-center urban,
academic medical center involving adult ED patients with suspected
infection admitted to a medical floor and receiving i.v. antibiotics with
either elevated lactate (2.0 to 3.9 mM) or transient hypotension (sBP <90
mmHg). Patients with overt shock (mechanical ventilation or vasopressor
requirement), pregnancy, or acute trauma were excluded. The Endotoxin
Activity Assay was measured at enrollment and again at 24 hours. Subjects
were followed for the development of increased organ failure (Sequential
Organ Failure Assessment (SOFA) score increase >1 point, mechanical
ventilation or vasopressor utilization) within 72 hours of admission or in-
hospital mortality.
Results: We enrolled 57 patients over a 12-month period. The primary
outcome was met in 63% of the cohort and 33% were transferred to the ICU
from their initial medical floor admission. Patients with the outcome of
increased organ failure had no difference in initial lactate, age, MAP or
exposure to hypotension. Outcome patients had similar initial and 12-hour
SOFA scores with higher scores at 24, 48, and 72 hours, a higher ICU transfer
rate (42% vs. 19%, P = 0.15) and increased ICU (2 vs. 0) and hospital length
of stays (13 vs. 8). Outcome patients had similar endotoxin levels at
enrollment compared with those not meeting outcome (0.61 vs. 0.51, P =
0.075) with increased levels at 24 hours (0.73 vs. 0.47, P = 0.005). An
increasing endotoxin level over 24 hours had a 71% specificity and 72% PPV
in predicting the primary outcome. Compared with serum lactate, there was
no relationship between endotoxin activity and initial serum lactate on
linear regression analysis (slope = 0.077, R
2 = 0.0004).
Conclusion: Within this moderate-severity sepsis cohort, physiologic data
in the ED were unable to differentiate those with progressive organ
dysfunction over 72 hours, while endotoxin levels were higher at 24 hours
in this outcome group. The high specificity and positive predictive value of
an increasing endotoxin level as a predictor of progressive organ
dysfunction can supplement clinical decision-making to aid clinicians in
identifying high-risk patients from this homogeneous population of
moderate-severity sepsis patients.
P103
Defining the impact of delayed antibiotic administration using a
comprehensive electronic health record screen to identify sepsis
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Background: The true effectiveness of early antibiotic administration
relative to the clinical identification of sepsis in a real-world setting is
unknown. Previous studies described the impact of antibiotic timing within
an isolated septic shock cohort. A novel electronic health record (EHR)
screening tool, Clinical Vigilance™ for Sepsis, is able to identify the presence
of sepsis and correlate with meaningful patient-centered outcomes. The
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relative to the clinical identification of sepsis using an EHR alert system.
Methods: A retrospective analysis of a prospectively compiled registry of
patient EHR records in a single-center 300-bed community hospital. A
consecutive assessment of all adult patients with suspected infection over
a 3-month period in 2011. A physician order for intravenous antibiotics
was used as a surrogate for the clinical suspicion of systemic infection
(sepsis). The test variable was application of a comprehensive automated
EHR screening tool, CV Alert, to identify high-risk sepsis patients based on
a multifactor alert system including labs, vital signs, and treatment team
documentation. The primary outcome was all cause in-hospital mortality,
and a secondary outcome was hospital length of stay (LOS). Antibiotic
delivery was defined a priori as the time a physician order was placed for
intravenous antibiotics and outcomes were assessed every 12 hours prior
to and subsequent to the CV Alert.
Results: We identified 2,255 consecutive patients with suspected
infection over a 3-month period from a total of 23,717 screened (9.5%).
CV Alert was triggered in 867 of 2,255 (38%). Patients identified by CV
Alert (n = 867) had an increased mortality rate (5.3% vs. 0.6%, P < 0.001)
and increased hospital LOS (5 vs. 2 days, P <0 . 0 0 1 )c o m p a r e dw i t h
patients not triggering an alert (n = 1,388). Patients given antibiotics 0 to
12 hours after the alert had a significantly increased mortality rate (8.9%
vs. 3.3%, P < 0.002) and longer LOS (6 vs. 4 days, P <0 . 0 0 1 )c o m p a r e d
with patients given antibiotics 0 to 24 hours prior to alert.
Conclusion: Among patients with suspected infection, those identified by
the CV Alert had an increased mortality rate and hospital length of stay.
Delayed antibiotics relative to the time of CV Alert were associated with a
progressive increase in mortality rate and hospital LOS. An EHR-based
screening tool applied to a real-time healthcare system could aid in the
early identification of at-risk patients within a sepsis cohort.
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Background: The application in clinical practice of evidence-based
guidelines for the cooperative management of patients with severe sepsis
and septic shock between community hospitals and tertiary referral
hospital is still poor. The purpose of this study was to examine the
outcome of patients with severe sepsis and septic shock admitted to the
ICU after implementation of a cooperative sepsis management protocol.
Methods: From 1 October to 30 November 2009, patients with severe
sepsis and septic shock admitted to the ICU received standard therapy
(control group). From 1 December 2009 through 31 January 2010,
patients with severe sepsis and septic shock (protocol group) were
managed with a cooperative sepsis management protocol. The protocol
included early recognition and the initiation of therapy by enabling
nurses and physicians in community hospitals to mobilize institutional
resources for the treatment of patients with severe sepsis and septic
shock (Figures 1 and 2). Using goal-directed resuscitation protocols, early
intensivist involvement and rapid transfer to the ICU from emergency
department were implemented in tertiary referral hospital.
Results: Sixty-two and 77 patients, respectively, were enrolled in the
control and protocol groups. Rapid transfer of patients with severe sepsis
and septic shock to the ICU from emergency department was observed
in 1/62 (1.5%) of the control group and 45/77 (58.4%) of the protocol
group (difference 56.9%; P = 0.01). The hospital mortality rate was 62.3%
in the control group and 37.7% in the protocol group (P = 0.01). The
protocol group had significant reductions in ICU length of stay, ICU cost
and numbers of organ failure (P = 0.01).
Conclusion: Empowerment of nurses and physicians in a community
hospital to mobilize hospital resources for taking care of patients with
severe sepsis and septic shock and implementation of a cooperative
sepsis management protocol between community hospitals and tertiary
referral hospital was temporally associated with improved outcomes.
Acknowledgements: The authors thank the Phitsanulok Co-operative
Sepsis Management Team.
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Background: In September 2010, 9 months after empowerment of caring
for patients with severe sepsis and septic shock and implementation of a
cooperative sepsis management protocol between community hospitals and
tertiary referral hospital in Phitsanulok, the Phitsanulok Co-operative Sepsis
Management (PCSM) team announced the Saving 500 Lives Campaign. This
campaign aimed to encourage the unity and importance of caring for
patients with severe sepsis and septic shock.
Methods: From October 2010 to September 2011, eight community
hospitals and one tertiary referral hospital in Phitsanulok established and
promoted a set of achievable goals and interventions for patients with
severe sepsis and septic shock (Figure 1). These interventions included:
establishing sepsis team in all hospitals to coordinate and monitor the
achievement goals; using a search out severity (SOS) score and a sepsis
screening tool to help early and more accurate diagnosis; providing early
resuscitation protocol and other measures as indicated by implementing a
checklist for sepsis management (sepsis six bundles, rule of three, early goal-
directed therapy); communication and providing important information
during transportation using a protocol; and early intensivist involvement
and rapid transfer to the ICU from the emergency department using a sepsis
fast-track protocol. Physician and nurse leadership actively engaged in the
data review and shared ideas in every hospital for improvement and closely
tracked progress against those goals and interventions. The mortality rate of
patients with severe sepsis and septic shock was used to measure the
success of the campaign.
Results: The Saving 500 Lives Campaign succeeded in efforts to saved
660 patients from 1,048 patients with severe sepsis and septic shock in
Phitsanulok, Thailand. The total mortality rate was 37% (decreased from
47% in the past year). The group of patients from community hospitals
that can be admitted directly to the ICU from the emergency department
using a sepsis fast-track protocol had the lowest mortality rate (19%).
Conclusion: Setting a numeric goal using the 500 Lives Campaign was
another way to support and empower the cooperation of sepsis care in
Phitsanulok, Thailand.
Acknowledgements: The authors thank the PCSM Team.
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Background: Neonatal sepsis contributes significantly to morbidity and
mortality and encompasses a multisystemic inflammatory response to a
microorganism. A lack of suitable diagnostic biomarkers and delays in
microbe identification (48 to 72 hours) challenge clinical decision-making. C-
reactive protein (CRP) is the current biomarker for sepsis in patients;
however, use of earlier markers such as procalcitonin (PCT) could prove
more effective. This study aims to assess the clinical utility of combining CRP
and PCT for a novel sepsis diagnostic biomarker platform (ASCMicroPlat).
Methods: Blood samples were obtained from 350 infants evaluated for
sepsis at the Coombe Women and Infants University Hospital. Eligible
infants met one or more inclusion criteria: age ≤6 weeks, clinical sepsis
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with alcohol prior to phlebotomy for microbial and biomarker tests. Blood
was collected in clotting activator tubes, and incubated at room
temperature for 1 hour before centrifuging to separate out serum for
later acute-phase protein quantification. For gold-standard tests, an
immunoturbimetric CRP assay was performed using a Beckman analyser
and a chemiluminescent Elecsys BRAHMS PCT immunoassay using a
Cobas e602 analyser.
Results: The mean age of infant evaluation was 2.29 ± 10.37 days. The
average gestational age at birth was 37.04 weeks (4.27), 30% of which
were preterm. Eighteen out of 350 samples (5%) were blood culture
positive. Thirteen samples met the criteria for a laboratory-confirmed
bloodstream infection (LCBSI), the most common organisms being
Escherichia coli (28%) and Streptococcus agalactiae (22%). CRP results (n =
350) ranged from ≤0.1 to 226 mg/l, sepsis-positive (≥5m g / l )C R Pt e s t s
occurred in 69% of LCBSI. PCT quantified samples to date (n =1 0 0 )
Figure 1(abstract P104) Checklist for early recognition patients with severe sepsis and septic shock.
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that suggested sepsis than positive blood culture numbers: 56 out of 350
cases had CRP levels ≥5 mg/l, for PCT 23 out of 100 individuals tested
positive at the cutoff (>0.5 ng/ml) for bacterial infection.
Conclusion: Sepsis diagnosis requires accurate detection biomarkers;
preliminary study findings show that CRP is present in the majority of
bloodstream infections. Furthermore, results using both biomarkers
suggest that blood culture results do not indicate all cases of
true sepsis. Further research will correlate the completed CRP and PCT
gold-standard dataset with that produced by ASCMicroPlat PCR-
based assays to assess the clinical utility of this device for sepsis
diagnostics.
Figure 2(abstract P104) Checklist for treatment and transport for severe sepsis and septic shock.
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GAPDH: is it a reliable housekeeper gene to use in sepsis research?
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Background: Quantitative gene expression data are often normalised to
the expression levels of control genes (that is, housekeeper genes). An
assumption in the use of housekeeper genes is that the expression of the
genes remains constant in the cells/tissues under investigation.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is one of the most
commonly used housekeeping genes used in comparisons of gene
expression data. Recent studies, however, have shown that GAPDH
expression is highly variable in different experimental settings. This study
aimed to characterise GAPDH mRNA expression in severe sepsis, using
whole blood from patients with severe sepsis and healthy controls.
Methods: Patients admitted to the ICU within 24 hours of onset of severe
sepsis were recruited. Healthy controls were also recruited. Exclusion
criteria included patients on immunosuppressants or chemotherapy and
those with a moribund status. Ethical approval (REC W06/Q1107/42) was
obtained. Whole blood (1 ml) was taken from the patients and Quantigene
RNA extraction techniques were used. The Quantigene plex assay was
used in duplicate to determine GAPDH mRNA expression. The assay uses
branched DNA signal amplification to enable the detection and
quantification of multiple RNA targets simultaneously. It has been
Figure 1(abstract P105) Severe sepsis and septic shock strategy in Phitsanulok, Thailand.
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was standardised to housekeeper genes succinate dehydrogenase (SDHA)
and hypoxanthine-guanine phosphoribosyltransferase (HPRT).
Results: Sixty-five patients with severe sepsis were included, of whom 27
died within 28 days. Seventeen control samples were included in the
study. The groups were age and sex matched. In terms of GAPDH mRNA
expression there was no significant difference between survivors and
nonsurvivors. However, with regards to overall GAPDH mRNA expression in
severe sepsis there was a marked increase in patients with severe sepsis.
GAPDH mRNA expression showed a 16-fold mean increase in expression
compared with control samples.
Conclusion: G A P D Hm R N Ae x p r e s s i o ni np a t i e n t sw i t hs e v e r es e p s i s
showed a marked increase compared with controls. These data question the
suitability of GAPDH as a housekeeper gene in gene expression profiling
studies in sepsis. The data also highlight GAPDH as another potential
biomarker of sepsis that requires further evaluation.
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Background: In patients with severe sepsis, previous work has suggested
that cytokine gene expression profiles may have diagnostic/prognostic
potential as biomarkers. Cytokines operate within complex networks; their
predictive value may be improved by the simultaneous measurement of
multiple cytokines. Cytokines are key inflammatory proteins involved in
sepsis. Gene expression profiling has been shown to have a clinical role in
the diagnosis of haematological malignancies. Gene expression profiling
may allow early, aggressive management in patients predicted to fare badly.
This study examined cytokine gene expression profiles in patients with
severe sepsis.
Methods: Patients admitted to the ICU within 24 hours of onset of severe
sepsis were recruited. Healthy controls were also recruited. Exclusion criteria
included patients on immunosuppressants or chemotherapy and those with
a moribund status. Ethical approval (REC W06/Q1107/42) was obtained.
Whole blood (1 ml) was taken from the patients and Quantigene RNA
extraction techniques were used. The following cytokines were measured in
duplicate using the Quantigene plex assay: IL-6, IL-8, IL-10, IL-12p40, IL-
12p35, IL-13, IL-17, MCP-1 and MIF. The assay uses branched DNA signal
amplification to enable the detection and quantification of multiple RNA
targets simultaneously. It has been compared with other techniques
favourably [1]. Cytokine mRNA expression was standardised to housekeeper
genes succinate dehydrogenase (SDHA) and hypoxanthine-guanine
phosphoribosyltransferase (HPRT).
Results: Sixty-five patients with severe sepsis were included, of whom 27
died within 28 days. Seventeen control samples were included in the study.
The groups were age and sex matched. Three cytokines showed marked
upregulation in severe sepsis compared with controls; IL-10 (15-fold), IL-18
(15-fold), IL-15 (twofold). However, IL-6, IL-8, IL-12p40, IL-12p35, IL-13, IL-17,
MCP-1 all showed a greater than twofold downregulation in severe sepsis.
There was no significant difference in profiles between survivors and
nonsurvivors of severe sepsis.
Conclusion: These results show a distinct cytokine gene expression profile
in severe sepsis. This includes the upregulation or downregulation of both
proinflammatory and anti-inflammatory cytokines. Cytokine gene expression
profiling using the Quantigene plex assay is able to demonstrate distinct
profiles in patients with severe sepsis. This has the potential to be
developed into a diagnostic/prognostic tool with larger studies.
Reference
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Background: Heart rate variability (HRV) has been reported to gradually
decrease long before the onset of sepsis [1,2]. Since the development of
systemic inflammatory response syndrome (SIRS) has been included in the
definition of sepsis, we compared temporal changes of HRV depending on
the SIRS state coming after.
Methods: Vital data of patients admitted in ICU were downloaded from
bedside monitoring systems. No specific registration criteria for disease were
defined. Vital signs regarding SIRS evaluation - that is, hear rate, respiration
rate, and core temperature - are recorded every 10 seconds, 0.1 Hz. By
taking the median of 60 data, the SIRS state was determined for each hour,
ignoring the count of white blood cells. The sampling rate of ECG data is
500 Hz, and the HRV for each minute (0.017 Hz) was calculated from that.
Abnormal heartbeats and trends were eliminated using a stochastic model,
and the power spectrum was derived with an autoregressive model [3]. We
considered the integral value within 0.04 to 0.4 Hz as an estimate of HRV.
Temporal linear trends of HRV were quantified as Spearman’s correlation
coefficient. Note that the target period for HRV trend evaluation is
immediately before the SIRS evaluation period. The following software was
used: IBM SPSS version 19, R version 2.15.0, and G*Power Version 3.1.4.
Results: Forty-nine patients were registered, and 34 patients (69.4%)
suffered from sepsis. The average age was 64.3 years, and the average ICU
stay was 31.4 days, ranging from 3 to 113 days. The number of data where a
SIRS state was identified was 21,919, and 56.5% (12,380) were evaluated as
SIRS-positive. Immediately before SIRS-positive states, the mean value of the
correlation coefficients was -0.00234 (SD 0.321). The mean value before SIRS-
negative states was 0.0201 (SD 0.309). The mean difference was 0.0224 (P <
0.05), and the statistical power was 99.9%.
Conclusion: Our analysis shows that the mean trend of the HRV value
immediately before developing SIRS was negative, and the mean trend of
HRV immediately before a non-SIRS state was positive. This result does
support previous results. For sepsis monitoring, however, further
investigation is mandatory. This result only suggests a stronger negative
trend of HRV when developing SIRS for the next period, regardless of the
current state.
Acknowledgements: Supported by the Ministry of Education, Culture,
Sports, Science and Technology Japan as a part of Regional Innovation
Cluster Program (City Area Type) in Southern Gifu Area.
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Page 55 of 58Background: Initially described in endothelial cells from the lung,
endothelial cell specific molecule 1 (ESM-1), also called endocan, is a
circulating proteoglycan of 50 kDa that can be easily quantified in
biological fluids (sera, plasma). This robust macromolecule is upregulated
in the presence of proinflammatory agents and has been described as a
biomarker of endothelial dysfunction in several disease conditions.
Methods: We here compared and analyzed the results obtained from
studies using a sandwich-type ELISA (DIYEK H1, Lunginnov) for evaluating
whether ESM-1 could be useful to predict organ failure in ICU patients
such as septic patients and polytrauma patients (n = 67). Data baseline
characteristics, APACHE II score, procalcitonin (PCT) and C-reactive protein
(CRP) levels and ICU course such as ICU length of stay were also evaluated
for each ICU patient admitted and compared with ESM-1 levels.
Results: In all studies we observed that elevated blood levels of ESM-1
correlated with the severity of sepsis and the poor outcome in patients
with severe sepsis or in septic shocka tI C Ua d m i s s i o n .W ef u r t h e r m o r e
evaluated the presence of ESM-1 and ESM-1 degradation products in the
biological fluids (sera, plasma and urines) from septic patients by ELISA,
immunoprecipitation and western blotting procedures. When compared
with data baseline characteristics, ESM-1 levels were shown to not
correlate with CRP and PCT levels. Interestingly we may suggested from
our analysis that blood ESM-1 >3 ng/ml represents an additional criterion
of severity in a context of SIRS that may be useful in the ICU. At
72 hours, ESM-1 exhibited a clear predictive value for acute lung injury
(sensitivity 85%; specificity 100%) in septic patients. In comparison, lower
levels of serum ESM-1 in polytrauma patients were associated with
development of acute lung injury and reflect respiratory failure.
Conclusion: No circulating molecule was up to now described as an
indicator of respiratory failure in septic patients and in polytrauma
patients. In a context where respiratory failure is still the first cause of
death in sepsis, our study analysis suggests that blood levels of ESM-1
may be a useful early biomarker of lung tissue injury and respiratory
failure in ICU patients.
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Background: The application of molecular profiling methods to a wide
variety of infections suggests that a polymicrobial community is much
more common than suggested by standard clinical culture [1]. Our goal
was to develop methods, using a microbiome approach, to improve
culture and molecular diagnostics for bacterial sepsis.
Methods: Culture and DNA extraction protocols were evaluated using
synthetic bacterial communities inoculated into whole blood. Disruption of
blood cells with a blood cell lysing detergent, with or without hypotonic
osmotic shock, was carried out and evaluated for the ability to recover the
community. Viable bacterial cells were recovered on solid media. Total DNA
was examined by terminal-restriction fragment-length polymorphism
(TRFLP) profiling. Efficiencies of recovery and limits of detection were
determined. The optimized methodology was applied to clinical samples
collected from consented patients in both the ICU and ED from two Calgary
hospitals. Cultured organisms were identified by 16S rRNA gene sequencing.
Molecular profiling was carried out using TRFLP and bacterial tag-encoded
FLX amplicon pyrosequencing (bTEFAP).
Results: Treatment of synthetic community organisms with a 5% wt/vol
detergent added at a 1:1 or 1:5 ratio did not significantly impact their
viability. TRFLP analysis indicated that the DNA from these communities
could be recovered from whole blood following lysis and removal of host
cells. Whole blood samples were analysed from septic patients. In three case
studies we identified two to 16 bacterial species in the primary infection
samples using direct culture and molecular methods. Conventional
diagnostics only reported one organism. Molecular profiling of blood
samples from these patients also identified correlating polymicrobial
communities. Blood cultures for these samples were either negative (two of
three cases) or monomicrobial (one of three cases), thereby underestimating
the diversity seen with the TRFLP and bTEFAP analysis. These methods have
been applied to 88 adult ICU blood samples, 20 primary infection samples,
36 adult ED samples, and seven pediatric ED samples with analysis ongoing.
Conclusion: We have successfully developed a novel method to analyse
whole blood in order to characterize the microbiome of sepsis infections.
Preliminary results indicate that sepsis infections are polymicrobial in
nature.
Acknowledgements: All samples were collected in collaboration with the
Alberta Sepsis Network through the Critical Care Epidemiologic and
Biologic Tissue Resource.
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Background: Perinatal sepsis is the leading problem for morbidity and
lethality of children under 1 year old. Antibacterial therapy from the very
first hours of decease development plays an important role in the
treatment of perinatal sepsis. To determine the adequacy of antibacterial
therapy of perinatal sepsis during 18 years we examined the etiology of
perinatal sepsis in two groups of newborns with surgical pathology.
Methods: There were 114 newborns in the first group, from 1992 to
2007. We determined the antibodies in blood to pathogenic microflora
extracted from joint bursas and in 52 newborns - extracted from the
abdominal cavity with peritonitis. These investigations were made using
the agglutination reaction to staphylococci as well as the latex-based test
for streptococci. The antibiotics were prescribed according to the results
of the investigations. In the second group from 2005 to 2010, we
undertook microbiological investigations of pathological material from
lesion foci in 43 newborns with surgical sepsis. These investigations are
devoted to the study of susceptibility and resistance of pathogenic
microflora to antibiotics.
Results: In the first group of infants, according to the data of serological
investigations in the blood of newborns with bone and joint sepsis, we
determined the antibodies to staphylococci in 80.3% cases, in 45.4% to
staphylococci and streptococci, in 54% cases in newborns with peritonitis
we determined the antibodies to Pseudomonas aerogenes, in 60.8% cases
to Enterobacter spp. and in 62.5% to Staphylococcus epidermidis.I n
newborns of this group the bacterial flora were 70% and fungal in 30%.
Our investigations determined the susceptibility to the limited range of
antibacterial and antifungal medicines. In the second group we selected
two subgroups of infants: one with sepsis as a complication of surgical
deceases, and the second with bone and joint sepsis. In the first
subgroup the bacterial microflora was detected in 94.7% of examined
newborns and represented in 52.6% as microbial associations. In the
second subgroup of newborns the bacterial flora was detected in 37.5%
of cases, in the rest of the cases the flora consisted of fungi and
protozoa. The analysis of susceptibility to pathogenic microflora showed
that two of seven cultures of staphylococcus were methicillin-resistant
Staphylococcus aureus, in five of eight cultures of staphylococcus they
were resistant to four to 10 antibiotics, and the highest resistance to the
antibiotics was detected in P. aerogenes (in nine of 18 cultures).
Conclusion: Microbiological and serological diagnostics are a compulsory
condition of adequate anti-inflammatory therapy for perinatal sepsis.
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Page 56 of 58Background: The investigations of A Fedorovska and L Nazarchuk (1995
to 2000) showed the necessity to introduce specific antigens of G class
for the treatment of sepsis in immunodeficiency patients. We refer
newborns to such patients. Effective treatment of sepsis in newborns and
children of a young age group is impossible without evaluation of
immunocompetent systems.
Methods: We successfully used intravenous normal human immuno-
globulin Bioven mono when extracting anti-staphylococcus, anti-proteus
and anti-pseudomonas antibodies in 150 newborns with postoperative
and bone and joint sepsis. This immunoglobulin has international
certification. During the last 10 years the main problem for treatment of
postoperative sepsis in newborns is the treatment of pseudomonade
infection. Regarding that traditional preparations have an insignificant
titer of anti-pseudomonade antibodies, we used new anti-pseudomonade
immunoglobulin received from specific plasma for 37 newborns and
children under 1 year old. There were 20 patients having sepsis with
esophageal atresia, two patients with angiocardiogenic sepsis, five with
laryngotracheostenosis, five with bone and joint sepsis, and five after
polytrauma with injury of pelvis bones and urinary bladder. In these
37 patients we used a new method for introduction of immunoglobulin
in combination with fresh frozen plasma (patented).
Results: Use of Bioven in combination with antibacterial therapy allowed
treatment of up to 90% of infants with severe sepsis. The use of new
anti-pseudomonade immunoglobulin allowed recovery of the
susceptibility of pathogenic flora to antibiotics after triple introduction of
specific immunoglobulin, to raise phagocytal response and thus to gain
positive results in 35 patients.
Conclusion: The experience of immune system correction in newborns
with postoperative and bone and joint sepsis allow one to consider this
method a leading one in clinic practice. The use of specific immune
preparations increases complementary activity of blood and antibiotic
susceptibility of pathogenic microflora.
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Background: Sepsis is a condition that has been known since 2,700 years
ago, but it is still a serious threat for human health [1]. Sepsis is a serious
public health problem [2]. It is a complex process that can affect any
individual and can originate fromm u l t i p l es i t e sa n db ec a u s e db y
multiple microorganisms [3].
Methods: We conducted a retrospective, observational study at
University Hospital Center, Tirana, involving 535 critically ill patients
diagnosed with sepsis admitted to the Department of Infection Diseases
from January 2006 to December 2011. Blood cultures were performed on
the admission day.
Results: During the study period there were 535 patients with sepsis
admitted to our hospital. From these, 288 (53.83%) were males and 247
(46.16%) were females. In the ICU, 103 cases (19.25%) with diagnosis of
sepsis or severe sepsis were admitted. The urinary tract was the
predominant site of infections in 39.81% of cases, followed by the lungs
in 34.95% of cases, intra-abdominal infection (not postoperative) in 15.7%
of cases, soft tissues in 2.24% of cases and with unknown origin in 7.28%
of cases. Organ failure (severe sepsis or multiorgan dysfunctions) was
found in 37.9% of patients. Blood culture results were positive in 23% of
the patients. See Table 1.
Conclusion: Our study shows a progressive increase in the incidence of
sepsis mostly in the last years. This could be explained by the possibility
of increasing cases with sepsis or the doctors being affiliated with sepsis
terminology. Urinary tract infection was the leading cause of sepsis. These
data could be explained because our hospital is not the only center for
treatment of sepsis and in our country we have another hospital for the
treatment of lung diseases. The low value of positive culture results could
be explained by our health system problems, using antibiotics much
more than needed or antibiotic therapy being started before admission
to our hospital. However, we propose that a developing country like
Albania needs to develop a national center for sepsis.
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Background: Based on a sepsis consensus conference in 1992 and after
that in 2001, sepsis is defined as a syndrome by the presence of both
infection and a systemic inflammatory response (SIRS). SIRS is considered
to be present when patients have more than one of the following clinical
findings: body temperature >38°C or <36°C; heart rate >90/minute;
hyperventilation evidenced by a respiratory rate >20/minute or PaCO2
<32 mmHg; and white blood cell count >12,000 cells/μlo r< 4 , 0 0 0 / μl[ 1 ] .
On the other hand visceral leishmaniasis (VL), or kala-azar, is a parasitic
disease that consists of a protracted course of fever, pallor, wasting,
hepatosplenomegaly and pancytopenia [2,3]. The aim of our study is to
start a discussion about VL and sepsis.
Methods: From 45 adults patients diagnosed with VL between January
2005 and December 2009 in the Service of Infectious Diseases, University
Hospital Centre of Tirana, Albania, we have selected 36 patients who
presented with fever >38°C and leucopenia <4,000/μl. The diagnosis of
VL was based on demonstration of leishmania parasites in bone marrow
smears.
Results: From 36 patients 58.3% were males and 41.6 were females.
Age ranged from 17 to 69 years, the average age was 43.2 years. Main
clinical and laboratory findings were: fever in 100%, malaise in 100%,
hepatosplenomegaly in 100%, anemia in 82%, leucopenia in 100%,
thrombocytopenia in 50%, and increased liver enzymes in 52.7% of
cases. Bone marrow aspirate was performed in all cases with
amastigotes identified in 100% of the cases. Meglumine antimoniate
was used in all cases as an initial treatment. Treatment failure occurred
in two cases (5.5%) that were treated subsequently with liposomal
amphotericin B. The case fatality was 5.5%. The main causes of death
were liver and cardiac failure.
Table 1(abstract P114) Distribution of cases with sepsis in department of infection diseases during 2006 to 2010
2006 2007 2008 2009 2010 2011 Total
Cases 59 57 63 76 122 158 535
Males 34 35 27 41 69 82 288
Females 25 22 36 35 53 76 247
Mean age 44.28 47.59 44.46 40.56 48.88 49.92 45.94
Standard deviation 18.98 18.96 19.18 18.77 20.03 19.34 19.21
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Page 57 of 58Conclusion: Based on the clinical and laboratory findings VL could be
considered a systemic inflammatory response. Maybe in this disease we
have not evaluated an inflammatory test like C-reactive protein or
procalcitonin to be convicted if higher than the normal value, but we think
we need to start a study about markers of sepsis in this systemic parasitic
disease, because our opinion is that VL is a SIRS plus parasitic systemic
infection - which does mean sepsis. In malaria, PCT levels are elevated in
both severe and uncomplicated Plasmodium falciparum malaria, but how
useful is this inflammatory test in VL [4]?
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Background: Sepsis is a systemic response to infection by microbial
organisms [1]. However, differentiating sepsis from non-infectious triggers of
the systemic inflammatory response syndrome (SIRS) is difficult. One
promising marker is procalcitonin (PCT), whose concentration has been
found to be elevated in sepsis [1-3]. The traditional clinical signs and the
routine laboratory tests for sepsis, such as C-reactive protein (CRP) or
leukocyte count, lack diagnostic accuracy and are sometimes misleading [1].
The use of biomarkers provides a novel, complementary approach to
diagnose infection. In most infections, a true gold standard for diagnosis
does not exist, thus the measurement of biomarkers, specifically the
hormokine PCT in a clearly defined setting, has been shown to significantly
improve the diagnostic certainty [3]. The aim of the study was to assess the
value of white blood cell count (WBC), CRP, and PCT for the diagnosis of
SIRS and sepsis. In Albania, PCT has been used as a serum marker for
bacterial sepsis since May 2010.
Methods: We evaluated WBC, CRP, and PCT in 143 adult patients presented
to the Service of Infection Diseases, University Hospital Center ‘Mother
Teresa’ and the American Hospital, Tirana, Albania. We used the Elycsys
BRAHMS PCT test Electro Chemiluminescent Immunoassay (ECLIA) for the
determination of PCT. We evaluated those parameters in three subgroups:
59 patients with sepsis, 64 patients with SIRS, and 20 patients as a control
group. The cutoff of PCT for sepsis positivity was ≥2 ng/ml. Blood cultures
were performed on the admission day or on the day of fever onset for the
hospitalized patients.
Results: In the sepsis subgroup the mean ± SD age was 53.4 ± 22.8 years.
Average values of PCT, PCR and WBC were respectively 17.8 ng/ml, 37.3
ng/l and 13.7 × 10
3 cells/mm
3. We excluded a case with septic shock with
PCT value 761 ng/l. In SIRS subgroups the mean age was 46.5 ± 18.3 years
and the average value of PCR and WBC were 21.3 ng/l and 11.6 × 10
3
cells/mm
3,b u tP C Tw a s≤2 ng/ml. In the control group the mean age was
44.3 ± 25.24 years, and WBC, PCR and PCT were in normal values
(respectively 3.5 to 10 × 10
3 cells/mm
3, 0 to 5 ng/l and 0.5 to 2 ng/ml).
Blood culture resulted positive in 40.6% of patients with sepsis.
Conclusion: The serum concentration of PCT is specifically elevated in
patients with sepsis. However, the evidence of PCT in infectious diseases
is limited. The diagnostic model based on the laboratory parameters,
using the combined predictors of PCT, CRP and WBC, can be a useful
means for predicting early onset of sepsis.
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Introduction: Sepsis is a leading cause of death in the ICU. It is
characterized by a systemic inflammatory response following bacterial
infection. Inflammatory dysregulation affects multiple organs through effects
on endothelial, epithelial and immune cells, which can lead to irreversible
damage and death of the host. Although exacerbated inflammation plays a
pivotal role in sepsis evolution, anti-inflammatory drugs fail to treat this
disease. In addition, anti-inflammatory therapy may inhibit clearance of
infection or favor secondary infections. Therefore, it is of interest to resolve
excessive inflammation without compromising host defense mechanisms. In
accordance, it has been shown that treatment with LXA4, a endogenous
anti-inflammatory agent with pro-resolution activity, increased survival in
experimental sepsis by reducing systemic inflammation as well as bacterial
spread. We therefore aimed to evaluate the role of a nonspecific LXA4
receptor, ALXR, in host response to sepsis induction by cecal ligation and
puncture in mice (CLP).
Methods: To assess the role of ALXR in the CLP model we used WT (C57BL/
6) mice treated or not with an ALXR antagonist, BOC-1 (2 mg/kg, i.v.),
30 minutes before sepsis induction. Then, 6 hours after mild and severe
sepsis induction, we evaluated the pulmonary damage, bacterial spread,
neutrophil recruitment and the levels of cytokines, chemokines in the lung,
peritoneal exudate and plasma.
Results: Animals submitted to mild and severe sepsis induction and
treated with BOC-1 presented decreased neutrophil migration, larger
bacterial loads in peritoneal exudate, and heightened lung damage when
compared with untreated control animals. Interestingly, ALXR blockade
did not alter levels of cytokines and chemokines such as IL-6, IL-1b, TNFa
and KC in all evaluated tissues.
Conclusion: Animals treated with the antagonist of ALXR receptor
demonstrated a worse outcome after sepsis induction when compared
with animals that received vehicle. These data suggest that the
membrane receptor ALXR plays a protective role during response to
sepsis induced by CLP.
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